Sentence,class,file
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/17/30/jpts-28-3122.PMC5140812.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/2b/9b/jpts-28-3125.PMC5140813.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e9/65/jpts-28-3131.PMC5140814.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/27/6b/jpts-28-3136.PMC5140815.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b9/48/jpts-28-3140.PMC5140816.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/fc/0d/jpts-28-3145.PMC5140817.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/af/76/jpts-28-3149.PMC5140818.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/2d/c0/jpts-28-3153.PMC5140819.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/62/e6/jpts-28-3158.PMC5140820.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e8/5f/jpts-28-3162.PMC5140821.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c0/d8/jpts-28-3165.PMC5140822.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/89/0a/jpts-28-3168.PMC5140823.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a1/45/jpts-28-3173.PMC5140824.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/jpts-28-3178.PMC5140825.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/47/c2/jpts-28-3183.PMC5140826.pdf
"https://locomo-joa.jp/en/index.pdf (Accessed Dec. 11, 2015) 14) Katoh M, Isozaki K: Reliability of isometric knee extension muscle strength measurements of healthy elderly subjects made with a hand-held dynamometer and a belt.",Non-OADS,/arxiv_data1/oa_pdf/47/c2/jpts-28-3183.PMC5140826.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/09/a5/jpts-28-3189.PMC5140827.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b8/3e/jpts-28-3197.PMC5140828.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e2/5a/jpts-28-3200.PMC5140829.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8a/b2/jpts-28-3205.PMC5140830.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/75/06/jpts-28-3209.PMC5140831.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/21/49/jpts-28-3213.PMC5140832.pdf
http://www1.mhlw.go.jp/topics/kenko21_11/b2.html (Accessed Jun.,Non-OADS,/arxiv_data1/oa_pdf/21/49/jpts-28-3213.PMC5140832.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c9/e5/jpts-28-3220.PMC5140833.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Review Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6d/1a/jpts-28-3227.PMC5140834.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case	Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/99/99/jpts-28-3232.PMC5140835.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/7c/ca/jpts-28-3236.PMC5140836.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case	Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/16/ec/jpts-28-3241.PMC5140837.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/50/2c/jpts-28-3243.PMC5140838.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case	Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/60/26/jpts-28-3249.PMC5140839.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c3/f3/jpts-28-3252.PMC5140840.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/jpts-28-3257.PMC5140841.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case	Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/3b/dc/jpts-28-3259.PMC5140842.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/19/c3/jpts-28-3261.PMC5140843.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e3/22/jpts-28-3264.PMC5140844.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2a/f6/1349-7235-55-3075.PMC5140851.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/2a/f6/1349-7235-55-3075.PMC5140851.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/14/71/1349-7235-55-3077.PMC5140852.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/14/71/1349-7235-55-3077.PMC5140852.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/98/f6/1349-7235-55-3079.PMC5140853.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/98/f6/1349-7235-55-3079.PMC5140853.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/bb/de/1349-7235-55-3085.PMC5140854.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/bb/de/1349-7235-55-3085.PMC5140854.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/04/b1/1349-7235-55-3091.PMC5140855.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/04/b1/1349-7235-55-3091.PMC5140855.pdf
"Materials and Methods Search strategy A search of the medical literature was conducted using the MEDLINE (PubMed), EMBASE, The Cochrane Libraryand the Clinical Trials Registry (http://clinicaltrials.gov/) da-tabases from inception until October 2014 to identify ran-domized controlled trials and cohort studies that assessedthe association between the GFR and mortality.",OADS,/arxiv_data1/oa_pdf/52/a9/1349-7235-55-3097.PMC5140856.pdf
"Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 42.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta- analysis detected by a simple, graphical test.",Non-OADS,/arxiv_data1/oa_pdf/52/a9/1349-7235-55-3097.PMC5140856.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/52/a9/1349-7235-55-3097.PMC5140856.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/52/a9/1349-7235-55-3097.PMC5140856.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/17/d1/1349-7235-55-3105.PMC5140857.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/17/d1/1349-7235-55-3105.PMC5140857.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/df/da/1349-7235-55-3113.PMC5140858.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/df/da/1349-7235-55-3113.PMC5140858.pdf
Available from: http://www.jsmo.or.jp/ (inJapanese).,Non-OADS,/arxiv_data1/oa_pdf/95/a7/1349-7235-55-3119.PMC5140859.pdf
Availablefrom: http://www.mhlw.go.jp/topics/2006/02/tp0201-2.html (inJapanese).,Non-OADS,/arxiv_data1/oa_pdf/95/a7/1349-7235-55-3119.PMC5140859.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/95/a7/1349-7235-55-3119.PMC5140859.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/95/a7/1349-7235-55-3119.PMC5140859.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/19/d9/1349-7235-55-3125.PMC5140860.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/19/d9/1349-7235-55-3125.PMC5140860.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2d/75/1349-7235-55-3131.PMC5140861.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/2d/75/1349-7235-55-3131.PMC5140861.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a1/02/1349-7235-55-3137.PMC5140862.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a1/02/1349-7235-55-3137.PMC5140862.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7f/d5/1349-7235-55-3143.PMC5140863.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/7f/d5/1349-7235-55-3143.PMC5140863.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/70/a8/1349-7235-55-3147.PMC5140864.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/70/a8/1349-7235-55-3147.PMC5140864.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/42/31/1349-7235-55-3151.PMC5140865.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/42/31/1349-7235-55-3151.PMC5140865.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/71/40/1349-7235-55-3155.PMC5140866.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/71/40/1349-7235-55-3155.PMC5140866.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/29/d3/1349-7235-55-3161.PMC5140867.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/29/d3/1349-7235-55-3161.PMC5140867.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/47/f3/1349-7235-55-3165.PMC5140868.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/47/f3/1349-7235-55-3165.PMC5140868.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/21/e3/1349-7235-55-3169.PMC5140869.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/21/e3/1349-7235-55-3169.PMC5140869.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a1/d0/1349-7235-55-3175.PMC5140870.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a1/d0/1349-7235-55-3175.PMC5140870.pdf
Available from: http://www.info.pmda.go.jp/fsearchnew/jsp/menu_fukusayou_base.jsp The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.,Non-OADS,/arxiv_data1/oa_pdf/44/13/1349-7235-55-3181.PMC5140871.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/44/13/1349-7235-55-3181.PMC5140871.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/44/13/1349-7235-55-3181.PMC5140871.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/eb/bd/1349-7235-55-3185.PMC5140872.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/eb/bd/1349-7235-55-3185.PMC5140872.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/11/2f/1349-7235-55-3191.PMC5140873.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/11/2f/1349-7235-55-3191.PMC5140873.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1e/4c/1349-7235-55-3197.PMC5140874.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/1e/4c/1349-7235-55-3197.PMC5140874.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1b/5d/1349-7235-55-3201.PMC5140875.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/1b/5d/1349-7235-55-3201.PMC5140875.pdf
Available from: http://www.who.int/tb/publications/global_report/en/ 2.Tuberculosis Surveillance Cente r. Tuberculosis annual report 2012: (1) Summary of tuberculosis notification statistics and foreign-born tuberculosis patients.,Non-OADS,/arxiv_data1/oa_pdf/6a/64/1349-7235-55-3205.PMC5140876.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6a/64/1349-7235-55-3205.PMC5140876.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6a/64/1349-7235-55-3205.PMC5140876.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a9/25/1349-7235-55-3211.PMC5140877.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a9/25/1349-7235-55-3211.PMC5140877.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b7/03/1349-7235-55-3215.PMC5140878.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/b7/03/1349-7235-55-3215.PMC5140878.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/29/32/1349-7235-55-3219.PMC5140879.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/29/32/1349-7235-55-3219.PMC5140879.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/63/82/1349-7235-55-3221.PMC5140880.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/63/82/1349-7235-55-3221.PMC5140880.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f4/f0/1349-7235-55-3225.PMC5140881.pdf
"Department of Gastroenterology, Otaru City General Hospital, Japan Received for publication December 21, 2015; Accepted for publication March 13, 2016Correspondence to Dr. Tomoya Iida, tomoya.iida.0306@gmail.com⡥2016 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/f4/f0/1349-7235-55-3225.PMC5140881.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/62/9e/1349-7235-55-3227.PMC5140882.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/62/9e/1349-7235-55-3227.PMC5140882.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/26/03/1349-7235-55-3229.PMC5140883.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/26/03/1349-7235-55-3229.PMC5140883.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/82/52/1349-7235-55-3231.PMC5140884.pdf
"Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Japan Received for publication January 29, 2016; Accepted for publication March 4, 2016Correspondence to Dr. Naoki Yanagisawa, naokiy-97@umin.ac.jp⡥2016 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/82/52/1349-7235-55-3231.PMC5140884.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/3a/f5/1349-7235-55-3233.PMC5140885.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/3a/f5/1349-7235-55-3233.PMC5140885.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/   © The Author(s) 2016 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/2b/a9/srep35896.PMC5141294.pdf
"Methods A total of 185 patients underwent ESD for gastric neo - plasms at Tsuchiura Kyodo General Hospital between Janu -J Rural Med 2016; 11(2): 41–45 ©2016 The Japanese Association of Rural MedicineReceived: March 28, 2016 Accepted: June 27, 2016Correspondence: Takashi Ichida, Department of Gastroenterology,  Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura, Ibaraki  300-0028, JapanE-mail: taka_taka_0621@yahoo.co.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/c6/65/jrm-11-041.PMC5141375.pdf
"In addition, agricultural production is failing because of in - adequate rainfall and the high cost and uneven availability of agricultural inputs (such as seed, fertilizer, farm tools, J Rural Med 2016; 11(2): 47–57 ©2016 The Japanese Association of Rural MedicineReceived: August 2, 2016 Accepted: September 16, 2016Correspondence: Keiko Nakamura, Department of Global Health En- trepreneurship, Division of Public Health, Graduate School of Tokyo  Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, JapanE-mail: nakamura.ith@tmd.ac.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from: https://www.humanitarianre - sponse.info/en/operations/yemen/document/yemen-humani-tarian-needs-overview-2016-english.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Avail - able from: http://www.unicef.org/appeals/files/UNICEF_Ye-men_Humanitarian_SitRep_9_Feb_2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from:  https://www.odi.org/sites/odi.org.uk/files/odi-assets/publica - tions-opinion-files/10333.pdf.,OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from: http://www.ilo.org/ipec/Infor - mationresources/WCMS_IPEC_PUB_27702/lang--en/index.htm.,OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from:  http://mics.unicef.org/tools?round=mics4.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from: http://www.worldbank.org/en/country/yemen.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from: http://data.world - bank.org/indicator/NY .GDP.PCAP.CD/countries/YE-XQ- XN?display=graph.,OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available  from: https://www.wfp.org/content/yemen-comprehensive- food-security-survey-november-2014.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from: http://www.unicef.org/about/annualreport/files/Yemen_COAR_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Avail - able from: http://www.who.int/childgrowth/software/en/.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from:  http://www.who.int/childgrowth/standards/technical_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
Available from:  http://www.unicef.org/media/files/CHILD_ALERT_YE-MEN-UNICEF_AUG_2015_ENG_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/78/a2/jrm-11-047.PMC5141376.pdf
"A.  Aichi Anjo Kosei Hospital, 28 Higashihirokute, Anjo-cho, Anjo 446- 8602, JapanE-mail: hiko2546@kosei.anjo.aichi.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/ba/10/jrm-11-059.PMC5141377.pdf
AUA guideline (2013) https://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm.,Non-OADS,/arxiv_data1/oa_pdf/ba/10/jrm-11-059.PMC5141377.pdf
EAU guideline (2014) http://uroweb.org/wp-content/uploads/1607-Prostate Cancer.,Non-OADS,/arxiv_data1/oa_pdf/ba/10/jrm-11-059.PMC5141377.pdf
"Complete blood J Rural Med 2016; 11(2): 63–68 ©2016 The Japanese Association of Rural MedicineReceived: February 3, 2016 Accepted: May 6, 2016Correspondence: Takashi Kurumiya, Department of Surgery, Kuwana  East Medical Center, 3-11 Kotobuki-cho, Kuwana city, Mie 511-0061,  JapanE-mail: kuru1@mac.com This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/3c/1d/jrm-11-063.PMC5141378.pdf
"Materials and Methods NOACs were administered to 313 patients (dabigatran:  173, rivaroxaban: 140) at our institute between 2011 and July J Rural Med 2016; 11(2): 69–72 ©2016 The Japanese Association of Rural MedicineReceived: August 3, 2015 Accepted: May 27, 2016Correspondence: Akira Tempaku, Department of Neurosurgery, Hoku- to Hospital, 7-5 Inadacho-Kisen, Obihiro, Hokkaido 080-0833, Japan E-mail: tenpaku@hokuto7.or.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/1e/8b/jrm-11-069.PMC5141379.pdf
"Anisakiasis has four  major clinical forms: gastric anisakiasis with epigastralgia, nausea, and vomiting, which is abrupt in onset and gener - ally occurs 1–12 h after ingestion of raw seafood infested by Anisakis  larvae; intestinal anisakiasis, which presents with  intermittent or constant abdominal pain 5–7 days after in - gesting food infested with Anisakis  larvae and sometimes  with ascites or peritoneal signs; ectopic or extra-gastrointes - tinal anisakiasis, caused by Anisakis  larva penetrating the  stomach or intestine; and allergic reactions, presenting as J Rural Med 2016; 11(2): 73–75 ©2016 The Japanese Association of Rural MedicineReceived: July 8, 2016 Accepted: October 19, 2016Correspondence: Mamiko Tsukui, Department of Medicine, Division  of Gastroenterology, Jichi Medical University, 3311-1 Yakushiji, Shi- motsuke, Tochigi Prefecture 329-0498, JapanE-mail: tsukui@jichi.ac.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/af/52/jrm-11-073.PMC5141380.pdf
"In addition to gender, the questionnaire contained J Rural Med 2016; 11(2): 77–80 ©2016 The Japanese Association of Rural MedicineReceived: March 3, 2016 Accepted: April 5, 2016Correspondence: Hiroki Ohmi, Department of Nutritional Sciences,  Faculty of Health and Welfare Science, Nayoro City University, W4- N8 Nayoro, Hokkaido 096-8641, JapanE-mail: hiohmi@nayoro.ac.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/ab/00/jrm-11-077.PMC5141381.pdf
http://kokuhoken.net/jstmj/ general/ [accessed: February 2016].,OADS,/arxiv_data1/oa_pdf/ab/00/jrm-11-077.PMC5141381.pdf
Allelic frequency Co-segregation with cancer Co-occurrence with a  pathogenic mutation Loss-of-heterozygosity  in tumour tissue Tumour pathologyMutation databases BIC (research.nhgri.nih.gov/bic/) UMD-BE (www.umd.be) DMuDB (www.dmudb.net) HGMD (www.hgmd.org) LOVD (http://www.lovd.nl/3.0/home) LOVD-IARC (http://brca.iarc.fr/ LOVD/home.php) Figure 4 VUS classi ﬁcation for BRCA : a complex task involving many elements.,OADS,/arxiv_data1/oa_pdf/fd/c5/ejhg201694a.PMC5141576.pdf
Available at : http://www.molecularecologist.com/next-gen- ﬁeldguide-2014/.,Non-OADS,/arxiv_data1/oa_pdf/fd/c5/ejhg201694a.PMC5141576.pdf
Available at: http://www.humanvario- meproject.org/brca-challenge.html.,Non-OADS,/arxiv_data1/oa_pdf/fd/c5/ejhg201694a.PMC5141576.pdf
October 2015; Available at https://www.england.nhs.uk/commissioning/wp- content/uploads/sites/12/2015/10/e01pb-brca-ovarian-canceroct15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/91/ejhg201695a.PMC5141577.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016Finding all BRCA mutation carriers N Hoogerbrugge and MCJ Jongmans S26 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/7d/91/ejhg201695a.PMC5141577.pdf
Available from: https://www.en.wikipedia.org/wiki/Holisticdentistry.,Non-OADS,/arxiv_data1/oa_pdf/41/76/CCD-7-423.PMC5141651.pdf
Available from: http://www.orasurgery.com/ecofriendly/want ‑is‑eco-friendly.php.,Non-OADS,/arxiv_data1/oa_pdf/41/76/CCD-7-423.PMC5141651.pdf
Available from: https://www.childwelfare.gov/pubpdfs/long_term_ consequences.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/e5/CCD-7-426.PMC5141652.pdf
"[15] Statistical analysis Data analysis was done using Windows PC based software  “MedCalc Statistical Software” version 13.3.1 (MedCalc  Software bvba, Ostend, Belgium; http://www.medcalc.org;  2014).",OADS,/arxiv_data1/oa_pdf/55/91/CCD-7-487.PMC5141663.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/1a/nsw102.PMC5141954.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/27/nsw103.PMC5141955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/c4/nsw110.PMC5141961.pdf
"For Permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/93/nsw115.PMC5141965.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
"Additionally, a list of house-keeping genes (HKGs) was obtained (http://www.wikicell.",Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
"All differential peak sets, signal tracks and genome-wide coverage tracks can be displayed using following UCSC genome browser trackhubs: http://goo.gl/5WI5w3 (FoxA1); http://goo.gl/HyfooK (H3K36me3); http://goo.gl/5uYXsn (H3K27ac).",OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
"( D) An example of a region, highlighting the difference between the different tools in terms of length of DR. A colour version of this ﬁgure is available online at BIB online: https://academic.oup.com/bib.Comparison of tools for differential ChIP-seq analysis |957",Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
A colour version of this ﬁgure is available online at BIB online: https://academic.oup.com/bib.958 | Steinhauser et al.,Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
A colour version of this ﬁgure is available online at BIB online: https://academic.oup.com/bib.Comparison of tools for differential ChIP-seq analysis |959,Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
A colour version of this ﬁgure is available online at BIB online: https://academic.oup.com/bib.Comparison of tools for differential ChIP-seq analysis |961,Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
A col- our version of this ﬁgure is available online at BIB online: https://academic.oup.com/bib.962 | Steinhauser et al.,Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
A colour version of this ﬁgure is available online at BIB online: https://academic.oup.com/bib.Comparison of tools for differential ChIP-seq analysis |963,Non-OADS,/arxiv_data1/oa_pdf/68/b0/bbv110.PMC5142015.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/jiw468.PMC5142090.pdf
Single-nucleotide polymorphism (SNP) multiple se-quence alignments were generated using Prephix and Phreconscripts (available at: https://github.com/codinghedgehog ).,OADS,/arxiv_data1/oa_pdf/56/d5/jiw468.PMC5142090.pdf
3.ftp://ftp.cdc.gov/pub/infectious_diseases/biotech/tsemm/ .,OADS,/arxiv_data1/oa_pdf/56/d5/jiw468.PMC5142090.pdf
21.http://www.cdc.gov/streplab/protocol-emm-type.html .,OADS,/arxiv_data1/oa_pdf/56/d5/jiw468.PMC5142090.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/43/jiw478.PMC5142092.pdf
"Cumulative number of con ﬁrmed human cases for avian in ﬂuenza A(H5N1) reported to WHO, 2003-2016. http://www.who.int/ inﬂuenza/human_animal_interface/EN_GIP_20150623cumulativeNumberH5N1 cases.pdf?ua=1 .",Non-OADS,/arxiv_data1/oa_pdf/ea/43/jiw478.PMC5142092.pdf
2014 .http://www.nih.go.jp/niid/images/lab-manual/in ﬂuenza2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/43/jiw478.PMC5142092.pdf
2003 .http://www.nih.go.jp/niid/images/lab-manual/ avian_in ﬂuenza_2003.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/43/jiw478.PMC5142092.pdf
2014 .http://www.fao.org/docrep/019/i3610e/i3610e.,Non-OADS,/arxiv_data1/oa_pdf/ea/43/jiw478.PMC5142092.pdf
"Geneva: WHO, August 2007 .http://www.who.int/csr/disease/avian_ inﬂuenza/guidelines/labtests/en/index.html .",Non-OADS,/arxiv_data1/oa_pdf/ea/43/jiw478.PMC5142092.pdf
http://dx.doi.org/10.1016/j.idcr.2016.10.009 2214-2509/ ã  2016  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/09/11/main.PMC5142102.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  106 –108 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/09/11/main.PMC5142102.pdf
"Intern  Med 2014;53:2543 –6,  doi:http://dx.doi.org/10.2169/internalmedicine.53.2247 .",Non-OADS,/arxiv_data1/oa_pdf/09/11/main.PMC5142102.pdf
http://dx.doi.org/10.1016/j.idcr.2016.10.002 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/66/7a/main.PMC5142103.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  109 –111 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/66/7a/main.PMC5142103.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/93/main.PMC5142260.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.06.001 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/9c/93/main.PMC5142260.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 259 e262,Non-OADS,/arxiv_data1/oa_pdf/9c/93/main.PMC5142260.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/18/main.PMC5142261.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.08.005 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/03/18/main.PMC5142261.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 237 e244,Non-OADS,/arxiv_data1/oa_pdf/03/18/main.PMC5142261.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/38/main.PMC5142262.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.05.003 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/7b/38/main.PMC5142262.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 252 e254,Non-OADS,/arxiv_data1/oa_pdf/7b/38/main.PMC5142262.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/ef/main.PMC5142263.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.09.002 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/27/ef/main.PMC5142263.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 233 e236,Non-OADS,/arxiv_data1/oa_pdf/27/ef/main.PMC5142263.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/c9/main.PMC5142264.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.09.001 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/24/c9/main.PMC5142264.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 197 e203,Non-OADS,/arxiv_data1/oa_pdf/24/c9/main.PMC5142264.pdf
"Recently, an anti- human Gd-IgA1 rat IgG monoclonal antibody (KM55) has beennewly released by IBL-Japan in 2016 ( http://www.ibl-japan.co.",Non-OADS,/arxiv_data1/oa_pdf/24/c9/main.PMC5142264.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/7c/main.PMC5142266.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.07.004 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/bb/7c/main.PMC5142266.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 219 e228,Non-OADS,/arxiv_data1/oa_pdf/bb/7c/main.PMC5142266.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.krcp.2016.07.004 .,OADS,/arxiv_data1/oa_pdf/bb/7c/main.PMC5142266.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/d0/main.PMC5142267.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.07.005 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/ec/d0/main.PMC5142267.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 229 e232,Non-OADS,/arxiv_data1/oa_pdf/ec/d0/main.PMC5142267.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/55/main.PMC5142291.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.08.002 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/b8/55/main.PMC5142291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 245 e251,Non-OADS,/arxiv_data1/oa_pdf/b8/55/main.PMC5142291.pdf
"Available at: https://www.usrds.org/atlas13.aspx [Date accessed: 02 August 2015] [3]Kim H, Kim KH, Park K, Kang SW, Yoo TH, Ahn SV, Ahn HS, Hann HJ, Lee S, Ryu JH, Kim SJ, Kang DH, Choi KB, Ryu DR: A population-based approach indicates an overall higher patient mortality withperitoneal dialysis compared to hemodialysis in Korea.",Non-OADS,/arxiv_data1/oa_pdf/b8/55/main.PMC5142291.pdf
Further in vivo studies are needed to Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Kidney Res Clin Pract 35 (2016) 195 e196 http://dx.doi.org/10.1016/j.krcp.2016.10.001 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/50/d4/main.PMC5142302.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/d4/main.PMC5142302.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC5142303.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.05.002 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC5142303.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 255 e258,Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC5142303.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Kidney Res Clin Pract 35 (2016) 263 e264 http://dx.doi.org/10.1016/j.krcp.2016.05.001 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/35/7c/main.PMC5142304.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/7c/main.PMC5142304.pdf
"The results from the VCE were helpful in the decision to perform a graftenterectomy and later listing for a retransplantation (Figure 2 ,Video, SDC, http://links.lww.com/TP/B363).",Non-OADS,/arxiv_data1/oa_pdf/2d/01/txd-2-e119.PMC5142358.pdf
Available at: http://www.bps.ac.uk/SpringboardWebApp/userfiles/bps/file/Clinical/BPSPrescribingStatement03Feb2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/5f/nmd-204-950.PMC5142359.pdf
Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII_Responsible_Use_Medicines_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/5f/nmd-204-950.PMC5142359.pdf
Available at: http://www.legislation.gov.uk/ukpga/2005/9.,Non-OADS,/arxiv_data1/oa_pdf/ba/5f/nmd-204-950.PMC5142359.pdf
Available at: http://www.guidelinesinpractice.co.uk/feb_01_ panting_patients_refuse_feb#.VIC-OtKsVPc.,Non-OADS,/arxiv_data1/oa_pdf/ba/5f/nmd-204-950.PMC5142359.pdf
Available at: http://www.westcoastdhb.org.nz/publications/ policies_n_procedures/policies_n_pr ocedures_docs/medication/Refusal- WithholdingOfMedicationProcedure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/5f/nmd-204-950.PMC5142359.pdf
"We excluded stud- ies that were not published in French or English, those reporting on ABO-incompatible transplantations or on other solid or- gan transplants, studies whose sole focus was AMR, case re- ports, studies reporting on pediatric populations, and those using a Banff version earlier than 1997, as the distinction be- tween CMR and AMR was not expected to be made explic- itly at that time.Data Sources and Search Strategy A search strategy ( Table S1, SDC, http://links.lww.com/ TXD/A30) was developed by a medical librarian and run up to October 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c6/c3/txd-2-e115.PMC5142362.pdf
"The participant char- acteristics by cancer site are presented in Supplementary Table 1 (Supplemental digital content 1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"1 (Supplemental digital content 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"As shown in Supplementary Table 2 (Supplemental digital content 3, http://links.lww.com/EJCP/A48 )n o Hosmer –Lemeshow tests of the inclusive model were statistically significant, except two for data sets of UATCand esophageal cancer in the validation study ( P=0.005 and P<0.001, respectively).",Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"2, Supplemental digital content 4, http://links.lww.com/EJCP/A49 ), and all of their calibration slopes were close to 1.0(Supplementary Table 2, Supplemental digital content 3,http://links.lww.com/EJCP/A48 ).",OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"3, Supplemental digital content 5, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"Even though the combined effect of the ALDH2 genotype and alcohol drinking is relatively low in head and neck cancer (Tables 2 –4, Supplementary Figs 1 –3, Supplemental digital content 2, http://links.lww.com/ EJCP/A47 , Supplemental digital content 4, http://links.",Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"lww.com/EJCP/A49 , Supplemental digital content 5, http://links.lww.com/EJCP/A50 ), this study showed that the risk was nevertheless h ighest for heavy drinkers with the Glu/Lys genotype.",Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
Available at: http://www.statisticalhorizons.,Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
Available at: http://globocan.iarc.fr/Default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/19/42/cej-26-38.PMC5142363.pdf
"S1a, SDC, http://links.lww.com/TXD/A31).",Non-OADS,/arxiv_data1/oa_pdf/f4/23/txd-2-e120.PMC5142364.pdf
"S1b, SDC , http://links.lww.com/TXD/A31).After logarithmic transformation, the total number of eplet HLA-ABDR mismatches exhibited a linear relationshipwith acute rejection, which best fit into 4 categories of 0 to 2, 3 to 10, 11 to 20, and >20 eplet HLA-ABDR mis- matches ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/f4/23/txd-2-e120.PMC5142364.pdf
"S2, SDC , http://links.lww.com/TXD/A31).",Non-OADS,/arxiv_data1/oa_pdf/f4/23/txd-2-e120.PMC5142364.pdf
2015.Available at: http://www.anzdata.org.au.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/txd-2-e120.PMC5142364.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/90/0b/hyp-69-189.PMC5142369.pdf
*These authors contributed equally to this work.The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/90/0b/hyp-69-189.PMC5142369.pdf
"Brown,* Philippe Ferber* Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.116.07716 See Editorial Commentary, pp 11–12Aldosterone Synthase Inhibitor",Non-OADS,/arxiv_data1/oa_pdf/90/0b/hyp-69-189.PMC5142369.pdf
"The significance of the difference in KCTD14 between the ACR group and protocol biopsy group disappeared ( Figure S1, SDC, http://links.lww.com/TABLE 3.",OADS,/arxiv_data1/oa_pdf/85/f0/txd-2-e118.PMC5142373.pdf
"Even in low AST level, the expression of anti-CHMP2B anti- body in ACR group is significantly higher than that in LD with- out ACR group ( Figure S2, SDC, http://links.lww.com/TP/B362).",Non-OADS,/arxiv_data1/oa_pdf/85/f0/txd-2-e118.PMC5142373.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/e0/main.PMC5142391.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.09.006 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/c3/e0/main.PMC5142391.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 204 e211,Non-OADS,/arxiv_data1/oa_pdf/c3/e0/main.PMC5142391.pdf
Available at: http://www.usrds.org/adr.htm [Data accessed: 30 June 2016] [6] Japanese Society for Dialysis Therapy.,Non-OADS,/arxiv_data1/oa_pdf/c3/e0/main.PMC5142391.pdf
Available at: http://www.jsdt.or.jp/ (Japa- nese).,Non-OADS,/arxiv_data1/oa_pdf/c3/e0/main.PMC5142391.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy— Oncolytics  website (http://www.nature.com/mto),Non-OADS,/arxiv_data1/oa_pdf/12/c3/mto201626.PMC5142425.pdf
"9 In animal models including solid tumors and hematologic malig- nancies, IL-12 addition is an effective antitumor therapy.10 Because of  this, ~70 IL-12-based clinical trials have been initiated to date; among them more than 20 involve gene or cell therapies (http://www.clini- caltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/32/83/mtm201674.PMC5142463.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/32/83/mtm201674.PMC5142463.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/c3/ba/mto201632.PMC5142464.pdf
"Negative con-trol DD tissue samples (F) demonstrated minimal staining  (See	PDF, Supplemental	 Digital	 Content	 2, which displays  DAB immunohistochemical–stained images of positive con- trol human samples, http://links.lww.com/PRSGO/A270).",Non-OADS,/arxiv_data1/oa_pdf/dc/1f/gox-4-e1064.PMC5142473.pdf
"(See	 PDF, Supplemen- tal	Digital	 Content	 3, which displays split immunofluorescent  immunohistochemical–stained images of DD cord presented in Figure 3 which shows ERG (A, red) and OCT4 (B, green)  on the same tissue section; ERG (C, red) and SALL4 (D,  green) on the same tissue section; and CD34 (E, G&I, green)  on the sections probed for SOX2 (F, red), pSTAT3 (H, red) and NANOG (J, red) http://links.lww.com/PRSGO/A271.)",Non-OADS,/arxiv_data1/oa_pdf/dc/1f/gox-4-e1064.PMC5142473.pdf
"Additional pictures can be seen as Supplemental	 Digital	 Content	 1 (see	pdf,	Sup- plemental	 Digital	 Content, which displays detailed pictures  of the treatment of the patient since preoperatory until 13 months postoperatory, http://links.lww.com/PRSGO/A282).",Non-OADS,/arxiv_data1/oa_pdf/6f/46/gox-4-e1072.PMC5142474.pdf
"As the US celebrates National Selfie  Day, surgeons reveal how front-facing PHONE CAMERAS have  caused an increase in people wanting cosmetic “tweakments.”  Available at http://www.dailymail.co.uk/femail/article-3652798/Say-cheese-celebrates-National-Selfie-Day-surgeons-reveal-facing- PHONE-CAMERAS-caused-increase-people-wanting-cosmetic- tweakments.html.",Non-OADS,/arxiv_data1/oa_pdf/33/95/gox-4-e1088.PMC5142478.pdf
Available  at: http://www.ohri.ca/programs/clinical_epidemiology/ox- ford.asp.,Non-OADS,/arxiv_data1/oa_pdf/c4/c4/gox-4-e1099.PMC5142481.pdf
"(See	 figure,	 Supplemental	 Digital	 Content	 1, which dis- plays intraoperative images of the radial forearm adipo-fascial reconstruction of the clival defect, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/gox-4-e1109.PMC5142483.pdf
"(See	 figure,	 Supplemen- tal	Digital	 Content	 2, which displays 1-year post-operative  endoscopic appearance, http://links.lww.com/PRSGO/ A290.)",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/gox-4-e1109.PMC5142483.pdf
"(See	 figure,	 Supplemental	 Digital	 Con- tent	 3, which displays 3-year follow-up T1-weighted MRI  scan highlighting the durability of the adipofascial flap without sinusitis, http://links.lww.com/PRSGO/A291.)",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/gox-4-e1109.PMC5142483.pdf
"The small ring of the Lap- Protector is inserted into patient’s oral cavity, so that the 2 rings enclose the lips, http://links.lww.com/PRSGO/A296).",Non-OADS,/arxiv_data1/oa_pdf/26/d3/gox-4-e1116.PMC5142487.pdf
"This video shows the stability  of the Lap-Protector during surgery, http://links.lww.com/ PRSGO/A297).",Non-OADS,/arxiv_data1/oa_pdf/26/d3/gox-4-e1116.PMC5142487.pdf
"the  small ring of the Lap-Protector is inserted into patient’s oral cavity so that the 2 rings enclose the lips, http://links.lww.com/PRSGO/A296.",Non-OADS,/arxiv_data1/oa_pdf/26/d3/gox-4-e1116.PMC5142487.pdf
"this video shows the  stability of the Lap-Protector during surgery, http://links.lww.com/PRSGO/A297.",Non-OADS,/arxiv_data1/oa_pdf/26/d3/gox-4-e1116.PMC5142487.pdf
This  video is available in the Related Videos section of the  Full-Text article on PRSGlobalOpen.com or available at  http://links.lww.com/PRSGO/A285.),Non-OADS,/arxiv_data1/oa_pdf/48/af/gox-4-e1117.PMC5142488.pdf
this video is available in the Related videos section of the Full- text  article on PRsGlobalopen.com or available at http://links.lww.com/PRSGO/A285.,Non-OADS,/arxiv_data1/oa_pdf/48/af/gox-4-e1117.PMC5142488.pdf
"The patient underwent wound debridement in the operating theatre and was commenced on negative pressure wound therapy  (See	 PDF,	 Supplemental	 Digital	 Content	 1, which displays  lateral and medial right foot wounds before treatment,  http://links.lww.com/PRSGO/A286).",Non-OADS,/arxiv_data1/oa_pdf/41/49/gox-4-e1119.PMC5142490.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or  available at http://links.lww.com/PRSGO/A283.),Non-OADS,/arxiv_data1/oa_pdf/eb/40/gox-4-e1120.PMC5142491.pdf
This video is available in the “Related Videos” section of the full-text article on pRSGlobalopen.com or available at http://links.lww.com/PRSGO/A283.,Non-OADS,/arxiv_data1/oa_pdf/eb/40/gox-4-e1120.PMC5142491.pdf
Available at: http://www.surgery.,Non-OADS,/arxiv_data1/oa_pdf/eb/40/gox-4-e1120.PMC5142491.pdf
This video is available in the “Related Videos” section of the full-text article on pRSGlobalopen.com or available at http://links.lww.com/PRSGO/A284.,Non-OADS,/arxiv_data1/oa_pdf/eb/40/gox-4-e1120.PMC5142491.pdf
Available at: http://emedicine.med-scape.com/article/1123316-overview.,Non-OADS,/arxiv_data1/oa_pdf/fa/fe/gox-4-e1124.PMC5142493.pdf
com or available at http://links.lww.com/PRSGO/A298).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “re- lated videos” section of the full-text article on PRSGlobalO- pen.com or available at http://links.lww.com/PRSGO/A298).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available  at http://links.lww.com/PRSGO/A299).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “related videos” section  of the full-text article on PRSGlobalOpen.com or available at  http://links.lww.com/PRSGO/A299).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
com or available at http://links.lww.com/PRSGO/A299).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
com or available at http://links.lww.com/PRSGO/A299).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the  “related videos” section of the full-text article on PRSGlo- balOpen.com or available at http://links.lww.com/PRSGO/ A299).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “related vid-eos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A299.,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “related videos” section of the  full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A300.,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or avail-able at http://links.lww.com/PRSGO/A298.,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
• Cleft Lip Repair 3PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A300).,Non-OADS,/arxiv_data1/oa_pdf/fc/37/gox-4-e1125.PMC5142494.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available  at http://links.lww.com/PRSGO/A292.),Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A293.),Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
com or available at http://links.lww.com/PRSGO/A294.),Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
This  video is available in the “Related Videos” section of the  Full-Text article on PRSGlobalOpen.com or available at  http://links.lww.com/PRSGO/A295.),Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A294.,Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A295.,Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A293.,Non-OADS,/arxiv_data1/oa_pdf/04/1b/gox-4-e1134.PMC5142498.pdf
Available at: http://www.plasticsurgery.org/Documents/ news-resources/statistics/2014-statistics/plastic-surgery-statsitics-full-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/f1/gox-4-e1139.PMC5142500.pdf
Available at: http://www.ishrs.,Non-OADS,/arxiv_data1/oa_pdf/bc/fd/gox-4-e1141.PMC5142501.pdf
"1)  was addressed using a polymethyl methacrylate and Mar - lex mesh construct with a pedicled latissimus dorsi myo- cutaneous flap for vascularized coverage (See	 Figure,	 Supplemental	 Digital	 Content	 1, which displays pedicled  latissimus dorsi musculocutaneous flap covering the mesh construct, http://links.lww.com/PRSGO/A301).",Non-OADS,/arxiv_data1/oa_pdf/c2/a7/gox-4-e1142.PMC5142502.pdf
This video is available in the “related videos” section of the full-text article on PRS- GlobalOpen.com or available at http://links.lww.com/ PRSGO/A302).,Non-OADS,/arxiv_data1/oa_pdf/97/f5/gox-4-e1145.PMC5142503.pdf
this video is available in the “related videos”  section of the full-text article on PRSglobalOpen.com or available at http://links.lww.com/PRSGO/A302.,Non-OADS,/arxiv_data1/oa_pdf/97/f5/gox-4-e1145.PMC5142503.pdf
Hospital Consumer Assessment of Healthcare Providers and Systems Survey: Available at: http://www.hcahpsonline.org/surveyinstru-ment.aspx.,Non-OADS,/arxiv_data1/oa_pdf/97/f5/gox-4-e1145.PMC5142503.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/1b/22/mtm201679.PMC5142508.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/4e/98/mtm201671.PMC5142510.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/93/cc/mtm201683.PMC5142511.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/a3/9a/mtm201681.PMC5142512.pdf
Data were also examined using Gene Ontology (GO) software  (http://go.princeton.edu).,OADS,/arxiv_data1/oa_pdf/98/00/mtm201678.PMC5142514.pdf
"Primers for these target genes and two ref-erence genes (Ppia and Hprt) were designed using Primer 3 software (MIT/Whitehead Institute, http://www-genome.wi.mit.edu) ( Table 2).",OADS,/arxiv_data1/oa_pdf/98/00/mtm201678.PMC5142514.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/98/00/mtm201678.PMC5142514.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/f1/97/mtm201682.PMC5142515.pdf
Next steps will be to work with educators and practitioners in the HBMT field to augment the ACIH Competencies for Optimal Prac-tice in Integrated environments ( http://accahc.org/ competencies ) and develop specific competencies for  hospital-based massage therapy.,Non-OADS,/arxiv_data1/oa_pdf/4d/a1/ijtmb-9-14.PMC5142709.pdf
http://www.sciencedirect.com/ science/article/pii/S0140673608616207  2.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://tan.sagepub.com/ content/4/2/83.long  3.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://www.sciencedirect.com/science/ article/pii/S0022510X0200312X  5.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://msj.sagepub.com/ content /6/3/ 181.long  8.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
https://www.ncbi.nlm.nih.gov/pubmed/12665396  9.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://www.sciencedirect.com/ science/article/pii/S0022510X05004387  10.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://onlinelibrary.wiley.com/ doi/10.1111/j.1468-1331.2004.00815.x/full  12.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
2004;63(5):919– 921. http://www.neurology.org/content/63/5/919.long  13.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://onlinelibrary.wiley.com/ doi/10.1016/j.ejpain.2004.11.005/fullBACKUS: IMPACT OF MT ON MS PATIENTS  14.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://nnr.sagepub.com/content/17/1/66.long  16.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://eprints.whiterose.ac.uk/1776/1/Beard_1.pdf  17.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://msj.sagepub.com/ content/11/3/322.long  18.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
https://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
https://www.ncbi.nlm.nih.gov/ pubmed/19254044  20.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
https://www.ncbi.nlm.nih.gov/ pubmed/14583932  21.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://cre.sagepub.com/ content/17/2/181.long  23.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://onlinelibrary.wiley.com/doi/10.1002/ oti.266/abstract  24.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://www.idibidikids.com.au/Cerebral_Palsy_Symptoms_in_Children_Decreased_Following_Massage_Therapy.pdf  27.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
2011;4(1):4. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3088531/,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://ptjournal.apta.org/ content /72/6/449.long  31.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
https://www.ncbi.nlm.nih.gov/ pubmed/19078022  32.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
2011;4(1):28. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3088529/  34.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://ptjournal.apta.org/content/ ptjournal /67/2/206.full.pdf  35.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://ptjournal.apta.org/content/ ptjournal/94/5/593.full.pdf  37.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://msj.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
2006;6:24.  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1544351/  40.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
2013. http://www.elapmassage.org/_files/ELAP_Blueprint.pdf .,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
2012;323(1):9– 15. http://www.sciencedirect.com/science/article/pii/ S0022510X12004364  44.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://www.sciencedirect.com/science/ article/pii/S105381191101319X  45.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://msj.sagepub.com/ content/12/4/367.long  46.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://onlinelibrary.wiley.com/ doi/10.1111/j.1468-1331.2007.01974.x/full  47.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
"http://msj.sagepub.com/ content /19/2/217.full.pdf+html Corresponding author: Deborah Backus, Shep- herd Center, 2020 Peachtree Rd.",Non-OADS,/arxiv_data1/oa_pdf/16/3d/ijtmb-9-4.PMC5142712.pdf
"12developed and tested a combined thermoresponsive hydrogel/microsphere eye drop thatis administered similarly to a traditional eye drop, butforms a pliable, nondegradable depot after exposure tobody temperature in the conjunctival cul de sac(available in the public domain at http://www.google.",Non-OADS,/arxiv_data1/oa_pdf/fb/93/i2164-2591-5-6-12.PMC5142715.pdf
"Drug release from highly porous hydrogels occurs very quickly relative to the micro- spheres [Hoare and Kohane, available in the public domain at http://www.sciencedirect.com/science/ article/pii/S0032386108000487 ], and thus, the pro- longed effect is presumed to be a result of the drug- loaded microspheres.",Non-OADS,/arxiv_data1/oa_pdf/fb/93/i2164-2591-5-6-12.PMC5142715.pdf
"36 NCI-MATCH (http://www.cancer.gov/about-cancer/treat- ment/clinical-trials/nci-supported/nci-match#1)37,38and Signa- ture (http://www.signaturetrial.com/en)39trials are basket trials that use pooling and borrowing, respectively.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"For exam-ple, ASCO’s TAPUR (http://www.tapur.org/) uses approvedtreatments off-label in a basket platform design in order to gener-ate hypotheses regarding toxicity and supplemental indication.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"The NIH NHGRI (National Human Genome Research Institute) has developed consent forms that anticipate indeﬁnite biobanking, future testing, and reinterpretation of historic testing (https://www.genome.gov/27026588/).",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"Fully collaborative molecular screening programs like the EORTCSPECTA coordinates several disease-speciﬁc platforms on a pan- European level with the aim of identifying, at an early stage, spe- ciﬁc druggable aberrations and offer speciﬁc targeted treatment to patients within clinical trials (http://spectacolor.eortc.org/).",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"recruitment can be built from provider electronic medical record systems, payer claims databases, disease-speciﬁc patient registries (EPAD Register, to be discussed later, http://ep-ad.org/), orsocial media patient communities (PatientsLikeMe https://www.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"86,87The UCSF project management ofﬁce in collaboration with I-SPY and Salesforce has developed TRANSCEND to integrate multiple data sources and enable real-time adaptive randomization.88The UCSF/I- SPY OneSource effort (http://www.quantumleaphealth.org/one- source) has the further goal to integrate the EHR and GCP clinical trial reporting systems.",OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
EPAD (http://ep-ad.org/) is an emerging Alzheimer’s disease PIPELINE that links RWE with applied adaptive umbrelladesigns.,OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"Largephilanthropic development organizations such as MMV (Medi-cines for Malaria Venture, http://www.mmv.org/) and the GatesFoundation (http://www.gatesfoundation.org) are in many ways creating PIPELINEs to serve developing country needs.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"Terry, C. & Lesser, N. Measuring the return from pharmaceutical innovation 2015 Transforming R & D returns in uncertain times.Deloitte Centre for Health Solutions .<https://www.bio.org/sites/ default/ﬁles/Clinical Development Success Rates 2006-2015 —BIO, Biomedtracker, Amplion 2016.pdf >(2015).",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"Jenkins, J.K. 2015: Another Strong Year for Patients in Need of New Drug Therapies .<http://blogs.fda.gov/fdavoice/index.php/2016/ 01/2015-another-strong-year-for-patients-in-need-of-new-drug-therapies >(2016).",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
<http://ec.europa.eu/health/ ﬁles/committee/73meeting/pharm672_regulatory_framework_and_early_access_annex.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
<http://tejas.iimb.ac.in/ articles/12.php >.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
Evolutionary Psychology: Complex Systems and Social Theory .<http://web.eecs.utk.edu/ /C24mclennan/papers/EPCSST.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
50<http://www.fda.gov/downloads/Drugs/.../Guidances/ ucm201790.pdf >(2010).,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
Fortune Insider .<http://fortune.com/author/donald-berry/ >(2015).,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"Esserman, L. I-SPY 2 & 3 Trials .<http://www.nationalacademies.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
<http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm328691.pdf>(2014).,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
"Wiley, A. NCI Wiki: caIntegrator .<https://wiki.nci.nih.gov/display/ caIntegrator/caIntegrator;WIKISESSIONID=D3560EA9100ACA3A8E4A7E7B54B8B24D >(2015).90.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
<https://wiki.nci.nih.gov/display/caIntegrator/ caIntegrator+Retirement+Announcement;WIKISESSIONID=B5DF- F09AEC12A1F6302D9A850324EF9F >(2016).,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
<http://www.fda.gov/downloads/MedicalDevices/NewsEvents/ WorkshopsConferences/UCM439440.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
Project Enigma .<http://www.mit- trust.org/projects/ >.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
<http://www.gatesfoundation.org/What-We-Do/Global- Health/Discovery-and-Translational-Sciences >.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/CPT-100-713.PMC5142736.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601646/DC1section A.,Non-OADS,/arxiv_data1/oa_pdf/bf/22/1601646.PMC5142797.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1600387/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/67/31/1600387.PMC5142798.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601660/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/90/82/1601660.PMC5142799.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601432/DC1 movie S1.,Non-OADS,/arxiv_data1/oa_pdf/19/52/1601432.PMC5142800.pdf
Sequence alignmentswere performed using Kalign (European Molecular Biology Laboratory)or CLUSTAW (http://www.genome.jp/ tools/clustalw/).,OADS,/arxiv_data1/oa_pdf/33/c3/1601941.PMC5142801.pdf
4; http://www.geneious.com).,Non-OADS,/arxiv_data1/oa_pdf/33/c3/1601941.PMC5142801.pdf
Images were analyzed and processed with ImageJ (http://imagej.nih.,OADS,/arxiv_data1/oa_pdf/33/c3/1601941.PMC5142801.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601941/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/33/c3/1601941.PMC5142801.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601835/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/da/dc/1601835.PMC5142806.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Toll-like receptor signaling-de ﬁcient mice are easy mobilizers: evidence that TLR signaling prevents mobilization of hematopoietic stem/progenitor cells in HO-1-dependent manner Leukemia (2016) 30,2416 –2419; doi:10.1038/leu.2016.236 Hematopoietic stem/progenitor cells (HSPCs) are mobilized from bone marrow (BM) into peripheral blood (PB) in steady-stateconditions in a circadian rhythm-dependent manner as well asin pathological processes related to tissue/organ injury andinﬂammation.",Non-OADS,/arxiv_data1/oa_pdf/f1/a9/leu2016236a.PMC5143204.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients Leukemia (2016) 30,2419 –2422; doi:10.1038/leu.2016.245 Chronic lymphocytic leukemia (CLL) is a neoplastic disease of mature B cells that express a functional immunoglobulin (Ig) B-cellreceptor (Ig-BCR) on the cell surface.1The Ig-BCR includes the binding site (idiotype) for the epitope of cognate antigen, whichresults from the stochastic and productive Ig variable genesrearrangement and possible somatic hypermutation.",Non-OADS,/arxiv_data1/oa_pdf/f1/a9/leu2016236a.PMC5143204.pdf
"(%)dStereotypicsubseteMimotopenameMimotope aa sequenceK D (nM)f CLL#1 CLL1 mIgCLL1 V3-11/D3-10/J6 κV1-39(1D-39)/J2 17 AREGLWFGELSYYGMDV 100 NA pCLL1 CSPAKELGC 34.03 CLL#2 CLL2 mIgCLL2-1 V3-73/D3-3/J6 κV1-33(1D-33)/J1 20 TFDFWSGYYDGY YYYY GMDV 80 NA pCLL2-1 CNTYSVSLC 10.81 mIgCLL2-2 TFDFWSGYYDGY YYYYGLDF 20 pCLL2-2 CKSYSVSLC 7.57 CLL#3 CLL3 mIgCLL3-1 V3-23/D3-22/J4 κV1-8(1D-8)J3 17 AKRDYSHRSDYAPLFEY 90 NA pCLL3-1 CPPQSVTEC 22.14 mIgCLL3-2 GKRDYSHSSDYAPLFEY 10 NA pCLL3-2 CDVWHSAYC 5.64 CLL#4-1 CLL4-1 mIgCLL4-1 V4-34/D7-27/J2 κV1-33(1D-33)/J1 17 ARRGTGDPPYWYFDL 77 NA pCLL4-1 CTTNPADSC 5.50 CLL#4-2 CLL4-2 mIgCLL4-2 V4-4/D6-19/J2 κV2-28(2D-28)J1 21 ARGTVGQQWLEVLDWYFGL 23 NA pCLL4-2 CVLWWSPIC 3.90 CLL#5-1 CLL5-1 mIgCLL5-1 V4-34/D3-22/J4 κV1D-12/J1 20 ARGGNNDKIVMLLYYFDF 57 NA pCLL5-1 CFSDDEWWC 7.08 CLL#5-2 CLL5-2 mIgCLL5-2 V4-59/D3-22/J3 κV1-13(1D-13)/J2 18 ARDYDYDTRKSDAFDIW 43 NA pCLL5-2 CPPFTNYEC 7.32 CLL#6-1 CLL6-1 mIgCLL6-1 V1-46/D3-10/J6 κV3D-15/J1 22 ARDWVATMVRGVIESRPTGMDV 65 NA pCLL6-1 CNQDWHKKC 57.53 CLL#6-2 CLL6-2 mIgCLL6-2 V4-34/D2-2/J6 κV1D-17/J1 24 ASRFYCSGSSCEAPRYYYYYGLDV 35 16 pCLL6-2 CTTV IPERC 22.67 aName of the CLL-derived monoclonal Ig γ1 antibodies expressing the indicated V HDJHand V LJLrearrangements.bNumber of amino acids of the VH CDR3.cVH CDR3 amino acid sequence according to the International ImMunoGeneTics information system (http://www.imgt.org).dPercentage of analyzed cells expressing the indicated VH CDR3.eStereotypic subset according to Agathangelidis et al.5NA, not attributable to a currently de ﬁned stereotypic subset.fKD values for the mimotope binding to the cognate mIgCLL, as estimated by the Scatchard plot analysis.",Non-OADS,/arxiv_data1/oa_pdf/f1/a9/leu2016236a.PMC5143204.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Atypical Neonatal Marfan Syndrome with p.Glu1073Lys Mutation  of FBN1 : the First Case in Korea Neonatal Marfan syndrome (nMFS) is considered to be on the most severe end of the  spectrum of type I fibrillinopathies.",Non-OADS,/arxiv_data1/oa_pdf/4d/da/jkms-32-1.PMC5143279.pdf
"Keywords:  Marfan Syndrome; Neonate; Diaphragmatic Eventration; Hydronephrosis;  Cisterna MagnaJu Sun Heo,1 Joo Young Song,1   Eun Young Choi,2 Eun-Hee Kim,1   Ji Hee Kim,1 So Eun Park,1   and Ji-Hyun Jeon1 1Department of Pediatrics, CHA Gangnam Medical  Center, CHA University, Seoul, Korea; 2Department  of Pediatrics, Sejong General Hospital, Bucheon,  Korea Received: 25 June 2016 Accepted: 4 October 2016 Address for Correspondence: Ji-Hyun Jeon, MD Department of Pediatrics, CHA Gangnam Medical Center, CHA  University, 566, Nonhyeon-ro, Gangnam-gu, Seoul 06135, Korea E-mail: goddaugh@chamc.co.krhttps://doi.org/10.3346/jkms.2017.32.1.1  • J Korean Med Sci 2017; 32: 1-3 In July 2015, a male newborn was born vaginally at 36+5 weeks  gestation to a G1P0 mother.",Non-OADS,/arxiv_data1/oa_pdf/4d/da/jkms-32-1.PMC5143279.pdf
• Atypical Neonatal Marfan Syndrome 2  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.1Fig.,Non-OADS,/arxiv_data1/oa_pdf/4d/da/jkms-32-1.PMC5143279.pdf
"• Atypical Neonatal Marfan Syndrome http://jkms.org   3 https://doi.org/10.3346/jkms.2017.32.1.1tions, such as diaphragmatic eventration, severe hydronephro - sis with hydroureter, and dilated cisterna magna.",Non-OADS,/arxiv_data1/oa_pdf/4d/da/jkms-32-1.PMC5143279.pdf
"ORCID Ju Sun Heo http://orcid.org/0000-0001-8928-289X Joo Young Song http://orcid.org/0000-0002-8635-8681 Eun Young Choi http://orcid.org/0000-0001-5936-9388 Eun-Hee Kim http://orcid.org/0000-0003-3143-9545 Ji Hee Kim http://orcid.org/0000-0001-6950-3982 So Eun Park http://orcid.org/0000-0003-0647-2597 Ji-Hyun Jeon http://orcid.org/0000-0002-4512-2728REFERENCES 1. von Kodolitsch Y, De Backer J, Schüler H, Bannas P , Behzadi C, Bernhardt  AM, Hillebrand M, Fuisting B, Sheikhzadeh S, Rybczynski M, et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/da/jkms-32-1.PMC5143279.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Therapeutic Response for Functional Abdominal Pain in Children  with Occult Constipation: Laxatives versus Prokinetic Drugs The relationship between functional abdominal pain (FAP) and occult constipation (OC) in  children who did not meet the Rome III criteria for constipation has rarely been reported.",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
"Keywords:  Functional Gastrointestinal Disorders; Laxatives; Occult Constipation;  Pediatrics; Rome III CriteriaEun Kyo Ha, Homin Jang,   and Su Jin Jeong Department of Pediatrics, CHA Bundang Medical  Center, CHA University, Seongnam, Korea Received: 12 May 2016 Accepted: 5 October 2016 Address for Correspondence: Su Jin Jeong, MD Department of Pediatrics, CHA Bundang Medical Center,   CHA University, 11, Yatap-ro 65-beon-gil, Bundang-gu,  Seongnam 13496, Republic of Korea E-mail: jinped@cha.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.102  • J Korean Med Sci 2017; 32: 102-107 INTRODUCTION Functional abdominal pain (FAP) is one of the most common  gastrointestinal complaints in children (1).",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
• Therapeutic Response for Functional Abdominal Pain in Children http://jkms.org   103 https://doi.org/10.3346/jkms.2017.32.1.102the prevalence of OC in those with FAP .,Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
• Therapeutic Response for Functional Abdominal Pain in Children 104  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.102described the pain they felt at the time of the interview.,Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
• Therapeutic Response for Functional Abdominal Pain in Children http://jkms.org   105 https://doi.org/10.3346/jkms.2017.32.1.102respectively.,Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
"• Therapeutic Response for Functional Abdominal Pain in Children 106  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.102Therefore, a larger, double-blind investigation is warranted.",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
ORCID Eun Kyo Ha http://orcid.org/0000-0001-8863-5729 Homin Jang http://orcid.org/0000-0002-5105-4952 Su Jin Jeong http://orcid.org/0000-0002-7388-8368   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
• Therapeutic Response for Functional Abdominal Pain in Children http://jkms.org   107 https://doi.org/10.3346/jkms.2017.32.1.102Dan Med J  2015; 62: 1-42.,Non-OADS,/arxiv_data1/oa_pdf/17/e1/jkms-32-102.PMC5143280.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Genetic Variations of the KISS1R  Gene in Korean Girls with  Central Precocious Puberty The timing of puberty onset varies greatly among individuals, and much of this variation is  modulated by genetic factors.",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"Received: 17 May 2016 Accepted: 15 September 2016 Address for Correspondence: Kee-Hyoung Lee, MD Department of Pediatrics, Korea University College of Medicine,  73, Inchon-ro, Seongbuk-gu, Seoul 02841, Korea E-mail: khlee218@kumc.or.kr Funding:  This work was supported by a Korea University grant  (2012) and research funding from the Korean Society of  Pediatric Endocrinology (2012-02).https://doi.org/10.3346/jkms.2017.32.1.108  • J Korean Med Sci 2017; 32: 108-114 INTRODUCTION Human puberty is initiated by an increase in the amplitude and  frequency of pulses of gonadotropin-releasing hormone (GnRH)  after a quiescent period during childhood.",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"• KISS1R  Gene Polymorphisms in CPP Girls http://jkms.org   109 https://doi.org/10.3346/jkms.2017.32.1.108ic causes of CPP (14,15).",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"• KISS1R  Gene Polymorphisms in CPP Girls 110  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.108RESULTS Clinical and hormonal characteristics of the study  population In the patient group, the mean age at diagnosis was 8.08 ± 0.77  years.",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"We assessed this variant using three in  silico prediction algorithms, Polymorphism Phenotyping-2 (Poly- Phen-2, http://genetics.bwh.harvard.edu/pph2/), Sorting In - tolerant from Tolerance (SIFT, http://sift.jcvi.org/) and Muta - tionTaster (http://www.mutationtaster.org/), and it was consid - ered as a benign polymorphism in all three in silico analyses.",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
• KISS1R  Gene Polymorphisms in CPP Girls http://jkms.org   111 https://doi.org/10.3346/jkms.2017.32.1.108in Table 4.,Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
• KISS1R  Gene Polymorphisms in CPP Girls 112  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.108tically significantly more frequently in the CPP group with a mod - erate P value (0.042).,Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"• KISS1R  Gene Polymorphisms in CPP Girls http://jkms.org   113 https://doi.org/10.3346/jkms.2017.32.1.108duced a synonymous change, it did not appear to affect the ac - tivity of the KISS1R .",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
ORCID Yeon Joung Oh http://orcid.org/0000-0002-1664-8480 Young-Jun Rhie http://orcid.org/0000-0002-1250-6469 Hyo-Kyoung Nam http://orcid.org/0000-0003-1512-2062 Hye Ryun Kim http://orcid.org/0000-0002-6199-3654Kee-Hyoung Lee http://orcid.org/0000-0002-4319-9019 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"• KISS1R  Gene Polymorphisms in CPP Girls 114  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.108eduzzi D, Silveira LF , Gucev ZS.",Non-OADS,/arxiv_data1/oa_pdf/e0/fb/jkms-32-108.PMC5143281.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of the Mortality and In-Hospital Outcomes of  Preterm Infants Treated with Ibuprofen for Patent Ductus  Arteriosus with or without Clinical Symptoms Attributable to the  Patent Ductus Arteriosus at the Time of Ibuprofen Treatment The aim of this study was to assess the differences in the mortality and in-hospital  outcomes of preterm infants with < 28 weeks of gestation who received ibuprofen  treatment according to the presence of clinical symptoms (any of oliguria, hypotension, or  moderate to severe respiratory difficulty) attributable to hemodynamically-significant  patent ductus arteriosus (hsPDA) at the time of first ibuprofen treatment.",Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
"Keywords:  Patent Ductus Arteriosus; Premature Infants; Treatment; Ibuprofen; Patient  Outcome AssessmentHani Yoo,1,2 Jin A Lee,1,3 Sohee Oh,4  Young Hwa Jung,1,5 Jin A Sohn,1,3   Seung Han Shin,1,2 Chang Won Choi,1,5  Ee-Kyung Kim,1,2 Han-Suk Kim,1,2   and Beyong Il Kim1,5 1Department of Pediatrics, Seoul National University  College of Medicine, Seoul, Korea; 2Department of  Pediatrics, Seoul National University Hospital, Seoul,  Korea; 3Department of Pediatrics, Seoul National  University Boramae Medical Center, Seoul, Korea; 4Department of Biostatistics, Seoul National  University Boramae Medical Center, Seoul, Korea; 5Department of Pediatrics, Seoul National University  Bundang Hospital, Seongnam, Korea Received: 7 June 2016 Accepted: 9 September 2016 Address for Correspondence: Jin A Lee, MD Department of Pediatrics, Seoul National University Boramae  Medical Center, 20, Boramae-ro 5-gil, Dongjak-gu, Seoul 07061,  Korea E-mail: ljinna@snu.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.115  • J Korean Med Sci 2017; 32: 115-123 INTRODUCTION Patent ductus arteriosus (PDA) is common in extremely pre - mature infants, affecting 60%–70% of infants with less than 28  weeks of gestation (1,2).",Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms 116  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.115Sehgal’s classification and the neonatal outcomes (13).,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
"• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms http://jkms.org   117 https://doi.org/10.3346/jkms.2017.32.1.115logic chorioamnionitis, pregnancy induced hypertension (PIH),  sepsis and inhaled nitric oxide use prior to treatment between  the two groups.",Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
(http://www.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms 118  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.115and 14 infants (15.4%) were treated with clinical symptoms at - tributable to the hsPDA.,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms http://jkms.org   119 https://doi.org/10.3346/jkms.2017.32.1.115population.,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms 120  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.115the clinical symptoms group and the no clinical symptoms group  (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
"• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms http://jkms.org   121 https://doi.org/10.3346/jkms.2017.32.1.115nal arteries (12,30).",Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
"• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms 122  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.115the neonatal outcomes in preterm infants, so further studies are  needed.",Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
ORCID Hani Yoo http://orcid.org/0000-0002-9402-1499 Jin A Lee http://orcid.org/0000-0002-9194-0529 Sohee Oh http://orcid.org/0000-0002-3010-448X Young Hwa Jung http://orcid.org/0000-0002-4159-586X Jin A Sohn http://orcid.org/0000-0002-4992-7128 Seung Han Shin http://orcid.org/0000-0002-7008-4073 Chang Won Choi http://orcid.org/0000-0003-1911-0253 Ee-Kyung Kim http://orcid.org/0000-0002-7063-168X Han-Suk Kim http://orcid.org/0000-0002-9777-3231 Beyong Il Kim http://orcid.org/0000-0003-0408-9279 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
• Outcomes of Preterm Patent Ductus Arteriosus Following Clinical Symptoms http://jkms.org   123 https://doi.org/10.3346/jkms.2017.32.1.115of hemodynamic significance attributable to the ductus arteriosus?,Non-OADS,/arxiv_data1/oa_pdf/14/f7/jkms-32-115.PMC5143282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Unfavorable Course of Subclinical Hypothyroidism in Children  with Hashimoto’s Thyroiditis Compared to Those with Isolated  Non-Autoimmune Hyperthyrotropinemia Subclinical hypothyroidism (SCH) is a common problem in pediatric population, and the  natural history of SCH varies depending on its etiology.",Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
"Keywords:  Hypothyroidism; Hashimoto Disease; Thyroid Disease; ChildrenYun Jeong Lee,1 So Yoon Jung,1   Hae Woon Jung,2 So Youn Kim,1   Young Ah Lee,1 Seong Yong Lee,3   Choong Ho Shin,1 and Sei Won Yang1 1Department of Pediatrics, Seoul National University  Children’s Hospital, Seoul National University  College of Medicine, Seoul, Korea; 2Department of  Pediatrics, Kyung Hee University College of  Medicine, Seoul, Korea; 3Department of Pediatrics,  Seoul Metropolitan Government, Seoul National  University Boramae Medical Center, Seoul, Korea Received: 7 July 2016 Accepted: 11 September 2016 Address for Correspondence: Young Ah Lee, MD Department of Pediatrics, Seoul National University Children’s  Hospital, 101, Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: nina337@snu.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.124  • J Korean Med Sci 2017; 32: 124-129 INTRODUCTION Subclinical hypothyroidism (SCH) is characterized by a slightly  elevated thyroid stimulating hormone (TSH) serum level (usu - ally < 10 mIU/L) when the serum concentrations of free and  total triiodothyronine (T3) and thyroxine (T4) are within the  reference range (1,2).",Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
"• Natural Course of Pediatric Subclinical Hypothyroidism http://jkms.org   125 https://doi.org/10.3346/jkms.2017.32.1.124Clinical and biochemical data Height was measured with a standard stadiometer (Holtain Ltd.,  Crymych, United Kingdom) to the first decimal place, and body  mass index (BMI) was calculated as weight divided by squared  height (kg/m2).",Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
• Natural Course of Pediatric Subclinical Hypothyroidism 126  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.124and goiter size was similar between the HT and iso-NAHT groups.,Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
• Natural Course of Pediatric Subclinical Hypothyroidism http://jkms.org   127 https://doi.org/10.3346/jkms.2017.32.1.124Table 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
"• Natural Course of Pediatric Subclinical Hypothyroidism 128  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.124DISCUSSION During a median follow-up of 2 years in pediatric SCH patients  without concomitant chronic disorders, the majority (89.9%) of  patients, whose TSH levels were less than 10 mIU/L, reverted to  normal TSH levels or maintained SCH status.",Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
"ORCID Yun Jeong Lee http://orcid.org/0000-0003-2847-2643 So Yoon Jung http://orcid.org/0000-0002-0604-5600 Hae Woon Jung http://orcid.org/0000-0003-0494-4626 So Youn Kim http://orcid.org/0000-0001-8309-4927 Young Ah Lee http://orcid.org/0000-0001-9179-1247 Seong Yong Lee http://orcid.org/0000-0002-7077-869X Choong Ho Shin http://orcid.org/0000-0002-9813-1134 Sei Won Yang http://orcid.org/0000-0002-5304-5750 REFERENCES 1. Cooper DS, Biondi B. Subclinical thyroid disease.",Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
• Natural Course of Pediatric Subclinical Hypothyroidism http://jkms.org   129 https://doi.org/10.3346/jkms.2017.32.1.12454.,Non-OADS,/arxiv_data1/oa_pdf/1e/98/jkms-32-124.PMC5143283.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Effects of Platelet-Rich Plasma on Kidney Regeneration in  Gentamicin-Induced Nephrotoxicity Platelet-rich plasma (PRP) as a source of growth factors may induce tissue repairing and  improve fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
"92-6792 from  Shiraz University of Medical Sciences, Shiraz, Iran.https://doi.org/10.3346/jkms.2017.32.1.13  • J Korean Med Sci 2017; 32: 13-21 INTRODUCTION Platelet-rich plasma (PRP), an autologous derivative of whole  blood, has grown as an attractive biologic instrument in regen - erative medicine.",Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
• Platelet Rich Plasma and Kidney Repair 14  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.13cardiac puncture to determine levels of BUN and Cr in serum.,Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
"• Platelet Rich Plasma and Kidney Repair http://jkms.org   15 https://doi.org/10.3346/jkms.2017.32.1.13age was estimated as (13):  V(shrinkage) = 1 − ( Area after / Area before )1.5  Final volume of kidney:  V(final kidney) =V(primary kidney) ×  (1−volume (shrinkage) ) Estimation of volume of connective tissue, cortex, and  medulla The total volume of connective tissue, cortex, and medulla were  estimated on the 5 µm sections stained by Masson Trichrome  and H & E. The slides were studied using a video-microscopy  system.",OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
• Platelet Rich Plasma and Kidney Repair 16  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.13glomerulus and renal corpuscle volume   Where the “ ∑Pstructure ” was the number of points hitting the profiles of structures above-mentioned and  “∑Ptotal of kidney ” was the number of points hitting the kidney.,OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
• Platelet Rich Plasma and Kidney Repair http://jkms.org   17 https://doi.org/10.3346/jkms.2017.32.1.13Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
"• Platelet Rich Plasma and Kidney Repair 18  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.13Statistical analysis Statistical analysis was performed using SPSS 20 (SPSS; IBM,  Armonk, NY, USA).",OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
• Platelet Rich Plasma and Kidney Repair http://jkms.org   19 https://doi.org/10.3346/jkms.2017.32.1.13Table 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
• Platelet Rich Plasma and Kidney Repair 20  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.13cortical convoluted tubules and cortex volume following GM  administration.,Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
"• Platelet Rich Plasma and Kidney Repair http://jkms.org   21 https://doi.org/10.3346/jkms.2017.32.1.13hadam A, Dehghani F .",Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
ORCID Abbas Moghadam http://orcid.org/0000-0002-5107-5569 Tahereh Talaei Khozani http://orcid.org/0000-0002-8425-8871 Afsaneh Mafi http://orcid.org/0000-0002-7160-5088 Mohammad Reza Namavar  http://orcid.org/0000-0002-6635- 2717 Farzaneh Dehghani http://orcid.org/0000-0003-2217-5672   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/05/jkms-32-13.PMC5143284.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Attitudes Regarding HPV Vaccinations of Children among  Mothers with Adolescent Daughters in Korea The aim of this study, carried out before the beginning of human papillomavirus (HPV)  vaccinations as a National Immunization Program (NIP) in Korea in 2016, is to assess the  ranges of perceptions and personal experience and their influences on attitudes regarding  HPV vaccinations of children, among mothers of adolescent (9–14 years of age) daughters  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
"Keywords:  Human Papillomavirus; Mothers’ Attitude; Adolescent; VaccinationKyong-No Lee,1 Kylie Hae-Jin Chang,2  Seong-Sik Cho,3 Sung-Ho Park,1   and Sung Taek Park1 1Department of Obstetrics and Gynecology, Hallym  University Kangnam Sacred Heart Hospital, Seoul,  Korea; 2Department of Obstetrics and Gynecology,  Samsung Medical Center, Sungkyunkwan University  School of Medicine, Seoul, Korea; 3Department of  Occupational and Environmental Medicine, Konkuk  University Chungju Hospital, Chungju, Korea Received: 24 June 2016 Accepted: 4 October 2016 Address for Correspondence: Sung Taek Park, MD Department of Obstetrics and Gynecology, Hallym University  School of Medicine, Kangnam Sacred Heart Hospital, 1, Singil- ro, Yeongdeungpo-gu, Seoul 07440, Korea E-mail: parkst96@naver.comhttps://doi.org/10.3346/jkms.2017.32.1.130  • J Korean Med Sci 2017; 32: 130-134 INTRODUCTION It is estimated that cervical cancer accounted for 3,100 (2.2%) of  all new cancers and 761 (2.6%) of all cancer deaths among Ko - rean women in 2015 (1,2).",Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
"• HPV Vaccination in Adolescent Girls http://jkms.org   131 https://doi.org/10.3346/jkms.2017.32.1.130MATERIALS AND METHODS Sample and setting From November 2015 to February 2016, we distributed a writ - ten questionnaire to 260 mothers who had daughters aged 9–14  in one elementary school and two middle schools in Seoul, Ko - rea.",Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
"• HPV Vaccination in Adolescent Girls 132  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.130who responded positively, the reasons included gaining protec - tion against cervical cancer (83 responses, 84%), physicians’  recommendations (13, 13%), their daughters having reached  the indicated age (2, 2%), and concerns about their daughters  being high-risk subjects (1, 1%).",Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
• HPV Vaccination in Adolescent Girls http://jkms.org   133 https://doi.org/10.3346/jkms.2017.32.1.130(18).,Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
ORCID Kyong-No Lee http://orcid.org/0000-0002-8796-0498 Kylie Hae-Jin Chang http://orcid.org/0000-0003-1010-5159 Seong-Sik Cho http://orcid.org/0000-0002-1875-1377 Sung-Ho Park http://orcid.org/0000-0003-2171-235X Sung Taek Park http://orcid.org/0000-0002-7841-4532 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
Available at http://www.who.int/immuni - zation/sage/meetings/2014/april/1_HPV_Evidence_based_recommen - dationsWHO_with_Appendices2_3.pdf [cited 10 June 2016].,OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
• HPV Vaccination in Adolescent Girls 134  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.130tion (CDC).,Non-OADS,/arxiv_data1/oa_pdf/54/96/jkms-32-130.PMC5143285.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Urologic Diseases in Korean Military Population: a 6-year  Epidemiological Review of Medical Records We sought to describe the incidence rate of the urologic disease in the Korean military by  reviewing diagnoses made in active duty soldiers from 2008 to 2013.",Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
"Keywords:  Epidemiology; Military; Urology; IncidenceSe Young Choi1,2 and Chang-gyo Yoon3 1Department of Urology, Il-dong Military Hospital,  Pocheon, Korea; 2Department of Urology, Asan  Medical Center, University of Ulsan College of  Medicine, Seoul, Korea; 3Department of Preventive  Medicine, The Armed Forces Medical Command,  Seongnam, Korea Received: 31 March 2016 Accepted: 15 September 2016 Address for Correspondence: Chang-gyo Yoon, MD Department of Preventive Medicine, The Armed Forces Medical  Command, 177, Saemaeul-ro, Bundang-gu, Seongnam 13574,  Republic of Korea E-mail: yoon.cg@gmail.comhttps://doi.org/10.3346/jkms.2017.32.1.135  • J Korean Med Sci 2017; 32: 135-142 INTRODUCTION The urologic disease that causes particular but common health  problems in a man’s life course not only affects quality of life  but also contributes shortening of survival.",Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
• Urologic Diseases in Korean Military 136  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.135MATERIALS AND METHODS Study population & data collection Eligible patients were searched through the Defense Medical  Statistics Information System (DMSIS) with criteria of male ac - tive duty members who had visited the Urology Department of  the military hospital between 1 January 2008 and 31 December  2013.,OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
• Urologic Diseases in Korean Military http://jkms.org   137 https://doi.org/10.3346/jkms.2017.32.1.135Medical Command (AFMC-14-IRB-048).,Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
• Urologic Diseases in Korean Military 138  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.135occupied two fifth of total hospitalized patients among ten ma - jor diseases.,OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
• Urologic Diseases in Korean Military http://jkms.org   139 https://doi.org/10.3346/jkms.2017.32.1.135incidence rates during the period than the Navy and the Air Force.,Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
• Urologic Diseases in Korean Military 140  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.135Table 7.,Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
"• Urologic Diseases in Korean Military http://jkms.org   141 https://doi.org/10.3346/jkms.2017.32.1.135is affected not only by disease occurrence but also by change of  health policy, transportation, and even unit training schedule.",Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
ORCID Se Young Choi http://orcid.org/0000-0002-4615-0966 Chang-gyo Yoon http://orcid.org/0000-0002-1543-4659 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
• Urologic Diseases in Korean Military 142  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.13510.,Non-OADS,/arxiv_data1/oa_pdf/5e/c3/jkms-32-135.PMC5143286.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Outdoor Air Pollution and Pterygium in Korea We investigated relationships between outdoor air pollution and pterygium in Korean  adults.",Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
"Received: 16 August 2016 Accepted: 5 October 2016 Address for Correspondence: Dong Hyun Kim, MD Department of Ophthalmology, Gachon University Gil Medical  Center, 21, Namdong-daero 774-beon-gil, Namdong-gu,  Incheon 21565, Republic of Korea E-mail: amidfree@gmail.comhttps://doi.org/10.3346/jkms.2017.32.1.143  • J Korean Med Sci 2017; 32: 143-150 INTRODUCTION According to the World Health Organization (WHO), air pollu - tion is of major public health concern, and its four common air  pollutants include particulate matter (PM), ozone (O 3), nitro - gen dioxide (NO 2), and sulfur dioxide (SO 2) (1).",Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
• Outdoor Air Pollution and Pterygium 144  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.143tioned method based on 2009 National Resident Demograph - ics.,OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
"• Outdoor Air Pollution and Pterygium http://jkms.org   145 https://doi.org/10.3346/jkms.2017.32.1.143RESULTS The baseline characteristics of 23,276 participants (9,961 men  and 13,315 women) were shown in Table 1.",OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
• Outdoor Air Pollution and Pterygium 146  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.143Fig.,Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
• Outdoor Air Pollution and Pterygium http://jkms.org   147 https://doi.org/10.3346/jkms.2017.32.1.143Table 3.,Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
• Outdoor Air Pollution and Pterygium 148  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.143Table 4.,Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
"• Outdoor Air Pollution and Pterygium http://jkms.org   149 https://doi.org/10.3346/jkms.2017.32.1.143poral exposure to air pollution on the ocular surface, although 2  years were not a long time enough to explain a cause-and-effect  relationship.",Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
ORCID Ki Woong Lee http://orcid.org/0000-0002-7989-1795 Yoon-Hyeong Choi http://orcid.org/0000-0003-3228-8179 Sung Ha Hwang http://orcid.org/0000-0003-2274-8573 Hae Jung Paik http://orcid.org/0000-0002-4187-9045 Mee Kum Kim http://orcid.org/0000-0001-7850-6894 Won Ryang Wee http://orcid.org/0000-0003-2590-5490 Dong Hyun Kim http://orcid.org/0000-0002-3985-990X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
• Outdoor Air Pollution and Pterygium 150  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.143Wee WR.,Non-OADS,/arxiv_data1/oa_pdf/8e/14/jkms-32-143.PMC5143287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differential Cell Count and CRP Level in Blood as Predictors for  Middle East Respiratory Syndrome Coronavirus Infection in  Acute Febrile Patients during Nosocomial Outbreak A case-control study was performed to identify clinical predictors for Middle East  respiratory syndrome coronavirus (MERS-CoV) infection among patients with acute febrile  illness during the nosocomial outbreak.",Non-OADS,/arxiv_data1/oa_pdf/c2/cd/jkms-32-151.PMC5143288.pdf
"Keywords:  Middle East Respiratory Syndrome; Coronavirus; Predictors; MonocytosisGa Eun Park,1 Cheol-In Kang,1   Jae-Hoon Ko,1 Sun Young Cho,1   Young Eun Ha,1 Yae-Jean Kim,2   Kyong Ran Peck,1 Jae-Hoon Song,1   and Doo Ryeon Chung1 1Division of Infectious Diseases, Department of  Medicine, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea;  2Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 20 June 2016 Accepted: 15 September 2016 Address for Correspondence: Cheol-In Kang, MD Division of Infectious Diseases, Department of Medicine,  Samsung Medical Center, Sungkyunkwan University School of  Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Korea E-mail: collacin@hotmail.comhttps://doi.org/10.3346/jkms.2017.32.1.151  • J Korean Med Sci 2017; 32: 151-154 The Republic of Korea experienced the largest outbreak of Mid - dle East respiratory syndrome coronavirus (MERS-CoV) infec - tion outside the Arabian Peninsula in 2015, including 186 labo - ratory-confirmed cases (1,2).",Non-OADS,/arxiv_data1/oa_pdf/c2/cd/jkms-32-151.PMC5143288.pdf
• Predictors for Middle East Respiratory Syndrome Coronavirus Infection  152  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.151Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/cd/jkms-32-151.PMC5143288.pdf
"• Predictors for Middle East Respiratory Syndrome Coronavirus Infection  http://jkms.org   153 https://doi.org/10.3346/jkms.2017.32.1.151ferase (ALT), aspartate aminotransferase (AST), and C-reactive  protein (CRP) levels.",Non-OADS,/arxiv_data1/oa_pdf/c2/cd/jkms-32-151.PMC5143288.pdf
• Predictors for Middle East Respiratory Syndrome Coronavirus Infection  154  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.151nosocomial outbreak setting.,Non-OADS,/arxiv_data1/oa_pdf/c2/cd/jkms-32-151.PMC5143288.pdf
ORCID Ga Eun Park http://orcid.org/0000-0001-7297-2683 Cheol-In Kang http://orcid.org/0000-0002-1741-4459 Jae-Hoon Ko http://orcid.org/0000-0002-9490-6609 Sun Young Cho http://orcid.org/0000-0001-9307-2369 Young Eun Ha http://orcid.org/0000-0001-5213-7082  Yae-Jean Kim http://orcid.org/0000-0002-8367-3424 Kyong Ran Peck http://orcid.org/0000-0002-7464-9780  Jae-Hoon Song http://orcid.org/0000-0001-5419-9789 Doo Ryeon Chung http://orcid.org/0000-0001-9267-101X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/cd/jkms-32-151.PMC5143288.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Pregnancy and Delivery in a Generalized Dystonia Patient  Treated with Internal Globus Pallidal Deep Brain Stimulation:   a Case Report Internal globus pallidus (GPi) deep brain stimulation (DBS) has been widely accepted as an  effective treatment modality of medically refractory dystonia.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/jkms-32-155.PMC5143289.pdf
"Keywords:  Deep Brain Stimulation; Dystonia; Globus Pallidus; Child Birth and CareHye Ran Park,1 Jae meen Lee,2   Hyeyoung Park,3 Chae Won Shin,3   Han-Joon Kim,3 Hee Pyoung Park,4   Dong Gyu Kim,2,5 Beom Seok Jeon,3,6   and Sun Ha Paek2,5 1Department of Neurosurgery, Soonchunhyang  University Seoul Hospital, Seoul, Korea; 2Department of Neurosurgery, Seoul National  University Hospital, Seoul, Korea; 3Department of Neurology, Seoul National  University Hospital, Seoul, Korea; 4Department of Anesthesiology and Pain Medicine,  Seoul National University Hospital, Seoul, Korea;  5Department of Neurosurgery, Seoul National  University College of Medicine, Seoul, Korea; 6Department of Neurology, Seoul National  University College of Medicine, Seoul, Korea Received: 24 August 2015 Accepted: 2 January 2016 Address for Correspondence: Sun Ha Paek, MD Department of Neurosurgery, Seoul National University Hospital, 103, Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: paeksh@snu.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.155  • J Korean Med Sci 2017; 32: 155-159 INTRODUCTION Dystonia, one of the most prevalent forms of movement disor ­ der, is defined as sustained or intermittent muscle contractions  usually producing twisting and repetitive movement or abnor ­ mal posture (1,2).",Non-OADS,/arxiv_data1/oa_pdf/ad/03/jkms-32-155.PMC5143289.pdf
• Deep Brain Stimulation and Pregnancy 156  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.1551A).,Non-OADS,/arxiv_data1/oa_pdf/ad/03/jkms-32-155.PMC5143289.pdf
• Deep Brain Stimulation and Pregnancy http://jkms.org   157 https://doi.org/10.3346/jkms.2017.32.1.155Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/03/jkms-32-155.PMC5143289.pdf
• Deep Brain Stimulation and Pregnancy 158  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.155genital anomaly.,Non-OADS,/arxiv_data1/oa_pdf/ad/03/jkms-32-155.PMC5143289.pdf
• Deep Brain Stimulation and Pregnancy http://jkms.org   159 https://doi.org/10.3346/jkms.2017.32.1.155ORCID Hye Ran Park http://orcid.org/0000­0003­0506­4882 Jae meen Lee http://orcid.org/0000­0002­5708­1644 Hyeyoung Park http://orcid.org/0000­0003­3504­4612 Chae Won Shin http://orcid.org/0000­0002­4157­492X Han­ Joon Kim http://orcid.org/0000­0001­8219­9663 Hee Pyoung Park http://orcid.org/0000­0002­4772­0780 Dong Gyu Kim http://orcid.org/0000­0002­5740­6189 Beom Seok Jeon http://orcid.org/0000­0003­2491­3544 Sun Ha Paek http://orcid.org/0000­0003­3007­8653   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/03/jkms-32-155.PMC5143289.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.1.160  • J Korean Med Sci 2017; 32: 160-161 Letter to the Editor:  Predatory Practices and How to   Circumvent Them: a Viewpoint from  India Vinod Ravindran,1 Durga Prasanna Misra,2 and Vir Singh Negi2 1Centre for Rheumatology, Calicut, Kerala, India; 2Department of Clinical  Immunology, Jawaharlal Institute of Postgraduate Medical Education and  Research, Puducherry, India Dear Editor-in-Chief, We read with great interest the articles on predatory practices  by Beall (1) and Gasparyan et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/31/jkms-32-160.PMC5143290.pdf
"• Predatory Practices: Viewpoint from India http://jkms.org   161 https://doi.org/10.3346/jkms.2017.32.1.160access publishing is a boon to clinical researcher provided it is  managed by reputed publishers, acquiring financial resources  from a professional society or a trust for the betterment of sci - ence without compromising good research practices and peer  review.",Non-OADS,/arxiv_data1/oa_pdf/0d/31/jkms-32-160.PMC5143290.pdf
ORCID Vinod Ravindran http://orcid.org/0000-0001-5842-1877 Durga Prasanna Misra http://orcid.org/0000-0002-5035-7396 Vir Singh Negi http://orcid.org/0000-0003-1518-6031 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/31/jkms-32-160.PMC5143290.pdf
Available at http://www.mciindia.org/Rules-and-Regulation/TEQ-REG - ULATIONS-16.05.15.pdf [accessed on 4 October 2016].,Non-OADS,/arxiv_data1/oa_pdf/0d/31/jkms-32-160.PMC5143290.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.1.162  • J Korean Med Sci 2017; 32: 162-163 Letter to the Editor:  Comment on Predatory Journals Fatema Jawad Department of Diabetology, Sindh Institute of Urology and Transplantation,  Karachi, Pakistan The wrong and deceptive method of inviting authors to publish  research in open-access journals with false metrics and no sta - bility has become a source of income for many publishers all  over the world.",Non-OADS,/arxiv_data1/oa_pdf/ed/83/jkms-32-162.PMC5143291.pdf
Jawad F • Comment on Predatory Journals http://jkms.org   163 https://doi.org/10.3346/jkms.2017.32.1.162ORCID Fatema Jawad http://orcid.org/0000-0003-4120-5072 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/83/jkms-32-162.PMC5143291.pdf
Available at http://www.goodreads.com/ quotes/57327-books-aren-t-written---they-re-rewritten-including-your- own-it [accessed on 16 October 2016].,Non-OADS,/arxiv_data1/oa_pdf/ed/83/jkms-32-162.PMC5143291.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.1.164  • J Korean Med Sci 2017; 32: 164CORRESPONDENCE Erratum: Correction of Funding Source The Burden of Cancer in Korea during 2012: Finding from a Prevalence-Based  Approach Young-hoon Gong, Seok-jun Yoon, Min-woo Jo, Arim Kim, Young Ae Kim, Jihyun Yoon, Hyeyoung Seo, Dong-woo Kim J Korean Med Sci.",Non-OADS,/arxiv_data1/oa_pdf/f2/ac/jkms-32-164.PMC5143292.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Impact of Initial Vancomycin Trough Concentration on Clinical  and Microbiological Outcomes of Methicillin-Resistant  Staphylococcus aureus  Bacteremia in Children It is important to use vancomycin in a proper manner to ensure optimal drug exposure.",Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
2014-0300).https://doi.org/10.3346/jkms.2017.32.1.22  • J Korean Med Sci 2017; 32: 22-28 INTRODUCTION Vancomycin is a glycopeptide antimicrobial with an important  therapeutic role in treating invasive methicillin-resistant Staph - ylococcus aureus  (MRSA) infection in children in community- associated (CA) and healthcare-associated (HA) settings (1).,Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
"• Vancomycin in Pediatric MRSA Bacteremia http://jkms.org   23 https://doi.org/10.3346/jkms.2017.32.1.22MRSA bacteremia is most common in premature infants and  immunocompromised individuals, even though vancomycin  trough serum concentrations ≥ 15 µg/mL are achieved (8).",Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
"• Vancomycin in Pediatric MRSA Bacteremia 24  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.22Asan Medical Center with a waiver of informed consent for ret - rospective, de-identified data collection and analysis (IRB No.",Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
"• Vancomycin in Pediatric MRSA Bacteremia http://jkms.org   25 https://doi.org/10.3346/jkms.2017.32.1.22ings such as vomiting or nausea were observed as an initial symp - tom in 5 (10.9%) patients, and 1 (2.2%) patient had no clinical  symptoms other than a finding of elevated C-reactive protein  (CRP).",Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
• Vancomycin in Pediatric MRSA Bacteremia 26  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.22day fatality (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
• Vancomycin in Pediatric MRSA Bacteremia http://jkms.org   27 https://doi.org/10.3346/jkms.2017.32.1.22ducted every 48 to 72 hours until a negative result is obtained in  our institute.,Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
Final approval of manu - script submission: all authors.ORCID Ree Nar Yoo http://orcid.org/0000-0003-1288-7158 Seo Hee Kim http://orcid.org/0000-0001-7564-7675 Jina Lee http://orcid.org/0000-0002-3435-251X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
"• Vancomycin in Pediatric MRSA Bacteremia 28  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.22resistant, extensively drug-resistant and pandrug-resistant bacteria: an  international expert proposal for interim standard definitions for acquired  resistance.",Non-OADS,/arxiv_data1/oa_pdf/a6/14/jkms-32-22.PMC5143293.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Seroprevalence of Severe Fever with Thrombocytopenia  Syndrome in Southeastern Korea, 2015 Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease  characterized by fever, thrombocytopenia and diarrhea.",Non-OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
"Keywords:  Bunyaviridae Infections; Zoonosis; Seroepidemiologic Studies; Communicable  Diseases, EmergingKye-Hyung Kim,1,2 Mee Kyung Ko,2,3  Namhee Kim,2,3 Hyung Hoi Kim,2,3   and Jongyoun Yi2,3 1Department of Internal Medicine, Pusan National  University School of Medicine, Busan, Korea;  2Department of Laboratory Medicine, Pusan  National University School of Medicine, Busan,  Korea; 3Biomedical Research Institute, Pusan  National University Hospital, Busan, Korea Received: 25 July 2016 Accepted: 11 September 2016 Address for Correspondence: Jongyoun Yi, MD Department of Laboratory Medicine, Pusan National University  School of Medicine, 179, Gudeok-ro, Seo-gu, Busan 49241,  Republic of Korea E-mail: socioliberal@yahoo.co.kr Funding:  This research was supported by Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Education (grant number  NRF-2014R1A1A4A01009748).https://doi.org/10.3346/jkms.2017.32.1.29  • J Korean Med Sci 2017; 32: 29-32 INTRODUCTION Severe fever with thrombocytopenia syndrome (SFTS) is an emerg - ing tick-borne disease caused by a novel bunyavirus known as  SFTS virus (SFTSV), which was first reported in China in 2011  (1).",Non-OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
"Busan is the sec - ond-largest city in Korea and has a population of 3.6 million,  with –0.006% of which are involved in farming, according to the  Census of Agriculture, Forestry and Fisheries of the Republic of  Korea (http://www.kosis.kr).",Non-OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
"• Seroprevalence of SFTS in Korea 30  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.29ences in seroprevalence between urban and rural areas, we de - fined urban areas as an address in a metropolitan city or city  according to the classification of the Local Autonomy Act, Stat - utes of the Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
"Annual incidences of SFTS To calculate regional annual incidences, annual numbers of  cases of SFTS from the Disease Web Statistics System, KCDC  (http://is.cdc.go.kr/) and population statistics based on resident  registration (http://www.kosis.kr) were used.",OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
"• Seroprevalence of SFTS in Korea http://jkms.org   31 https://doi.org/10.3346/jkms.2017.32.1.29from Busan (2.1%, 18/838) and Gyeongnam Province (2.1%,  4/191).",Non-OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
• Seroprevalence of SFTS in Korea 32  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.29ORCID Kye-Hyung Kim http://orcid.org/0000-0001-9682-9654 Mee Kyung Ko http://orcid.org/0000-0002-3974-7852 Namhee Kim http://orcid.org/0000-0003-0844-5058 Hyung Hoi Kim http://orcid.org/0000-0003-3989-2037 Jongyoun Yi http://orcid.org/0000-0001-9098-3765 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/48/jkms-32-29.PMC5143294.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Polymorphisms of Promoter Region of TNF-α Gene in Iranian  Azeri Turkish Patients with Behçet’s Disease Behçet’s disease (BD) is a complex chronic relapsing inflammatory disorder of unknown  etiology.",Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
"Keywords:  Behçet’s Disease; Tumor Necrosis Factor- α; Iranian Azeri Turks; PolymorphismReza Abdolmohammadi1,2   and Mortaza Bonyadi1,3 1Liver & Gastrointestinal Disease Research Center,  Tabriz University of Medical Sciences, Tabriz, Iran; 2Department of Biology, Faculty of Natural Sciences,  University of Tabriz, Tabriz, Iran; 3Department of  Molecular-Medical Genetics, Center of Excellence  for Biodiversity, Faculty of Natural Sciences,  University of Tabriz, Tabriz, Iran Received: 4 November 2013 Accepted: 24 May 2014 Address for Correspondence: Mortaza Bonyadi Department of Molecular-Medical Genetics, Center of  Excellence for Biodiversity, Faculty of Natural Sciences,  University of Tabriz, Tabriz 51368, Iran E-mail: Jabbarpour@tabrizu.ac.ir Funding:  This project was financially supported by the Center of  Excellence for Biodiversity, University of Tabriz, Iran.https://doi.org/10.3346/jkms.2017.32.1.33  • J Korean Med Sci 2017; 32: 33-37 INTRODUCTION Behçet’s disease (BD) is a complex chronic relapsing inflam - matory disorder which is more common along the Mediterra - nean and Eastern Asia, than in the other areas (1).",Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
• TNF-α Polymorphisms in Behçet’s Disease Patients 34  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.33jects.,Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
• TNF-α Polymorphisms in Behçet’s Disease Patients http://jkms.org   35 https://doi.org/10.3346/jkms.2017.32.1.33Table 2.,Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
"• TNF-α Polymorphisms in Behçet’s Disease Patients 36  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.33the TNF  genes’ biological properties and roles of these cytokines  in inﬂammatory disorders, it has been postulated that polymor - phic TNF  genes could play an important role in the BD (24).",Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
ORCID Reza Abdolmohammadi http://orcid.org/0000-0002-6670-6781 Mortaza Bonyadi http://orcid.org/0000-0003-3216-2947 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
• TNF-α Polymorphisms in Behçet’s Disease Patients http://jkms.org   37 https://doi.org/10.3346/jkms.2017.32.1.33Hippocrates to the third millennium.,Non-OADS,/arxiv_data1/oa_pdf/8d/b7/jkms-32-33.PMC5143295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357BRAF -Mutated Colorectal Cancer Exhibits Distinct  Clinicopathological Features from Wild-Type BRAF -Expressing  Cancer Independent of the Microsatellite Instability Status In patients with colorectal cancer (CRC), the BRAF V600E mutation has been reported to  be associated with several clinicopathological features and poor survival.",Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
"Received: 24 May 2016 Accepted: 15 September 2016 Address for Correspondence: Hye Seung Han, MD Department of Pathology, Konkuk University School of Medicine, 120-1, Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea E-mail: 20040002@kuh.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.38  • J Korean Med Sci 2017; 32: 38-46 INTRODUCTION Colorectal cancer (CRC) is among the leading causes of cancer- related death worldwide (1) and is also the fourth-leading cause  of death among Korean cancer patients, based on a 2013 report  from the Korean National Cancer Center (2).",Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer http://jkms.org   39 https://doi.org/10.3346/jkms.2017.32.1.38clinicopathological features of CRC and to validate the clinical  significance of this mutation with regard to survival prognosis.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer 40  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.38Health Organization (WHO) classification.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer http://jkms.org   41 https://doi.org/10.3346/jkms.2017.32.1.38Most cases involved locally advanced tumors.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer 42  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.38than did the MSS/MSI-L subgroup.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer http://jkms.org   43 https://doi.org/10.3346/jkms.2017.32.1.38 We also evaluated the clinicopathological characteristics of  CRCs with respect to BRAF  V600E mutation status in the MSS/ MSI-L subgroup (Supplementary Table 1).,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer 44  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.38Fig.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer http://jkms.org   45 https://doi.org/10.3346/jkms.2017.32.1.38BRAF  mutation.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
ORCID Min Hye Jang http://orcid.org/0000-0002-4270-8897 Sehun Kim http://orcid.org/0000-0002-2637-9229 Dae Yong Hwang http://orcid.org/0000-0001-9082-8431 Wook Youn Kim http://orcid.org/0000-0003-4024-8791 So Dug Lim http://orcid.org/0000-0003-2036-0313 Wan Seop Kim http://orcid.org/0000-0001-7704-5942 Tea Sook Hwang http://orcid.org/0000-0002-3602-9257 Hye Seung Han http://orcid.org/0000-0002-3591-9995 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
Available at http://www.cancer.go.kr/mbs/cancer/subview.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
• Distinct Features of BRAF-Mutated Colorectal Cancer 46  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.38Cancer Res 2008; 14: 3408-15.,Non-OADS,/arxiv_data1/oa_pdf/a3/96/jkms-32-38.PMC5143296.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Having a Physician Rather than a Place as a Usual Source of Care  Would Be Better - from 2012 Korea Health Panel Data A usual source of care (USC) in primary care improves health care quality and can result in  improved health.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
"Keywords:  Primary Health Care; Health Policy; Korea; Surveys and QuestionnairesKyeong-min Kim, Hyunsoo Jeon,   and Jae-Ho Lee Department of Family Medicine, The Catholic  University of Korea College of Medicine, Seoul,  Korea Received: 9 June 2016 Accepted: 10 September 2016 Address for Correspondence: Jae-Ho Lee, MD Department of Family Medicine, The Catholic University of  Korea College of Medicine, 222, Banpo-daero, Seocho-gu,   Seoul 06951, Korea E-mail: jaeholee@catholic.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.4  • J Korean Med Sci 2017; 32: 4-12 INTRODUCTION One’s usual source of care (USC) is “the particular medical pro - fessional, doctor’s office, clinic, health center, or other place  where a person would usually go if sick or in need of advice about  his or her health (1).",Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
"• A Usual Physician is Better than a Usual Place http://jkms.org   5 https://doi.org/10.3346/jkms.2017.32.1.4medicine as a specialty was officially incepted for providing pri - mary care services in 1986 (15,16).",Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
• A Usual Physician is Better than a Usual Place 6  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.4tional Safety and Health Act of Korea so that their patterns seek - ing medical care services could be different from those of self- employed people.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
"Ethics statement This study was approved by the Institutional Review Board of  the Catholic University of Korea with a waiver for informed con - sent because the data were obtained from a public database  (https://www.khp.re.kr:444/, IRB approval No.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
"• A Usual Physician is Better than a Usual Place http://jkms.org   7 https://doi.org/10.3346/jkms.2017.32.1.4sician with a place (799,969 ± 1,168,298 won/year) ( P> 0.05)  (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
• A Usual Physician is Better than a Usual Place 8  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.41.46; P= 0.013) for poor (vs. good) subjective health.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
• A Usual Physician is Better than a Usual Place http://jkms.org   9 https://doi.org/10.3346/jkms.2017.32.1.4P= 0.136 for having had ER visits.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
• A Usual Physician is Better than a Usual Place 10  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.4Table 4.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
"• A Usual Physician is Better than a Usual Place http://jkms.org   11 https://doi.org/10.3346/jkms.2017.32.1.4Kong, 60.2% (n = 1,896) of respondents had a regular primary  care doctor out of 3,148 subjects.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
ORCID Kyeong-min Kim http://orcid.org/0000-0002-7747-3944 Hyunsoo Jeon http://orcid.org/0000-0002-3903-9696 Jae-Ho Lee http://orcid.org/0000-0001-5184-7437 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
• A Usual Physician is Better than a Usual Place 12  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.4difference?,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
Available at http://www.oecd.org/els/health-sys - tems/health-data.htm [accessed on 11 May 2016].,OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
Available at: http://www.law.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
Available at http://health.re.kr/wp-content/up - loads/2015/09/20150916_012656.pdf [accessed on 18 August 2016].,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
Available at http://www.kingsfund.org.uk/sites/files/kf/ Avoiding-Hospital-Admissions-Sarah-Purdy-December2010.pdf [accessed  on 14 May 2016].,Non-OADS,/arxiv_data1/oa_pdf/ff/80/jkms-32-4.PMC5143297.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Role of Pharmacomechanical Endovascular Intervention for  Iliofemoral Vein Thrombosis Compared to Conventional  Anticoagulation Therapy Although anticoagulation therapy is the primary treatment for deep vein thrombosis (DVT),  it has not been associated with the rapid recanalization of the venous occlusion.",Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
"Keywords:  Venous Thrombosis; Post-thrombotic Syndrome; Endovascular Procedure;  Deep Vein Thrombosis AnticoagulantsIn-sub Kim and Won-Min Jo Department of Thoracic and Cardiovascular Surgery,  Korea University Ansan Hospital, Ansan, Korea Received: 7 May 2016 Accepted: 14 September 2016 Address for Correspondence: Won-Min Jo, MD Department of Thoracic and Cardiovascular Surgery, Korea  University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu,  Ansan 15355, Republic of Korea E-mail: jowonmin@korea.ac.kr Funding:  This work was supported by Korea University Grant  (K1609851).https://doi.org/10.3346/jkms.2017.32.1.47  • J Korean Med Sci 2017; 32: 47-53 INTRODUCTION The incidence of first deep vein thrombosis (DVT) in the gener - al population is about 5 per 10,000 person years (1).",Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
"• Pharmacomechanical Endovascular Intervention in Iliofemoral Thrombosis 48  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.47venography, and conventional venography), from January 2004  to December 2013.",Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
• Pharmacomechanical Endovascular Intervention in Iliofemoral Thrombosis http://jkms.org   49 https://doi.org/10.3346/jkms.2017.32.1.47group ( P= 0.035).,Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
• Pharmacomechanical Endovascular Intervention in Iliofemoral Thrombosis 50  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.47Table 4.,Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
"• Pharmacomechanical Endovascular Intervention in Iliofemoral Thrombosis http://jkms.org   51 https://doi.org/10.3346/jkms.2017.32.1.47DISCUSSION Despite its long history in the medical literature, the etiology of  venous thrombosis was only elucidated in 1856 by Virchow and  Sevitt (14,15), and the treatment of DVT began relatively recent - ly in the 1930s (16).",Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
"• Pharmacomechanical Endovascular Intervention in Iliofemoral Thrombosis 52  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.47develop mild PTS, and 13% of DVT patients have moderate to  severe PTS.",Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
Approval of final manuscript: all authors.ORCID In-sub Kim http://orcid.org/0000-0002-1773-0072 Won-Min Jo http://orcid.org/0000-0002-0082-0098  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
• Pharmacomechanical Endovascular Intervention in Iliofemoral Thrombosis http://jkms.org   53 https://doi.org/10.3346/jkms.2017.32.1.4715.,Non-OADS,/arxiv_data1/oa_pdf/c1/23/jkms-32-47.PMC5143298.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Associations between Soluble Receptor for Advanced Glycation  End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality  in Long-term Hemodialysis Patients Hemodialysis (HD) patients experience vascular calcification, ultimately leading to high  mortality rates.",Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
"Received: 7 July 2016 Accepted: 9 October 2016 Address for Correspondence: Ji Yong Jung, MD Division of Nephrology, Department of Internal Medicine,  Gachon University Gil Medical Center, 21, Namdong-daero  774-beon-gil, Namdong-gu, Incheon 21565, Republic of Korea E-mail: jyjung@gachon.ac.krhttps://doi.org/10.3346/jkms.2017.32.1.54  • J Korean Med Sci 2017; 32: 54-59 INTRODUCTION Mortality in hemodialysis (HD) patients is higher than in the  general population, and cardiovascular disease (CVD) is the  leading cause of death (1).",Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
• RAGEs and Mortality in HD Patients http://jkms.org   55 https://doi.org/10.3346/jkms.2017.32.1.54box 1 (11).,Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
• RAGEs and Mortality in HD Patients 56  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.54yses results are presented as hazard ratios (HRs) and 95% confi - dence intervals (CIs).,OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
• RAGEs and Mortality in HD Patients http://jkms.org   57 https://doi.org/10.3346/jkms.2017.32.1.54iate analysis.,Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
• RAGEs and Mortality in HD Patients 58  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.5418.79 ng/mL) were correlated with overall mortality (S100A12  ≥ 18.79 ng/mL; HR 2.267; 95% CI 1.195–4.302; P= 0.012).,Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
ORCID Eul Sik Jung http://orcid.org/0000-0003-3898-4693 Wookyung Chung http://orcid.org/0000-0001-7657-130X Ae Jin Kim http://orcid.org/0000-0001-5017-8649 Han Ro http://orcid.org/0000-0001-7170-0571 Jae Hyun Chang http://orcid.org/0000-0003-3947-0715 Hyun Hee Lee http://orcid.org/0000-0002-0319-6390 Ji Yong Jung http://orcid.org/0000-0003-1271-8012   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
• RAGEs and Mortality in HD Patients http://jkms.org   59 https://doi.org/10.3346/jkms.2017.32.1.54with end-stage renal disease.,Non-OADS,/arxiv_data1/oa_pdf/cf/04/jkms-32-54.PMC5143299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Lobeglitazone, a Novel Thiazolidinedione, Improves Non- Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and  Predictive Factors Related to Responsiveness Despite the rapidly increasing prevalence of non-alcoholic fatty liver disease (NAFLD) in  type 2 diabetes (T2D), few treatment modalities are currently available.",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"The funders had no role in study  design, data collection and analysis, decision to publish, or  preparation of the manuscript.https://doi.org/10.3346/jkms.2017.32.1.60  • J Korean Med Sci 2017; 32: 60-69 INTRODUCTION Obesity is a worldwide epidemic that leads to the development  of chronic metabolic disorders, such as type 2 diabetes (T2D),  cardiovascular disease, and non-alcoholic fatty liver disease  (NALFD) (1-3).",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"• Lobeglitazone for NAFLD in Type 2 Diabetes http://jkms.org   61 https://doi.org/10.3346/jkms.2017.32.1.60called controlled attenuation parameter (CAP), has been devel - oped based on the properties of ultrasonic signals examined by  transient liver elastography (Fibroscan®; Echosens, Paris, France).",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"• Lobeglitazone for NAFLD in Type 2 Diabetes 62  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.60an accurate CAP value, we only calculated US attenuation when  the matched LSM was valid, while attempting to collect ≥ 10  valid LSMs.",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
• Lobeglitazone for NAFLD in Type 2 Diabetes http://jkms.org   63 https://doi.org/10.3346/jkms.2017.32.1.6024 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"• Lobeglitazone for NAFLD in Type 2 Diabetes 64  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.60Changes in glycemic, lipid, and hepatic profiles after  lobeglitazone treatment for 24 weeks Among secondary endpoints, the 24-week treatment with lobe - glitazone significantly improved glycemic parameters, such as  GA and the fasting levels of glucose and insulin ( P< 0.001) (Ta - ble 2).",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
• Lobeglitazone for NAFLD in Type 2 Diabetes http://jkms.org   65 https://doi.org/10.3346/jkms.2017.32.1.60pendent variables (Tables 3 and 4).,Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
• Lobeglitazone for NAFLD in Type 2 Diabetes 66  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.60es in LSM and ALT levels.,Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"• Lobeglitazone for NAFLD in Type 2 Diabetes http://jkms.org   67 https://doi.org/10.3346/jkms.2017.32.1.60 There have been studies that investigate the pharmacologic  mechanisms of TZDs in altering fat content and adipocytes (13),  and these mechanisms are thought to positively affect the dis - tribution of fat mass and the proliferation of adipocytes result - ing in weight gain (32).",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"• Lobeglitazone for NAFLD in Type 2 Diabetes 68  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.60of the manuscript: Lee YH, Kim JH, Kim SR, Lee BW.",Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
ORCID Yong-ho Lee http://orcid.org/0000-0002-6219-4942 Jae Hyeon Kim http://orcid.org/0000-0001-5001-963X So Ra Kim http://orcid.org/0000-0002-5778-370X Heung Yong Jin http://orcid.org/0000-0002-1841-2092 Eun-Jung Rhee http://orcid.org/0000-0002-6108-7758 Young Min Cho http://orcid.org/0000-0002-2331-6126 Byung-Wan Lee http://orcid.org/0000-0002-9899-4992   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
• Lobeglitazone for NAFLD in Type 2 Diabetes http://jkms.org   69 https://doi.org/10.3346/jkms.2017.32.1.6025.,Non-OADS,/arxiv_data1/oa_pdf/d0/b6/jkms-32-60.PMC5143300.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association between Lumbar Bone Mineral Density and Carotid  Intima-Media Thickness in Korean Adults: a Cross-sectional  Study of Healthy Twin Study Bone mineral density (BMD) has been suggested to be associated with atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
This study was  supported by Samsung Biomedical Research Institute  (SMO1161741).https://doi.org/10.3346/jkms.2017.32.1.70  • J Korean Med Sci 2017; 32: 70-76 INTRODUCTION Low bone mineral density (BMD) and atherosclerosis are de - generative changes commonly accompanying aging.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
"• Lumbar Bone Mineral Density and Carotid Atherosclerosis http://jkms.org   71 https://doi.org/10.3346/jkms.2017.32.1.70 To resolve these discrepancies, we evaluated the association  between BMD and segment-specific CIMT according to sex and  menopausal status with adjustment for a wide range of cardio - vascular risk factors.",Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
• Lumbar Bone Mineral Density and Carotid Atherosclerosis 72  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.70variables and the chi-square test for categorical  variables.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
• Lumbar Bone Mineral Density and Carotid Atherosclerosis http://jkms.org   73 https://doi.org/10.3346/jkms.2017.32.1.70Table 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
• Lumbar Bone Mineral Density and Carotid Atherosclerosis 74  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.70and CIMT depending on the age level in men (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
• Lumbar Bone Mineral Density and Carotid Atherosclerosis http://jkms.org   75 https://doi.org/10.3346/jkms.2017.32.1.70our study.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
ORCID Jinyoung Shin http://orcid.org/0000-0001-9558-1853 Joo-Hyun Park http://orcid.org/0000-0002-4358-4208 Yun-Mi Song http://orcid.org/0000-0001-9232-5563 Kayoung Lee http://orcid.org/0000-0002-2816-554X Joohon Sung http://orcid.org/0000-0001-9948-0160 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
• Lumbar Bone Mineral Density and Carotid Atherosclerosis 76  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.70is related to atherosclerosis in postmenopausal Moroccan women.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/jkms-32-70.PMC5143301.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus  Fluoroquinolone among Patients with Severe Community- Acquired Pneumonia?",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
"Keywords:  Pneumonia; Intensive Care Units; Mortality; Macrolides; FluoroquinoloneJong Hoo Lee,1 Hyun Jung Kim,2   and Yee Hyung Kim3 1Department of Internal Medicine, Jeju National  University Hospital, Jeju, Korea; 2Institute for  Evidence-based Medicine, Department of Preventive  Medicine, Korea University College of Medicine,  Seoul, Korea; 3Division of Pulmonary and Critical  Care Medicine, Department of Internal Medicine,  Kyung Hee University Hospital at Gangdong, Seoul,  Korea Received: 2 May 2016 Accepted: 15 September 2016 Address for Correspondence: Yee Hyung Kim, MD Division of Pulmonary and Critical Care Medicine, Department  of Internal Medicine, Kyung Hee University Hospital at  Gangdong, 892, Dongnam-ro, Gangdong-gu, Seoul 05278, Korea E-mail: yhkim2007@hotmail.co.kr Funding:  This research was supported by the 2016 scientific  promotion program funded by Jeju National University.https://doi.org/10.3346/jkms.2017.32.1.77  • J Korean Med Sci 2017; 32: 77-84 INTRODUCTION Community-acquired pneumonia (CAP) is a leading cause of  infectious death worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
"• Antibiotic Therapies for Severe Community-Acquired Pneumonia 78  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.77“Pneumonia, Bacterial.",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
• Antibiotic Therapies for Severe Community-Acquired Pneumonia http://jkms.org   79 https://doi.org/10.3346/jkms.2017.32.1.77 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
"• Antibiotic Therapies for Severe Community-Acquired Pneumonia 80  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.77> 50%, indicating a substantial level of between-study hetero - geneity.",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
• Antibiotic Therapies for Severe Community-Acquired Pneumonia http://jkms.org   81 https://doi.org/10.3346/jkms.2017.32.1.77Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
• Antibiotic Therapies for Severe Community-Acquired Pneumonia 82  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.77Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
• Antibiotic Therapies for Severe Community-Acquired Pneumonia http://jkms.org   83 https://doi.org/10.3346/jkms.2017.32.1.77important issues in antibiotic trials.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
ORCID Jong Hoo Lee http://orcid.org/0000-0003-2626-7099 Hyun Jung Kim http://orcid.org/0000-0003-2018-2385 Yee Hyung Kim http://orcid.org/0000-0002-2921-0314 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
• Antibiotic Therapies for Severe Community-Acquired Pneumonia 84  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.77community-acquired pneumonia: a systematic review and meta-analy - sis.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/jkms-32-77.PMC5143302.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Physicians Should Provide Shared Decision-Making for Anti-TNF  Therapy to Inflammatory Bowel Disease Patients Shared decision-making may increase the effectiveness of inflammatory bowel disease (IBD)  treatment, as different anti-tumor necrosis factor (anti-TNF) administrations may have  different effects on the quality of life (QOL).",Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
"Received: 14 April 2016 Accepted: 9 October 2016 Address for Correspondence: Suk-Kyun Yang, MD Department of Gastroenterology, University of Ulsan College of  Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa- gu, Seoul 05505, Korea E-mail: sky@amc.seoul.kr Funding:  This study was supported by a grant of the Korean  Health Technology R &D Project, Ministry of Health and Welfare,  Republic of Korea (A120176).https://doi.org/10.3346/jkms.2017.32.1.85  • J Korean Med Sci 2017; 32: 85-94 INTRODUCTION Inflammatory bowel disease (IBD) is a chronic, disabling disor - der of the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
"• Preference for anti-TNF therapy in IBD 86  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.85may be influenced by demographic factors, knowledge about  IBD, their experience and relationship with healthcare profes - sionals (14).",Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
"The information sheet provides  patients with reliable, accurate, and unbiased information to  help them choose an appropriate anti-TNF therapy based on  information provided by the Crohn’s and Colitis Foundation of  America (http://www.ccfa.org/resources/biologic-therapies.",Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
"• Preference for anti-TNF therapy in IBD http://jkms.org   87 https://doi.org/10.3346/jkms.2017.32.1.85analysis was performed using the Statistical Package for the So - cial Sciences (SPSS) version 18.0 for Windows (SPSS Inc., Chi - cago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
"• Preference for anti-TNF therapy in IBD 88  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.85 Demographic, clinical, and disease-related characteristics of  IBD patients were compared according to the patients’ prefer - ence to anti-TNF therapies.",Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
• Preference for anti-TNF therapy in IBD http://jkms.org   89 https://doi.org/10.3346/jkms.2017.32.1.85other study reported that subcutaneous anti-TNF was preferred  over intravenous anti-TNFs (1.8:1) in 36 CD patients (9).,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
ORCID Jae Myung Cha http://orcid.org/0000-0001-9403-230X Dong Il Park http://orcid.org/0000-0003-2307-8575 Sang Hyoung Park http://orcid.org/0000-0002-5366-5749 Jeong Eun Shin http://orcid.org/0000-0001-5706-3967 Wan Soo Kim http://orcid.org/0000-0001-9545-0140 Suk-Kyun Yang http://orcid.org/0000-0003-2772-2575,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
• Preference for anti-TNF therapy in IBD 90  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.85REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
• Preference for anti-TNF therapy in IBD http://jkms.org   91 https://doi.org/10.3346/jkms.2017.32.1.85Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
• Preference for anti-TNF therapy in IBD 92  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.85Appendix 2.,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
• Preference for anti-TNF therapy in IBD http://jkms.org   93 https://doi.org/10.3346/jkms.2017.32.1.85Appendix 3.,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
• Preference for anti-TNF therapy in IBD 94  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.85Appendix 4.,Non-OADS,/arxiv_data1/oa_pdf/7a/19/jkms-32-85.PMC5143303.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty  Liver Disease?",Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
"Keywords:  Vitamin D; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome X;   Intra-Abdominal Fat; SexDanbee Park,1 Hyuktae Kwon,1,2   Seung-Won Oh,2 Hee-Kyung Joh,1,3,4  Seung-sik Hwang,5 Jin Ho Park,1   Jae Moon Yun,1 Hyejin Lee,1   Goh Eun Chung,6 Sangjoon Ze,1   Jae Hong Park,1 Yeseul Bae,1   and Arang Lee1 1Department of Family Medicine, Seoul National  University Hospital, Seoul, Korea; 2Department of  Family Medicine, Healthcare System Gangnam  Center, Seoul National University Hospital, Seoul,  Korea; 3Department of Medicine, Seoul National  University College of Medicine, Seoul, Korea;  4Department of Family Medicine, Seoul National  University Health Service Center, Seoul, Korea;  5Department of Social and Preventive Medicine,  Inha University School of Medicine, Incheon, Korea;  6Department of Internal Medicine, Healthcare  System Gangnam Center, Seoul National University  Hospital, Seoul, Korea Received: 25 June 2016 Accepted: 8 October 2016 Address for Correspondence: Hyuktae Kwon, MD Department of Family Medicine, Seoul National University  Hospital, 101, Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: hyuktae@gmail.com Funding:  This work was supported by the Technology Innovation  Program (10050154, Business Model Development for  Personalized Medicine Based on Integrated Genome and Clinical  Information) funded by the Ministry of Trade, Industry and  Energy (MI, Korea).https://doi.org/10.3346/jkms.2017.32.1.95  • J Korean Med Sci 2017; 32: 95-101 INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) includes simple fatty  liver, nonalcoholic steatohepatitis, cirrhosis, and hepatocellular  carcinoma (1).",Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
• Vitamin D and Nonalcoholic Fatty Liver Disease 96  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.95gested that a low vitamin D level is related to NAFLD after con - trolling for visceral fat in subjects with diabetes or IR (14).,Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
"• Vitamin D and Nonalcoholic Fatty Liver Disease http://jkms.org   97 https://doi.org/10.3346/jkms.2017.32.1.95ferase (ALT), gamma glutamyltransferase (GGT), calcium, phos - phorus, hepatitis B surface antigen, antibody to hepatitis C vi - rus, and 25(OH)D 3 levels.",Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
• Vitamin D and Nonalcoholic Fatty Liver Disease 98  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.95Table 1.,Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
• Vitamin D and Nonalcoholic Fatty Liver Disease http://jkms.org   99 https://doi.org/10.3346/jkms.2017.32.1.95Vitamin D deficiency and NAFLD Table 3 shows that the odds ratio (OR) for NAFLD increased se - quentially with a deteriorating vitamin D status in all models.,Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
• Vitamin D and Nonalcoholic Fatty Liver Disease 100  http://jkms.org https://doi.org/10.3346/jkms.2017.32.1.95cy is a risk factor of NAFLD (21).,Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
ORCID Danbee Park http://orcid.org/0000-0003-1402-4890 Hyuktae Kwon http://orcid.org/0000-0002-0312-3650 Seung-Won Oh http://orcid.org/0000-0003-3800-0754 Hee-Kyung Joh http://orcid.org/0000-0003-3854-7012 Seung-sik Hwang http://orcid.org/0000-0002-1558-7831 Jin Ho Park http://orcid.org/0000-0002-3942-6813 Jae Moon Yun http://orcid.org/0000-0003-0927-4721 Hyejin Lee http://orcid.org/0000-0001-5279-340X Goh Eun Chung http://orcid.org/0000-0001-9755-0452 Sangjoon Ze http://orcid.org/0000-0003-3641-8081 Jae Hong Park http://orcid.org/0000-0002-7653-491X Yeseul Bae http://orcid.org/0000-0003-0763-5458 Arang Lee http://orcid.org/0000-0002-5899-3602 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
• Vitamin D and Nonalcoholic Fatty Liver Disease http://jkms.org   101 https://doi.org/10.3346/jkms.2017.32.1.95can Gastroenterological Association.,Non-OADS,/arxiv_data1/oa_pdf/de/44/jkms-32-95.PMC5143304.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/2f/main.PMC5143339.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.005,OADS,/arxiv_data1/oa_pdf/30/2f/main.PMC5143339.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/8b/main.PMC5143350.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.001,OADS,/arxiv_data1/oa_pdf/91/8b/main.PMC5143350.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/4d/main.PMC5143351.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.007,OADS,/arxiv_data1/oa_pdf/68/4d/main.PMC5143351.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/64/main.PMC5143352.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.004,OADS,/arxiv_data1/oa_pdf/ab/64/main.PMC5143352.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/19/main.PMC5143353.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.003,OADS,/arxiv_data1/oa_pdf/f6/19/main.PMC5143353.pdf
The cutoff point for the PHGDH expression score was computed usingthe X-tile software program ( http://www.tissuearray.org/rimmlab ) [15].,OADS,/arxiv_data1/oa_pdf/f6/19/main.PMC5143353.pdf
The level 3 TCGA data(TCGA_LUNG_exp_HiSeqV2 –2015 –02-24) were obtained at the website of UCSC cancer browser ( http://genome-cancer.ucsc.edu ).,OADS,/arxiv_data1/oa_pdf/f6/19/main.PMC5143353.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2016.09.011,Non-OADS,/arxiv_data1/oa_pdf/4c/ab/main.PMC5143354.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: WillpowerSelf-controlRecoveryQualitative researchTrait self-controlStrategies 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/05/main.PMC5143362.pdf
http://dx.doi.org/10.1016/j.abrep.2016.09.002 2352-8532/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/05/main.PMC5143362.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/05/main.PMC5143362.pdf
"Canadian Aesthetics Journal/Revue Canadienne d'Esthétique ,4(http://www.uqtr.ca/AE/vol_4/sartwell.htm ).",Non-OADS,/arxiv_data1/oa_pdf/ee/05/main.PMC5143362.pdf
Sequences variants were identi ﬁed by comparison with the NCBI reference sequence (NM 198239.1) and annotated by ANNOVAR (http://www.openbioinformatics.org/anno var).,OADS,/arxiv_data1/oa_pdf/50/95/hgv201641.PMC5143363.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/50/95/hgv201641.PMC5143363.pdf
"ﬁgshare.hgv.903, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/50/95/hgv201641.PMC5143363.pdf
"ﬁgshare.hgv.906, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/50/95/hgv201641.PMC5143363.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Novel WISP3 mutations W Yan et al 4 Human Genome Variation (2016) 16041 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/50/95/hgv201641.PMC5143363.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/72/d3/onc2016295a.PMC5143365.pdf
Two hundred and six annotated human pathways were downloaded from GenMAPP (http://www.genmapp.org) and WikiPathways (http://www.wikipathways.org).,OADS,/arxiv_data1/oa_pdf/2d/99/onc2016157a.PMC5143367.pdf
"Weperformed in silico analyses to identify potential targets of miRNA using TargetScanHuman 6.0 (http://www.targetscan.org), miRDB (http://www.mirdb.",OADS,/arxiv_data1/oa_pdf/2d/99/onc2016157a.PMC5143367.pdf
"org), PicTar (http://www.pictar.mdc-be rlin.de), microRNA.org (http://www.",OADS,/arxiv_data1/oa_pdf/2d/99/onc2016157a.PMC5143367.pdf
microrna.org) and DIANAmicroT-CDS (http://www.microrna.gr/microT-CDS).,OADS,/arxiv_data1/oa_pdf/2d/99/onc2016157a.PMC5143367.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)miR-135b impacts myxoid liposarcoma progression Y Nezu et al 6188 Oncogene (2016) 6177 –6188 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/2d/99/onc2016157a.PMC5143367.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/57/main.PMC5143409.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.08.015 428,OADS,/arxiv_data1/oa_pdf/2f/57/main.PMC5143409.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/93/b2/main.PMC5143410.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.012 430,OADS,/arxiv_data1/oa_pdf/93/b2/main.PMC5143410.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by- nc-sa/4.0/ © The Author(s) 2016,Non-OADS,/arxiv_data1/oa_pdf/f5/58/cr2016133a.PMC5143419.pdf
"We thank  Mr Jing Lan from WYATT Technology for SEC-MALS technical support, Mr Fenfei Wang from Quantum Design China & Nano-Temper Technologies GmbH for MST technical support, and Dr  José Ramón Andrade Candelario for production of the animation  (http://www.3dciencia.com/) .",Non-OADS,/arxiv_data1/oa_pdf/4a/12/cr2016136a.PMC5143422.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/4a/12/cr2016136a.PMC5143422.pdf
The  molecular graphics were illustrated with CueMol (http://www.cue-mol.org/).,OADS,/arxiv_data1/oa_pdf/f6/af/cr2016140a.PMC5143425.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/f6/af/cr2016140a.PMC5143425.pdf
This  is  an  open  access  article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/71/main.PMC5143426.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.029 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/6b/71/main.PMC5143426.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/db/main.PMC5143427.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.017 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/20/db/main.PMC5143427.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/19/main.PMC5143428.pdf
An  ulcer  formation  was  also  observed  in  the  stricture http://dx.doi.org/10.1016/j.ijscr.2016.10.038 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/38/19/main.PMC5143428.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  John D Lang, MD, Associate Professor,  Department of Anesthesiology and Pain Medicine, University of  Washington, 1959 NE Pacific Street, Seattle, WA 98195,  United States.",Non-OADS,/arxiv_data1/oa_pdf/65/8b/WJH-8-1489.PMC5143429.pdf
Role of nitric oxide in liver trans -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1489World J Hepatol   2016  December 8; 8(34): 1489-1496 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/65/8b/WJH-8-1489.PMC5143429.pdf
World J Hepatol  2016;  8(34): 1489-1496  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/65/8b/WJH-8-1489.PMC5143429.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/65/8b/WJH-8-1489.PMC5143429.pdf
Data are available from:  URL: https://optn.transplant.hrsa.gov/data/.Waiting list additions Transplants Waiting list deathsFukazawa K  et al.,OADS,/arxiv_data1/oa_pdf/65/8b/WJH-8-1489.PMC5143429.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/65/8b/WJH-8-1489.PMC5143429.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Hani M Wadei, MD,  Department of  Transplant,  Mayo Clinic,  4500 San Pablo Road, Jacksonville, FL  32224, United States.",Non-OADS,/arxiv_data1/oa_pdf/b9/f7/WJH-8-1497.PMC5143430.pdf
Calculated positive predictive value Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1497World J Hepatol   2016  December 8; 8(34): 1497-1501 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/b9/f7/WJH-8-1497.PMC5143430.pdf
World J Hepatol  2016; 8(34): 1497-1501  Available from: URL:   http://www.wjgnet.co m/1948-5182 /full/v8/i34/1497.,Non-OADS,/arxiv_data1/oa_pdf/b9/f7/WJH-8-1497.PMC5143430.pdf
htm  DOI:  http://dx.doi.org/10.4254/wjh.v8.i34.1497 INTRODUCTION Kidney dysfunction is common in patients with end-stage  liver disease (ESLD).,Non-OADS,/arxiv_data1/oa_pdf/b9/f7/WJH-8-1497.PMC5143430.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b9/f7/WJH-8-1497.PMC5143430.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dhanny Gomez, MD, FRCS,  Department  of Hepatobiliary and Pancreatic Surgery, Queen’s Medical Centre,  Nottingham University Hospitals NHS Trust, Derby Road, Notting - ham NG5 1PB, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/9f/73/WJH-8-1502.PMC5143431.pdf
Response Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1502World J Hepatol   2016  December 8; 8(34): 1502-1510 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/9f/73/WJH-8-1502.PMC5143431.pdf
World J Hepatol  2016;  8(34): 1502-1510  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/9f/73/WJH-8-1502.PMC5143431.pdf
com/ 1948-5182 /full/v8/i34/1502.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/73/WJH-8-1502.PMC5143431.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9f/73/WJH-8-1502.PMC5143431.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Xue-En Liu, MD, Associate Professor,  Department of Microbiology and Infectious Disease Center, School  of Basic Medical Sciences , Peking University Health Science  Center, 38 Xueyuan Road, Haidian District, Beijing 100191,  China.",Non-OADS,/arxiv_data1/oa_pdf/48/e3/WJH-8-1511.PMC5143432.pdf
METHODS Seventy-six HBeAg-positive CHB patients received 96-wk Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1511World J Hepatol   2016  December 8; 8(34): 1511-1520 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/48/e3/WJH-8-1511.PMC5143432.pdf
World J Hepatol  2016;  8(34): 1511-1520  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/48/e3/WJH-8-1511.PMC5143432.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/e3/WJH-8-1511.PMC5143432.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/48/e3/WJH-8-1511.PMC5143432.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Aneley Getahun, MD, MTCM, DTMH,  Assistant Professor  in Primary Care, Department of Public  Health and Primary Care, College of Medicine Nursing and Health  Sciences, Fiji National University, Princess Road, Tamavua, Suva,  Fiji Islands.",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
From March to June Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1521World J Hepatol   2016  December 8; 8(34): 1521-1528 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
World J Hepatol  2016; 8(34): 1521-1528   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/ v8/i34/1521.,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i34.1521INTRODUCTION Hepatitis B virus (HBV) infection occurs worldwide.,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
Available from: URL: http://www.statistics.gov.sb/statistics/ demographic-statistics/census 7 United Nations Development Program .,OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
"Available  from: URL: http://hdr.undp.org/sites/all/themes/hdr_theme/ country-notes/SLB.pdf 8 Villar J , Ba’aqeel H, Piaggio G, Lumbiganon P, Miguel Belizán  J, Farnot U, Al-Mazrou Y , Carroli G, Pinol A, Donner A, Langer  A, Nigenda G, Mugford M, Fox-Rushby J, Hutton G, Bergsjø P,  Bakketeig L, Berendes H, Garcia J.",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
Available from: http://accessmedicine.mhmedical.com/content.,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
Available from: URL: http://www.wpro.who.int/ immunization/documents/docs/POA_HepB.pdf 27 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
Available from: URL: http://www.standardia.com/en/home/ product/Rapid_Diagnostic_Test/HBsAg.html 29 Murex HBsAg ELISA test kit .,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
"Available  from: URL: http://www.bio-group.in/Products/Diasorin/ IFUk_en_9F80-05_01-Murex_HBsAg.pdf 30 Milne A , Rodgers E, Hopkirk N. Hepatitis B vaccination of babies in  Melanesia.",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
"Available from: URL: http://www.who.int/diagnostics_laboratory/ evaluations/141010_public_report_diasorin_murex_hbsag_v1.pdf 34 Khan JK , Lone DS, Hameed A, Munim R, Bhatti M, Khattak  AA, Usman M, Nadeem MF, Satti HS, Munir M. Evaluation of  the performance of two rapid immunochromatographic tests for  detection of hepatitis B surface antigen and anti HCV antibodies  using ELISA tested samples.",OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/WJH-8-1521.PMC5143433.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to:  Cristian Dominguez, MD,  Centro Integral  de Gastroenterología, Ecuador 1481 PB, Capital Federal, Buenos  Aires C1425EUG, Argentina.",Non-OADS,/arxiv_data1/oa_pdf/27/bc/WJH-8-1529.PMC5143434.pdf
"Alcoholism, detected in 58 patients (58%), was the  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1529World J Hepatol   2016  December 8; 8(34): 1529-1534 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/27/bc/WJH-8-1529.PMC5143434.pdf
World J Hepatol  2016;  8(34): 1529-1534  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/27/bc/WJH-8-1529.PMC5143434.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/bc/WJH-8-1529.PMC5143434.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/27/bc/WJH-8-1529.PMC5143434.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Yusuke Ome, MD,  Department of  Surgery, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki City,  Okayama 710-8602, Japan.",Non-OADS,/arxiv_data1/oa_pdf/55/f8/WJH-8-1535.PMC5143435.pdf
The targeted Glissonean pedicle to Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i34.1535World J Hepatol   2016  December 8; 8(34): 1535-1540 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/55/f8/WJH-8-1535.PMC5143435.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/55/f8/WJH-8-1535.PMC5143435.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Elisa Giovannetti, MD, PhD, Department  of Medical Oncology, VU University Medical Center, room 1.53,  De Boelelaan 1117, 1081 HV Amsterdam,  The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/37/c2/WJCO-7-425.PMC5143436.pdf
"Despite  their different genetic backgrounds, all cell lines (EBC ­ 1, World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i6.425World J Clin Oncol  2016 December 10; 7(6): 425-432 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/37/c2/WJCO-7-425.PMC5143436.pdf
"World J Clin Oncol  2016; 7(6): 425-432  Available from:  URL:  http://www.wjgnet.com/ 2218-4333 /full/v7/i6/425.htm  DOI:  http://dx.doi.org/10.5306/wjco.v7.i6.425 INTRODUCTION During the last decade, targeted therapies have revolu­ tionized the treatment for non ­ small cell lung cancer  (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/37/c2/WJCO-7-425.PMC5143436.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/37/c2/WJCO-7-425.PMC5143436.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dr .,Non-OADS,/arxiv_data1/oa_pdf/d5/4f/WJCO-7-433.PMC5143437.pdf
After  separation of the mononuclear cells by Ficoll-Hypaque World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i6.433World J Clin Oncol  2016 December 10; 7(6): 433-440 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/d5/4f/WJCO-7-433.PMC5143437.pdf
"World J Clin Oncol  2016; 7(6): 433-440   Available from: URL:  http://www.wjgnet.com/ 2218-4333 /full/v7/ i6/433.htm  DOI: http://dx.doi.org/10.5306/wjco.v7.i6.433 INTRODUCTION Colorectal cancer is a leading cause of cancer-related death,  with almost 50000 estimated deaths in the United States  in 2016[1].",Non-OADS,/arxiv_data1/oa_pdf/d5/4f/WJCO-7-433.PMC5143437.pdf
Available from: URL: http://www.cancerresearchuk.,Non-OADS,/arxiv_data1/oa_pdf/d5/4f/WJCO-7-433.PMC5143437.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d5/4f/WJCO-7-433.PMC5143437.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/45/main.PMC5143438.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.09.003 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/0b/45/main.PMC5143438.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 212 e218,Non-OADS,/arxiv_data1/oa_pdf/0b/45/main.PMC5143438.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Natally Horvat, MD,  Radiology  Department, Hospital das Clínicas da Faculdade de Medicina da  Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 75,  Cerqueira César - São Paulo, SP 05403-010,  Brazil.",Non-OADS,/arxiv_data1/oa_pdf/0a/83/WJG-22-10002.PMC5143746.pdf
"Two  blinded abdominal radiologists, with 12 and 3 years  of experience analyzed the CTE regarding localization  (small bowel, colonic, both, or no disease detected); Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10002 10002 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10002-10008  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/0a/83/WJG-22-10002.PMC5143746.pdf
"World J  Gastroenterol  2016; 22(45): 10002-10008  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i45/10002.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.i45.10002 INTRODUCTION Inflammatory bowel disease (IBD) is considered an  important healthcare problem worldwide, with a high  morbidity and poor quality of life.",Non-OADS,/arxiv_data1/oa_pdf/0a/83/WJG-22-10002.PMC5143746.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/0a/83/WJG-22-10002.PMC5143746.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to: Toshiyuki Kubo, MD,  Department of  Gastroenterology and Hepatology, Sapporo Medical University,  S1W16 Chuo-ku, Sapporo 0608543,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/9f/cd/WJG-22-10009.PMC5143747.pdf
"Antiplatelet or  anticoagulant agents were prescribed for 210 (26.6%) Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10009 10009 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10009-10014  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9f/cd/WJG-22-10009.PMC5143747.pdf
World J Gastroenterol  2016; 22(45): 10009-10014   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i45/10009.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/9f/cd/WJG-22-10009.PMC5143747.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/9f/cd/WJG-22-10009.PMC5143747.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mitsuhiro Kida, MD, PhD,  Department of  Gastroenterology, Kitasato University School of Medicine, 1-15-1  Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0375, Japan.",Non-OADS,/arxiv_data1/oa_pdf/8f/97/WJG-22-10015.PMC5143748.pdf
"RESULTS The DT was 17.2 mo for GIST, as compared with 231.2  mo for le iomyoma, 104.7 mo for schwannoma, 274.9 Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10015 10015 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10015-10023  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8f/97/WJG-22-10015.PMC5143748.pdf
"World J  Gastroenterol  2016; 22(45): 10015-10023  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i45/10015.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i45.10015 INTRODUCTION   In Japan, gastrointestinal submucosal tumors (SMTs)  are often detected on radiographic and conventional  endoscopic examinations during health checkups.",Non-OADS,/arxiv_data1/oa_pdf/8f/97/WJG-22-10015.PMC5143748.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/8f/97/WJG-22-10015.PMC5143748.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: De-Liang Fu, MD, PhD, Professor,  Department of Pancreatic Surgery, Pancreatic Disease Institute,  Huashan Hospital, Fudan University, 12 Urumchi Middle Road,  Shanghai 200040, China.",Non-OADS,/arxiv_data1/oa_pdf/5d/05/WJG-22-10024.PMC5143749.pdf
"PDAC  patients with no distant metastases who underwent  curative resection served as the control group.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10024 10024 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10024-10037  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5d/05/WJG-22-10024.PMC5143749.pdf
World J Gastroenterol  2016;  22(45): 10024-10037  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/5d/05/WJG-22-10024.PMC5143749.pdf
com/1007-9327/full/v22/i45/10024.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/05/WJG-22-10024.PMC5143749.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/5d/05/WJG-22-10024.PMC5143749.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Bang-Mao Wang,  Department of  Gastroenterology and Hepatology, General Hospital, Tianjin  Medical University, Tianjin Institute of Digestive Disease, Heping  District 154 Anshan Road, Tianjin 300052,  China.",Non-OADS,/arxiv_data1/oa_pdf/ab/04/WJG-22-10038.PMC5143750.pdf
"In addition, we analysed Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10038 10038 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10038-10044  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ab/04/WJG-22-10038.PMC5143750.pdf
World J Gastroenterol  2016; 22(45): 10038 ­10044   Available from: URL: http://www.wjgnet.com/1007 ­9327/full/ v22/i45/10038.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/ab/04/WJG-22-10038.PMC5143750.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/ab/04/WJG-22-10038.PMC5143750.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10045 10045 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10045-10052  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/56/89/WJG-22-10045.PMC5143751.pdf
World J Gastroenterol  2016;  22(45): 10045-10052  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/56/89/WJG-22-10045.PMC5143751.pdf
com/1007-9327/full/v22/i45/10045.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/89/WJG-22-10045.PMC5143751.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/56/89/WJG-22-10045.PMC5143751.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to: Yan-Qing Li, MD, PhD,  Department of  Gastroenterology, Laboratory of Translational Gastroenterology,  Shandong University, Qilu Hospital, 107 Wenhuaxi Road, Jinan  250012, Shandong Province, China.",Non-OADS,/arxiv_data1/oa_pdf/7b/3d/WJG-22-10053.PMC5143752.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10053 10053 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10053-10063  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/7b/3d/WJG-22-10053.PMC5143752.pdf
World J Gastroenterol  2016; 22(45): 10053-10063   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i45/10053.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/7b/3d/WJG-22-10053.PMC5143752.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/7b/3d/WJG-22-10053.PMC5143752.pdf
"NCT02023177, found  in the URL: https://ClinicalTrials.gov/ct2/show/NCT02023177  ?term=aldo+toore&rank=7.",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/WJG-22-10064.PMC5143753.pdf
"detoal@yahoo.com Telephone: +52-155-54870900  Received: August 9, 2016 Peer-review started: August 9, 2016 First decision: September 21, 2016 Revised: September 27, 2016 Accepted: October 30, 2016    Article in press: October 30, 2016 Published online: December 7, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10064 10064 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10064-10070  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/WJG-22-10064.PMC5143753.pdf
World J Gastroenterol  2016; 22(45): 10064-10070   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i45/10064.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/WJG-22-10064.PMC5143753.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/WJG-22-10064.PMC5143753.pdf
"Heightened  awareness of the dangers of dietary supplements Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.10071 10071 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 10071-10076  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/95/a6/WJG-22-10071.PMC5143754.pdf
Available from: http://naturaldatabase.thera - peuticresearch.com 9 Swanson Premium Garcinia Cambogia 5:1 Extract: Swanson  Health Products.,Non-OADS,/arxiv_data1/oa_pdf/95/a6/WJG-22-10071.PMC5143754.pdf
"Available from:  http://www.swansonvitamins.com/swanson-premium-garcinia- cambogia-5-1-extract-80-mg-60-caps 10 Heymsfield SB , Allison DB, Vasselli JR, Pietrobelli A, Greenfield  D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential  antiobesity agent: a randomized controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/95/a6/WJG-22-10071.PMC5143754.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/95/a6/WJG-22-10071.PMC5143754.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Michele Pier Luca Guarino, MD, PhD,  Digestive Disease Unit of Campus Bio Medico University of  Rome, Via Alvaro del Portillo 200, 00128 Rome,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/af/7a/WJG-22-9871.PMC5143755.pdf
"EDITORIALSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9871 9871 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9871-9879  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/af/7a/WJG-22-9871.PMC5143755.pdf
World J Gastroenterol  2016; 22(45): 9871-9879   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i45/9871.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/af/7a/WJG-22-9871.PMC5143755.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/af/7a/WJG-22-9871.PMC5143755.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Rustam N Karanjia,  Liver Unit, Division  of Digestive Health, Department of Surgery and Cancer, Imperial  College London, St Mary's Campus, 10th Floor QEQM Wing,  South Wharf Street, London W2 1NY ,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
"rk2311@ic.ac.u k  Telephone:  +44-207-8866454   Fax:  +44-207-7249369 Received:  September 2, 2016 Peer-review started:  September 3, 2016 First decision:  September 28, 2016 Revised:  October 10, 2016REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9880 9880 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9880-9897  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
World J Gastroenterol  2016; 22(45):  9880-9897  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
com/1007-9327/full/v22/i45/9880.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
Available from: URL: http://www.who.int/mediacentre/factsheets/Karanjia RN et al.,OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
Available from: URL: http://www.who.int/mediacentre/factsheets/ fs204/en/index.html 5 Campbell TC .,Non-OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/e0/49/WJG-22-9880.PMC5143756.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dirk Bandorski, MD, FESC, FACC,  University of Giessen and Marburg Lung Center, Member of  the German Center for Lung Research, Klinikstrasse 33, 35392  Giessen, Germany.",Non-OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
"Key words:  Video capsule endoscopy; Contraindications;  Stenosis; Pacemaker; Aspiration; Pregnancy; Magnetic REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9898 9898 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9898-9908  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
World J Gastroenterol  2016; 22(45): 9898-9908   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i45/9898.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
2015 Available from: URL: https://www.biotronik.com/files/ 75891733AA975C3AC1257F16003351D8/$FILE/Stoerbeeinfluss ungen_Implantate_BIOTRONIK.pd f  75 Medtronic .,Non-OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
Available from:  URL: http://www.medtronicheart.com/wcm/groups/mdtcom_sg/@ emanuals/@era/@crdm/documents/documents/contrib_193764.pd f 76 International Organization for Standardization .,OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
"2012 Available from: URL: http://www.iso.org/ iso/catalogue_detail.htm?csnumber=54472 77 Lucendo AJ , González-Castillo S, Fernández-Fuente M, De  Rezende LC.",OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
"2012  Available from: URL: http://www.accessdata.fda.gov/cdrh_docs/ reviews/k123666.pdf 100 Anderson BW , Liang JJ, Dejesus RS.",Non-OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/9f/14/WJG-22-9898.PMC5143757.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9909 9909 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9909-9920  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c5/bf/WJG-22-9909.PMC5143758.pdf
World J Gastroenterol 2016; 22(45): 9909-9920   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i45/9909.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/WJG-22-9909.PMC5143758.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/c5/bf/WJG-22-9909.PMC5143758.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Eric Tse, MBBS, PhD,  Department of  Medicine, The University of Hong Kong, Queen Mary Hospital,  Hong Kong, China.",Non-OADS,/arxiv_data1/oa_pdf/3f/57/WJG-22-9921.PMC5143759.pdf
"Given its diverse  oncogenic functions in hepatocarcinogenesis, PIN1 REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9921 9921 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9921-9932  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/3f/57/WJG-22-9921.PMC5143759.pdf
World J Gastroenterol  2016;  22(45): 9921-9932  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/3f/57/WJG-22-9921.PMC5143759.pdf
com/1007-9327/full/v22/i45/9921.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/57/WJG-22-9921.PMC5143759.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/3f/57/WJG-22-9921.PMC5143759.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: De- Sheng Wang, MD, Professor,  Department of Hepatobiliary Surgery, Xijing Hospital, Fourth  Military Medical University, 127 West Changle Street, Xi’an  710032, Shaanxi Province, China.",Non-OADS,/arxiv_data1/oa_pdf/47/b3/WJG-22-9933.PMC5143760.pdf
"REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9933 9933 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9933-9943  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/47/b3/WJG-22-9933.PMC5143760.pdf
"World J Gastroenterol  2016; 22(45): 9933-9943  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i45/9933.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i45.9933 INTRODUCTION Hepatocellular carcinoma is the second leading cause  of cancer-related death in the world, responsible for  approximately 700000 deaths annually[1].",Non-OADS,/arxiv_data1/oa_pdf/47/b3/WJG-22-9933.PMC5143760.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/47/b3/WJG-22-9933.PMC5143760.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Stefano Crippa, MD, PhD,  Division of  Pancreatic Surgery, Pancreas Translational and Clinical Research  Center, San Raffaele Scientific Institute, Via Olgettina 60, 20132  Milan, Italy.",Non-OADS,/arxiv_data1/oa_pdf/ed/d7/WJG-22-9944.PMC5143761.pdf
"The need for a revision of current classification system  is stressed being well differentiated NEC a more  indolent disease compared to poorly differentiated  tumors.MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9944 9944 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9944-9953  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ed/d7/WJG-22-9944.PMC5143761.pdf
World  J Gastroenterol  2016; 22(45): 9944-9953  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i45/9944.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i45.9944 INTRODUCTION The 2010  World Health Organization (WHO) classi­ fication of pancreatic neuroendocrine tumors (PNEN)  introduced a major change compared with the  previous ones.,Non-OADS,/arxiv_data1/oa_pdf/ed/d7/WJG-22-9944.PMC5143761.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/ed/d7/WJG-22-9944.PMC5143761.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Lee F Peng, Associate Medical Director  of Liver Transplantation, Associate Professor of Medicine,  Temple University Health System, 3509 N. Broad St., 9th Floor,  Philadelphia, PA 19140, United States.",Non-OADS,/arxiv_data1/oa_pdf/59/33/WJG-22-9954.PMC5143762.pdf
"We further studied the effect of mipomersen, an FDA- approved antisense inhibitor of apo B100, on HCV using  in vitro  cell-culture competent HCV and determined its Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9954 9954 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9954-9965  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/59/33/WJG-22-9954.PMC5143762.pdf
wjgnet.com/1007-9327/full/v22/i45/9954.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/33/WJG-22-9954.PMC5143762.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/59/33/WJG-22-9954.PMC5143762.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Gideon M Hirschfield, Professor,  Consultant Hepatologist,  Centre for Liver Research, NIHR  Birmingham Liver Biomedical Research Unit, University of  Birmingham, Birmingham B152TT,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/f7/bd/WJG-22-9966.PMC5143763.pdf
"PH in the PCLD  cohort was defined by the one or more of following  parameters: (1) presence of radiological or endoscopic  documented varices fro m our own centre or the referral  centre; (2) splenomegaly (> 11 cm) on radiology in Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9966 9966 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9966-9973  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f7/bd/WJG-22-9966.PMC5143763.pdf
World J Gastroenterol  2016;  22(45): 9966-9973  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f7/bd/WJG-22-9966.PMC5143763.pdf
com/1007-9327/full/v22/i45/9966.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/bd/WJG-22-9966.PMC5143763.pdf
Available from: URL: http://www.odt.nhs.,Non-OADS,/arxiv_data1/oa_pdf/f7/bd/WJG-22-9966.PMC5143763.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/f7/bd/WJG-22-9966.PMC5143763.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Eny Maria Goloni-Bertollo, PhD, Genetics  and Molecular Biology Research Unit - UPGEM, Department  of Molecular Biology, São José do Rio Preto Medical School,  FAMERP , São José do Rio Preto, Av.",Non-OADS,/arxiv_data1/oa_pdf/78/1c/WJG-22-9974.PMC5143764.pdf
"eny.goloni@famerp.b r Telephone:  +55-17-32015720  Fax:  +55-17-32015708 Received:  August 10, 2016 Peer-review started:  August 12, 2016 First decision:  September 12, 2016 Revised:  October 8, 2016 Accepted:  November 15, 2016 Article in press:  November 16, 2016 Published online: December 7, 2016 Abstract AIM To investigate the contribution of polymorphisms in Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9974 9974 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9974-9983  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/78/1c/WJG-22-9974.PMC5143764.pdf
World J  Gastroenterol  2016; 22(45): 9974-9983  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i45/9974.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i45.9974 INTRODUCTION Sporadic colorectal cancer (SCRC) includes mali­ gnancies that occur in the large intestine (colon) and  rectum.,Non-OADS,/arxiv_data1/oa_pdf/78/1c/WJG-22-9974.PMC5143764.pdf
Available from: URL: http://www.inca.gov.,Non-OADS,/arxiv_data1/oa_pdf/78/1c/WJG-22-9974.PMC5143764.pdf
"Available from: URL: http://globocan.iarc.fr 3 Botteri E , Iodi ce S, Bagnardi V, Raimondi S, Lowenfels AB,  Maisonneuve P. Smoking and colorectal cancer: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/78/1c/WJG-22-9974.PMC5143764.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/78/1c/WJG-22-9974.PMC5143764.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Patrizia Ferroni, MD, PhD,  San Raffaele  Roma Open University, IRCCS San Raffaele Pisana, Via di Val  Cannuta 247, 00166 Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/e0/af/WJG-22-9984.PMC5143765.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9984 9984 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9984-9993  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e0/af/WJG-22-9984.PMC5143765.pdf
"World J  Gastroenterol  2016; 22(45): 9984-9993  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i45/9984.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i45.9984 INTRODUCTION Type 2 diabetes (T2D) and colorectal cancer (CRC) are among the major causes of morbidity and mortality  worldwide, and their increasing prevalence represents  a significant public health burden[1-3].",Non-OADS,/arxiv_data1/oa_pdf/e0/af/WJG-22-9984.PMC5143765.pdf
"9987 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comBelgium; http://www.medcalc.org; 2014).",Non-OADS,/arxiv_data1/oa_pdf/e0/af/WJG-22-9984.PMC5143765.pdf
Cox-proportional hazards  analysis was performed by a free web-based application  (http://statpages.org/) to evaluate the association  between clinical-pathological variables and PFS.,OADS,/arxiv_data1/oa_pdf/e0/af/WJG-22-9984.PMC5143765.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/e0/af/WJG-22-9984.PMC5143765.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Corrado Pedrazzani, MD,  Division of  General and Hepatobiliary Surgery, Department of Surgical  Sciences, Dentistry, Gynecology and Pediatrics, University of  Verona, Piazzale Scuro 10, 37134 Verona,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/b7/d4/WJG-22-9994.PMC5143766.pdf
"Fibrinogen  is involved in tumourigenesis as well as tumour Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i45.9994 9994 December 7, 2016 |Volume 22 |Issue 45 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 7; 22(45): 9994-10001  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b7/d4/WJG-22-9994.PMC5143766.pdf
World J Gastroenterol  2016;  22(45): 9994-10001  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/b7/d4/WJG-22-9994.PMC5143766.pdf
com/1007-9327/full/v22/i45/9994.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b7/d4/WJG-22-9994.PMC5143766.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   5",Non-OADS,/arxiv_data1/oa_pdf/b7/d4/WJG-22-9994.PMC5143766.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http:// creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.11.317 0019-4832/ /C223  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/0e/c5/main.PMC5143804.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/a9/main.PMC5143805.pdf
1See  Appendix  A.Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0090019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/36/a9/main.PMC5143805.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/a9/main.PMC5143805.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/0d/main.PMC5143806.pdf
E-mail  address:  abhisekh.mhnt@gmail.com  (A.  Mohanty).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0150019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/12/0d/main.PMC5143806.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/0d/main.PMC5143806.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
Kiselev).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0020019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1001/ jama.291.14.1720 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1093/eurheartj/ehl272 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1378/chest.128.2_suppl.39S .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1016/j.jtcvs.2007.08.049 .,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1002/phar.1485 .13.,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.15275/annaritmol.2014.1.1 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
2014;34:1167– 1173.  http://dx.doi.org/10.1002/phar.1485 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1111/1755- 5922.12062 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1053/j.jvca.2015.01.001 .,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
2014;44:205– 209.  http://dx.doi.org/10.4070/kcj.2014.44.4.205 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1097/FJC.,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.5681/ apb.2014.015 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/ 10.1016/j.ahj.2007.10.027 .,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1111/eci.12237 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1016/j.amjcard.2009.09.007 .,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
2014;45:17– 26.  http://dx.doi.org/10.1093/ejcts/ezt181 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1016/ j.mgene.2015.07.001 .,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1371/journal.pone.0137720 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/ 10.1371/journal.pone.0050126 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
2006;97:55– 60.  http://dx.doi.org/10.1016/j.amjcard.2005.07.124 .,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1161/01.ATV.17.8.1521 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1161/01.CIR.103.21.2598 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/ 10.1161/CIRCULATIONAHA.106.621763 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1016/j.jtcvs.2009.03.054 e1.,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.5761/atcs.oa.10.01588 .O.L.,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/ 10.1536/ihj.52.7 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.5152/akd.2014.5531 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1111/ j.1755-5922.2009.00098.x .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1111/echo.,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1093/eurheartj/ ehr158 .,Non-OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1016/j.jtcvs.2010.,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
http://dx.doi.org/10.1016/S1473-3099(14)70731-5 .O.L.,OADS,/arxiv_data1/oa_pdf/38/ca/main.PMC5143807.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/51/main.PMC5143808.pdf
Peringadan).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0250019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/07/51/main.PMC5143808.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/51/main.PMC5143808.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/32/main.PMC5143809.pdf
Narayanan).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.06.0020019-4832/ /C223 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/7e/32/main.PMC5143809.pdf
E-mail  address:  rajeevgg@gmail.com  (R.  Gupta).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.0270019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/7c/30/main.PMC5143810.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/30/main.PMC5143810.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  8  3  2  –  8  4  0  833,Non-OADS,/arxiv_data1/oa_pdf/7c/30/main.PMC5143810.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/cb/main.PMC5143811.pdf
"1Present  address:  Department  of  Cardiology,  Govt  TD  Medical  College, Alappuzha,  Kerala,  India.Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0070019-4832/ /C223 2016  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/b4/cb/main.PMC5143811.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/cb/main.PMC5143811.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC5143812.pdf
Saha).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0240019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC5143812.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC5143812.pdf
http://dx.doi.org/10.3349/ymj.2013.54.5.1119 .,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC5143812.pdf
2015;4:5.  http://dx.doi.org/10.4172/2324-8602.1000228 .,Non-OADS,/arxiv_data1/oa_pdf/96/c4/main.PMC5143812.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/1b/main.PMC5143813.pdf
Shah).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.09.0020019-4832/ /C223 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/29/1b/main.PMC5143813.pdf
Gupta@WMCHealth.org Available  online  1  April  2016 http://dx.doi.org/10.1016/j.ihj.2016.03.019 0019-4832/ #  2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/main.PMC5143814.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  7  5  3  –  7  5  5  755,Non-OADS,/arxiv_data1/oa_pdf/1c/37/main.PMC5143814.pdf
"Modiﬁed  from  Terantini,  2010.6Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.06.0110019-4832/ /C223 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/d1/13/main.PMC5143815.pdf
2012.  http://dx.doi.org/10.1093/eurheartj/ ehs219 .,Non-OADS,/arxiv_data1/oa_pdf/d1/13/main.PMC5143815.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/be/main.PMC5143816.pdf
E-mail  address:  akapoor65@gmail.com  (A.  Kapoor).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0230019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/fd/be/main.PMC5143816.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/be/main.PMC5143816.pdf
E-mail  address:  jjdalal@hotmail.com  (J.J.  Dalal).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.0130019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC5143817.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC5143817.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  8  5  1  –  8  5  5 852,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC5143817.pdf
Available  at: https://www.nice.org.uk/guidance/dg15/resources/ myocardial-infarction-acute-early-rule-out-using-highsensitivity-troponin-tests-elecsys-troponin-t-highsensitive-architect-stat-high-sensitive-troponini-and- accutni3-assays-1053631469509 Accessed  04.09.15.,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC5143817.pdf
Available  at: https://www.nice.org.uk/guidance/dg15/documents/myocardial-infarction-acute-early-rule-out-using-highsensitivity-troponin-tests-elecsys-troponin-t- highsensitive-architect-stat-high-sensitive-troponini-and- accutni3-assays-overview2 .,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC5143817.pdf
Available  at:  http://www.abbott.,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC5143817.pdf
http://dx.doi.org/10.1056/NEJMoa1410489 .Indian  Heart  Journal  68  (2016)  756–757 Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.09.006 0019-4832/ /C223  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/46/b3/main.PMC5143818.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/65/main.PMC5143819.pdf
E-mail  address:  vinayakumard@gmail.com  (D.  Vinayakumar).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0170019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/f0/65/main.PMC5143819.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/65/main.PMC5143819.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/13/main.PMC5143820.pdf
E-mail  address:  ozcanozeke@gmail.com  (O.  Ozeke).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0010019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/d0/13/main.PMC5143820.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/13/main.PMC5143820.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/86/main.PMC5143821.pdf
E-mail  address:  manishaiims@hotmail.com  (M.  Bansal).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.0180019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/aa/86/main.PMC5143821.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/86/main.PMC5143821.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/77/main.PMC5143822.pdf
E-mail  address:  rajibrbhandari@yahoo.com  (R.  Rajbhandari).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0200019-4832/ /C223 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/f7/77/main.PMC5143822.pdf
"As  this  study  was conducted  in  north  India,  the  reader  must  assume  the  subjects studied  are  of  north  Indian  origin  and,  bearing  in  mind  the variation  noted  between  different  Hispanic  communities  in  the Echo-SOL  study,  it  would  be  important  to  clarify  –  in  future  studies on  this  subject  –  if  there  are  signiﬁcant  differences  between  north and  south  Indian  populations  or  whether  one  reference  range  is applicable  cross  the  entire  subcontinent.Indian  Heart  Journal  68  (2016)  758–759 Keywords: Echocardiography EthnicityLeft ventricleContents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.0040019-4832/ /C223 2016  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5143823.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5143823.pdf
2016.  http://dx.doi.org/10.1161/CIRCIMAGING.115.003597 .,Non-OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5143823.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/main.PMC5143824.pdf
E-mail  address:  abdulmomen71@yahoo.com  (A.  Momen).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.0210019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/main.PMC5143824.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/main.PMC5143824.pdf
http://dx.doi.org/10.1067/S0002-8703 (03)00415-0 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/main.PMC5143824.pdf
http://dx.doi.org/10.1067/S0002-8703(03)00415-0 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/main.PMC5143824.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/0e/main.PMC5143825.pdf
E-mail  address:  jomaa_w@hotmail.fr  (W.  Jomaa).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.0200019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/12/0e/main.PMC5143825.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/0e/main.PMC5143825.pdf
E-mail  address:  sundeepmishraihj@gmail.com  (S.  Mishra).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.11.3180019-4832/ /C223 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/d6/d4/main.PMC5143826.pdf
2011  Available  from:  https://www.nice.org.uk/guidance/cg126/ evidence/full-guideline-183176605.,Non-OADS,/arxiv_data1/oa_pdf/d6/d4/main.PMC5143826.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/3e/main.PMC5143827.pdf
E-mail  address:  jkgupta81@rediffmail.com  (J.K.  Gupta).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.06.0100019-4832/ /C223 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/81/3e/main.PMC5143827.pdf
This  is  an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/67/main.PMC5143828.pdf
E-mail  address:  drsundeepmishraihj@gmail.com.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.054 0019-4832/ #  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/dc/67/main.PMC5143828.pdf
This  is  an  open  access  article  under  the  CC  BY- NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/67/main.PMC5143828.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Breast cancer HbA1CDiabetesTumor stageObesity 1.,Non-OADS,/arxiv_data1/oa_pdf/91/ef/main.PMC5144103.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.04.005 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/91/ef/main.PMC5144103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/ef/main.PMC5144103.pdf
[13] http://tri.uams.edu/research-resources-services-directory/biomedical-informatics- data-services/electronic-health-care-data-for-research/ .,OADS,/arxiv_data1/oa_pdf/91/ef/main.PMC5144103.pdf
[16] http://www.breastcancer.org .,Non-OADS,/arxiv_data1/oa_pdf/91/ef/main.PMC5144103.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sutures CraniosynostosisMolecular signalingPolycystinsMechanical stimuliCraniosynostosis therapies Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/71/b4/main.PMC5144105.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.04.006 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/b4/main.PMC5144105.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/b4/main.PMC5144105.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/c3/main.PMC5144110.pdf
http://dx.doi.org/10.1016/j.ejro.2016.03.001 2352-0477/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/c3/main.PMC5144110.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/87/c3/main.PMC5144110.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC5144111.pdf
Comparison  of lesion  characteristics  assessed  by  readers  between  low  dose  CT  and http://dx.doi.org/10.1016/j.ejro.2016.03.002 2352-0477/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC5144111.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC5144111.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
It  is  faster  to  calculate  and  is  provided  automatically  by  the  MRI http://dx.doi.org/10.1016/j.ejro.2016.04.002 2352-0477/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Imaging  35  (2012) 257–279,  http://dx.doi.org/10.1002/jmri.22786 .",OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"18  (2008)  477–485,  http://dx.doi.org/10.1007/s00330- 007-0785-9 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Menu,  Evaluation  of  liver diffusion isotropy  and  characterization  of  focal  hepatic  lesions  with  two single-shot  echo-planar  MR  imaging  sequences:  prospective  study  in  66patients,  Radiology  226  (2003)  71–78,  http://dx.doi.org/10.1148/radiol.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"188  (2007)  1001–1008, http://dx.doi.org/10.2214/AJR.06.0601 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"193  (2009)  1044–1052, http://dx.doi.org/10.2214/AJR.08.1461 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Geschwind, Unresectable  hepatocellular  carcinoma:  serial  early  vascular  and  cellular changes  after  transarterial chemoembolization as  detected  with MR imaging, Radiology  250  (2009)  466–473,  http://dx.doi.org/10.1148/radiol.2502081988 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"[8] M.  Wagner,  S.  Doblas,  J.-L.  Daire,  V.  Paradis,  N.  Haddad,  H.  Leitao,  et  al., Diffusion-weighted  MR  imaging  for  the  regional  characterization  of  liver tumors,  Radiology  264  (2012)  464–472,  http://dx.doi.org/10.1148/radiol.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"[9] G.  d’Assignies,  P.  Fina,  O.  Bruno,  M.-P.  Vullierme,  F.  Tubach,  V.  Paradis,  et  al., High  sensitivity  of  diffusion-weighted  MR  imaging  for  the  detection  of  liver metastases  from  neuroendocrine  tumors:  comparison  with  T2-weighted  and dynamic  gadolinium-enhanced  MR  imaging,  Radiology  268  (2013)  390–399, http://dx.doi.org/10.1148/radiol.13121628 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"48  (2013)  722–728,  http://dx.doi.org/10.1097/ RLI.0b013e3182915912 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"188  (2007)  409–414,  http://dx.doi.org/ 10.2214/AJR.05.1918 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"49  (2014)  93–100,  http://dx.doi.org/10.1097/ RLI.0b013e3182a71cc3 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"19  (2009) 1981–1990,  http://dx.doi.org/10.1007/s00330-009-1384-8 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Barentsz, et al.,  Prostate  cancer  aggressiveness:  in  vivo  assessment  of  MR spectroscopy  and  diffusion-weighted  imaging  at  3T,  Radiology  265  (2012) 457–467,  http://dx.doi.org/10.1148/radiol.12111744 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"48  (2013)  152–157,  http://dx.doi.org/10.1097/RLI.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"48  (2013)  779–786,  http://dx.doi.org/10.1097/RLI.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"196 (2011)  1351–1361,  http://dx.doi.org/10.2214/AJR.10.5515 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"44  (2000)  852–859, http://dx.doi.org/10.1002/1522-2594(200012)44:6<852:AID-MRM5>3.0.CO;2-A .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"53  (2005)  1432–1440, http://dx.doi.org/10.1002/mrm.20508 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Imaging  30  (2012)  1534–1540,  http://dx.doi.org/ 10.1016/j.mri.2012.04.020 .",OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Imaging  32  (2014)  413–420,  http://dx.doi.org/10.1016/j.mri.",OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"64  (2010)  616–622,  http://dx.doi.org/10.1002/mrm.2243 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Mussi,  J.  Melamed, et  al.,  Prostate  cancer:  feasibility  and  preliminary  experience  of  a  diffusional kurtosis  model  for  detection  and  assessment  of  aggressiveness  of  peripheral zone  cancer,  Radiology  264  (2012)  126–135,  http://dx.doi.org/10.1148/radiol.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"22  (2012)  2186–2192, http://dx.doi.org/10.1007/ s00330-012-2469-3 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Digital  Imaging  17  (2004)  205–216, http://dx.doi.org/10.1007/s10278-004-1014-6 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"20  (2013)  243–248,  http://dx.doi.org/10.1007/s00534-011- 0491-5 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Aubin,  J.  Vignaud,  M.  Laval-Jeantet, Separation  of  diffusion  and  perfusion  in  intravoxel  incoherent  motion  MR imaging,  Radiology  168  (1988)  497–505,  http://dx.doi.org/10.1148/radiology.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"11  (1963)  431–441,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"19  (2006)  236–247,  http://dx.doi.org/10.1002/nbm.1020 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"00  (2014)  1–6,  http://dx.doi.org/10.1097/RLI.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"44  (2009) 769–775,  http://dx.doi.org/10.1097/RLI.0b013e3181b62271 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"46 (2011)  57–63,  http://dx.doi.org/10.1097/RLI.0b013e3181fb3bf2 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"66  (2011)  1327–1332,  http://dx.doi.org/10.1002/mrm.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Choi,  Intravoxel incoherent  motion  diffusion-weighted MR imaging for characterization  of focal  pancreatic  lesions,  Radiology  270  (2014)  444–453,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"201  (2013)  1002–1008,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"49 (2008)  383–386,  http://dx.doi.org/10.1080/02841850801895381 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"68  (2013),  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"Imaging  33  (2011)  136–142,  http://dx.doi.org/10.1002/jmri.22414 .",OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"23  (2010)  698–710,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
"21  (2011) 2567–2574, http://dx.doi.org/10.1007/s00330-011-2220-5 .",Non-OADS,/arxiv_data1/oa_pdf/1b/a2/main.PMC5144112.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/d5/main.PMC5144113.pdf
"To  facilitate  the  use  of low dose  chest  CT,  adequacy  of  a  low  dose  CT  protocol  as  a  routine http://dx.doi.org/10.1016/j.ejro.2016.04.001 2352-0477/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/d5/main.PMC5144113.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/52/d5/main.PMC5144113.pdf
"[http://dx.doi.org/10.1016/S0958-1669(03)00092-2 ] [PMID: 12943856 ] [3] Miller, H.K.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/S1040-8428(98)00015-8 ] [PMID: 9768345 ] [6] Oza, V.P.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1021/jf030204+ ] [PMID: 14705871 ] [8] El-Bessoumy, A.A.; Sarhan, M.; Mansour, J.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.5483/BMBRep.2004.37.4.387 ] [PMID: 15469724 ] [9] Grover, C.E.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1042/bj0210857 ] [PMID: 16743911 ] [10] Michalska, K.; Bujacz, G.; Jaskolski, M. Crystal structure of plant asparaginase.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.jmb.2006.04.066 ] [PMID: 16725155 ] [11] Batool,  T.;  Makky,  E.A.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1007/s12010-015-1917-3 ] [PMID: 26547852 ] [12] T.; Hemalatha, T.; Sankaranarayanan, P.; Puvanakrishnan, R. Enzyme therapy: Current perspectives.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1080/07388550601173926 ] [PMID: 17364689 ] [18] Mashburn, L.T.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/0003-9861(64)90032-3 ] [PMID: 14186753 ] [19] North, A.C.; Wade, H.E.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1038/224594a0 ] [PMID: 5346599 ] [20] Narta, U.K.; Kanwar, S.S.; Azmi, W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.critrevonc.2006.07.009 ] [PMID: 17011787 ] [21] Izadpanah Qeshmi, F.; Javadpour, S.; Malekzadeh, K.; Jahromi, S.T.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1038/227680a0 ] [PMID: 5432063 ] [23] Imada, A.; Igarasi, S.; Nakahama, K.; Isono, M. Asparaginase and glutaminase activities of micro-organisms.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1099/00221287-76-1-85 ] [PMID: 4723072 ] [24] Bradford, M.M.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/0003-2697(76)90527-3 ] [PMID: 942051 ] [25] Rahimzadeh, M.; Khajeh, K.; Mirshahi, M.; Khayatian, M.; Schwarzenbacher, R. Probing the role of asparagine mutation in thermostability of Bacillus KR-8104 α-amylase.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.ijbiomac.2011.11.014 ] [PMID: 22126991 ] [26] Sant’Anna, V.; Cladera-Olivera, F.; Brandelli, A.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.foodchem.2011.07.001 ] [PMID: 23265459 ] [27] Abdel-Fattah, Y.R.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/S0032-9592(02)00067-5 ] [28] Kumar,  S.;  Dasu,  V.V.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.9735/0975-4423.3.2.88-99 ] [30] Amena, S.; Vishalakshi, N.; Prabhakar, M.; Dayanand, A.; Lingappa, K. Production, purification and characterization of l-asparaginase from streptomyces gulbargensis.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1590/S1517-83822010000100025 ] [PMID: 24031478 ] [31] Nawaz,  M.S.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1007/s002530051336 ] [PMID: 9866175 ] [32] Pattnaik, S.; Kabi, R.; Janaki Ram, K.; Bhanot, K.K.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1007/s12088-008-0018-1 ] [PMID: 23100730 ] [34] Kamble, V.P.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1007/BF00295504 ] [PMID: 7766157 ] [36] Zuo, S.; Zhang, T.; Jiang, B.; Mu, W. Recent research progress on microbial L-asparaginases.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1007/s00253-014-6271-9 ] [PMID: 25492420 ] [37] Cappelletti,  D.;  Chiarelli,  L.R.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2008.10.118 ] [PMID: 18983825 ] [38] Jia, M.; Xu, M.; He, B.; Rao, Z. Cloning, expression, and characterization of L-asparaginase from a newly isolated Bacillus subtilis  B11-06.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1021/jf402636w ] [PMID: 24003863 ] [39] Kumari, P.V.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.7326/0003-4819-74-6-893 ] [PMID: 5281051 ] [41] Whelan, H.A.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1021/bi00834a020 ] [PMID: 4895020 ] [42] Mesas, J.M.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1099/00221287-136-3-515 ] [PMID: 2391490 ] [43] Chityala,  S.;  Venkata  Dasu,  V.;  Ahmad,  J.;  Prakasham,  R.S.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1007/s00449-015-1464-x ] [PMID: 26440965 ] [44] Kumar, S.; Venkata Dasu, V.; Pakshirajan, K. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum  MTCC 1428.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.biortech.2010.07.114 ] [PMID: 20832300 ] [45] Zhang, S.; Xie, Y.; Zhang, C.; Bie, X.; Zhao, H.; Lu, F.; Lu, Z. Biochemical characterization of a novel l-asparaginase from Bacillus megaterium  H-1 and its application in French fries.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/j.foodres.2015.08.031 ] [46] Declerck, N.; Machius, M.; Chambert, R.; Wiegand, G.; Huber, R.; Gaillardin, C. Hyperthermostable mutants of Bacillus licheniformis  alpha- amylase: thermodynamic studies and structural interpretation.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1093/protein/10.5.541 ] [PMID: 9215572 ] [47] Daniel, R.M.",OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"[http://dx.doi.org/10.1016/0141-0229(95)00174-3 ] [48] Agrawal, V.; Woo, J.H.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/22/TOBIOCJ-10-35.PMC5144114.pdf
Available at: http://www.nhp.gov.in/sites/default/ ﬁles/pdf/ nhp_1983.pdf (accessed on 2 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://www.nhp.gov.in/sites/default/ ﬁles/pdf/ NationaL_Health_Pollicy.pdf (accessed on 2 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://mohfw.nic.in/index2.php?,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://nrhm.gov.in/nhm/nrhm/guidelines/indian-public-health-standards.html (accessed on 3 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://nrhm.gov.in/images/pdf/about-nrhm/nrhm-framework-implementation/ nrhm-framework-latest.pdf (accessed on 25 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at:http://nrhm.gov.in/images/pdf/mis-report/Sept-2015/1-NRHM.pdf (accessed on 2 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: https://nrhm-mis.nic.in/RURAL%20HEALTH%20STATISTICS/(A)RHS%20-%202015/CoverPage.pdf (accessed on 2 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ ﬁveyr/ welcome.html.,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ ﬁveyr/ welcome.html (accessed on 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ﬁveyr/welcome.html (accessed on 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ ﬁveyr/welcome.html (accessed on 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ﬁveyr/9th/vol2/v2c3-4.htm (accessed on 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ ﬁveyr/10th/volume2/v2_ch2_8.pdf (accessed on 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ﬁveyr/11th/11_v2/11v2_ch3.pdf (accessed on 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://planningcommission.nic.in/plans/planrel/ ﬁveyr/12th/pdf/12fyp_vol3.pdf (accessed 13 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Available at: http://nrhm.gov.in/images/pdf/programmes/rmncha-strategy.pdf (accessed on 13 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
Availableat: http://www.censusindia.gov.in/vital_statistics/SRS_Reports_2013.html (acces-sed on 10 April 2016).,OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
"Of ﬁce of the Registrar General and Census Commissioner of India, Ministry of Home Affairs, New Delhi.Available at: http://www.censusindia.gov.in/vital_statistics/SRS_Bulletins/MMR_Bulletin-2010-12.pdf (accessed on 10 April 2016).",Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Health Systems M Chokshi et al S12 Journal of Perinatology (2016), S9 –S12",Non-OADS,/arxiv_data1/oa_pdf/91/00/jp2016184a.PMC5144115.pdf
"Available from: http://www.censusindia.gov.in/vital_statistics/SRS_ Reports_2013.html, Copyright 2013, Of ﬁce of the Registrar General and Census Commissioner, India.Facility care of newborn SB Neogi et al S21 Journal of Perinatology (2016), S18 –S23",Non-OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Available from http://www.jhpiego.org/ ﬁles/MNHPolComp.pdf (accessed on 31 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Available from http://www.unicef.org/india/SCNU_book1_ April_6.pdf (accessed on 31 October 2012).,Non-OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Available from http://nrhm.gov.in/about-nrhm/ guidelines/indian-public-health-standards.html (accessed on 14 Feb 2013) .,Non-OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Available from: http://wcd.nic.in/sites/default/ ﬁles/IGMSYscheme.pdf.,OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Availablefrom http://www.nrhm.gov.in/nrhm-components/rmnch-a/child-health-immuni-zation/child-health/guidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Government of India.Available from http://nrhm.gov.in/nrhm-components/rmnch-a/child-health-immunization.html?id = 405.,Non-OADS,/arxiv_data1/oa_pdf/02/81/jp2016186a.PMC5144116.pdf
Available from: http://health.govmu.org/English/Docu ments/ncd-2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/53/ijo2016176a.PMC5144117.pdf
Available from: http://health.govmu.org/English/Statistics/Documents/Mauritius%20NCD%20Survey%202015%20Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/53/ijo2016176a.PMC5144117.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)BMI vs body fat in Mauritian Indians and Creoles S Hunma et al 1914 International Journal of Obesity (2016) 1906 –1914",Non-OADS,/arxiv_data1/oa_pdf/27/53/ijo2016176a.PMC5144117.pdf
"Ministry of Health and Family Welfare, Government of India,New Delhi (http://www.nhm.gov.in/images/pdf/mis-report/March-2016/1-NRHM.pdf), copyright 2016 Child Health Division, Ministryof Health and Family Welfare.Home-based newborn care in India SB Neogi et al S15 Journal of Perinatology (2016), S13 –S17",Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
"Available at http://nrhm.gov.in/images/pdf/media/publication/ Annual_Report-Mohfw.pdf (accessed on 19 January 2015).30 Division of Child Health and Immunization, Ministry of Health and Family Welfare.",Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at: http://nrhm.gov.in/images/pdf/programmes/child-health/guidelines/Revised_Home_ Based_New_Born_Care_Operational_Guidelines_2014.pdf (accessed on 17 August2016).,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at http://nrhm.gov.in/commu nitisation/asha/about-asha.html (accessed on 19 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at http://www.nipi.org.in/Dis playMoreNew.aspx?itemid = 2316 (accessed on 20 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at: http://globalcenters.columbia.edu/mumbai/ ﬁles/globalcenters_mumbai/F.%20FINAL_NRHM_ Report%202009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at http://www.intrahealth.org/page/strengthening-asha-support-mechanisms-for-improved-newborn-care-in-uttar-pradesh-technical-brief (accessed on 5 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at http://www.sewa.org/ (accessed on 31 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at: http://www.newbornwhocc.org/SOIN_PRINTED%2014-9-2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Home-based newborn care in India SB Neogi et al S17 Journal of Perinatology (2016), S13 –S17",Non-OADS,/arxiv_data1/oa_pdf/07/db/jp2016185a.PMC5144118.pdf
Available at http://data.un.org/Explorer.,Non-OADS,/arxiv_data1/oa_pdf/53/6c/jp2016183a.PMC5144119.pdf
Available at http://www.censusindia.gov.in/2011-prov-results/PPT_2.html (accessed on 20 August 2014).,OADS,/arxiv_data1/oa_pdf/53/6c/jp2016183a.PMC5144119.pdf
Available at http://planningcommission.nic.in/data/data table/index.php?data = datatab (accessed on 14 April 2014).,OADS,/arxiv_data1/oa_pdf/53/6c/jp2016183a.PMC5144119.pdf
Available at http://www.newbornwhocc.org/pdf/nnpd_report_2002-03.PDF (accessed on 2 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/53/6c/jp2016183a.PMC5144119.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Newborn health in India MJ Sankar et al S8 Journal of Perinatology (2016), S3 –S8",Non-OADS,/arxiv_data1/oa_pdf/53/6c/jp2016183a.PMC5144119.pdf
We registered this study through the Chinese Clinical Trial Register(http://www.chictr.org.cn/).,Non-OADS,/arxiv_data1/oa_pdf/2f/0b/jhh20168a.PMC5144121.pdf
The manuscript was drafted following the CONSORT Checklist (http://www.consort-statement.org/).,Non-OADS,/arxiv_data1/oa_pdf/2f/0b/jhh20168a.PMC5144121.pdf
"Sample size The sample size was estimated using an online tool (http://www.openepi.com/) based on the following parameters: (1) percent of unexposed withoutcome, p1 = 60%; (2) percent of exposed with outcome, p2 = 75%; (3)α= 0.05; (4) β= 0.2.",OADS,/arxiv_data1/oa_pdf/2f/0b/jhh20168a.PMC5144121.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)Supervision for patients with hypertension in rural China Y Shen et al 36 Journal of Human Hypertension (2017) 29 –36 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/2f/0b/jhh20168a.PMC5144121.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)eNOS/iNOS and ER stress-induced apoptosis in PE LD u et al 55 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/08/18/jhh201617a.PMC5144123.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Affordable neonatal care equipment V Sashi Kumar et al S36 Journal of Perinatology (2016), S32 –S36",Non-OADS,/arxiv_data1/oa_pdf/c7/4b/jp2016188a.PMC5144124.pdf
"Available from http://www.censusindia.gov.in/2011-common/Sample_Registration_System.html.Copyright 2013, Of ﬁce of the Registrar General and Census Commissioner, India.",OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at http://www.censusindia.gov.in/2011-common/Sample_Registration_Sys- tem.html.,OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
"Adapted with permission from Registrar General of India.Sample Registration System (SRS) Statistical Report, New Delhi.Available at http://censusindia.gov.in/2011-common/Sample_Regis- tration_System.html.",OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
"Available at: http://www.censusindia.gov.in/2011-Common/AHSurvey.html.Copyright 2013, Of ﬁce of the Registrar General and Census Commissioner, India.Urban newborn J Sharma et al S25 Journal of Perinatology (2016), S24 –S31",Non-OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at: http://www.censusindia.gov.in/2011-Common/AHSur-vey.html.,OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
"Available at:http://www.censusindia.gov.in/2011-Common/AHSurvey.html.Copyright 2013, Of ﬁce of the Registrar General and Census Commissioner, India.Urban newborn J Sharma et al S26 Journal of Perinatology (2016), S24 –S31",Non-OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at http://censusindia.gov.in/2011-prov-results/paper2/data_ ﬁles/India2/1.%20Data%20High light.pdf.,OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at:http://planningcommission.nic.in/aboutus/committee/wrkgrp12/hud/wg_Final_Urb_Pvt.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at: http://www.censusindia.gov.in/2011-Common/AHSurvey.html.,OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at: http://www.path.org/publications/ ﬁles/CP_india_sure_start_bro.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available at: http://data.worldbank.org/indicator/SH.XPD.,OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
available at: http://www.delhi.gov.in/wps/wcm/connect/3cd0a5004d9238eeaa5eaf09e0ee946a/guidelines.pdf?MOD =AJPERES.,Non-OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Urban newborn J Sharma et al S31 Journal of Perinatology (2016), S24 –S31",Non-OADS,/arxiv_data1/oa_pdf/af/12/jp2016187a.PMC5144125.pdf
Available from: http://www.nobelprize.org.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/AIAN-19-448.PMC5144463.pdf
Available from: http://www.irlssg.org/diagnostic‑criteria/.,OADS,/arxiv_data1/oa_pdf/46/f7/AIAN-19-472.PMC5144468.pdf
Available from: http://www.cdsco.nic.in/writereaddata/ADR%20 form%20PvPI.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/f7/AIAN-19-472.PMC5144468.pdf
Available from: http://www.qnostics.com/ molecular‑controls/.,Non-OADS,/arxiv_data1/oa_pdf/a8/62/AIAN-19-482.PMC5144470.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/a8/62/AIAN-19-482.PMC5144470.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/a8/62/AIAN-19-482.PMC5144470.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/AIAN-19-514.PMC5144477.pdf
"Image processing was performed  using the VBM 8 toolbox (http://dbm.neuro.unijena.de/vbm),  implemented in Statistical Parametric Mapping 8 (SPM 8,  UK, http://www.fil.ion.ucl.ac.uk/spm).",OADS,/arxiv_data1/oa_pdf/ea/7b/AIAN-19-518.PMC5144479.pdf
"To perform TBSS analysis, all raw DTI data were preprocessed  with FSL (http://www.fmrib.ox.au.uk/fsl).",OADS,/arxiv_data1/oa_pdf/ea/7b/AIAN-19-518.PMC5144479.pdf
Available from: http://www.epilepsyindia.org/ ies/GUIDELINES/Gemind_Combine.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/e6/AIAN-19-531.PMC5144484.pdf
Available from: http://www.epilepsyindia.org/ ies/GUIDELINES/Gemind_Combine.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/d0/AIAN-19-532.PMC5144485.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc- nd/4.0/ Executive summary •	Mannose-anchored thiolated chitosan (MTC) nanocarriers were designed and evaluated against  intramacrophage amastigote parasites.",Non-OADS,/arxiv_data1/oa_pdf/d0/a8/nnm-12-99.PMC5144491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hpb.2016.09.007 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).980 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HPB 981,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).982 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HPB 983,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
"Statistical analyses were performed using code developed in R (R Devel-opmental Core Team http://www.R-project.org ) and Metab- oAnalyst 3.0 (Xia, J., Sinelnikov, I., Han, B., and Wishart, D.S.",OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
( http://dx.doi.org/10.1093/nar/ gkv380 ).,OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).984 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HPB 985,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).986 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HPB 987,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).988 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HPB 989,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).990 HPB,Non-OADS,/arxiv_data1/oa_pdf/35/d3/main.PMC5144552.pdf
"Copyright © 2016 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7 http://e-eht.org/ Introduction Metal pollution has become a serious environmental threat  since the Industrial Revolution.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
"Essential metals  such as iron, copper (Cu), manganese (Mn) and zinc (Zn) play  an important role in biological systems, whereas some non-essen - tial metals like cadmium (Cd), lead (Pb) and mercury are consid -Evaluation of metal contamination and  phytoremediation potential of aquatic  macrophytes of East Kolkata Wetlands, India Amina Khatun1, Sandipan Pal2, Aloke Kumar Mukherjee3, Palas Samanta1,4, Subinoy Mondal1,  Debraj Kole1, Priyanka Chandra1, Apurba Ratan Ghosh1 1Department of Environmental Science, University of Burdwan, Burdwan; 2Department of Environmental Science,  Aghorekamini Prakashchandra Mahavidyalaya, Hooghly; 3Department of Conservation Biology, Durgapur Government  College, Durgapur, India; 4Division of Environmental Science and Ecological Engineering, Korea University, Seoul, Korea • Original ArticleOpen Access Environmental Health and Toxicology Volume: 31, Article ID: e2016021, 7 pages https://doi.org/10.5620/eht.e2016021 eISSN: 2233-6567  Objectives  The present study analyzes metal contamination in sediment of the East Kol - kata Wetlands, a Ramsar site, which is receiving a huge amount of domestic and indus - trial wastewater from surrounding areas.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
"Keywords : East Kolkata Wetlands, Metals, Phytoremediation, Colocasia esculenta, Scir - pus articulatusCorrespondence:  Apurba Ratan Ghosh  Golapbag, Burdwan 713104, West Bengal,  India  Tel: +91-3422657938 Fax: +91-3422657938 E-mail: apurbaghosh2010@gmail.com  Received:  June 22, 2016 Accepted:  September 8, 2016 Published:  September 8, 2016 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
http://e-eht.org/ Page 2 of 7Environmental Health and Toxicology    2016;31:e2016021 ered toxic even at low concentrations [5].,Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
"http://e-eht.org/ Page 3 of 7Amina Khatun, et al.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
http://e-eht.org/ Page 4 of 7Environmental Health and Toxicology    2016;31:e2016021 BCF and TF of the two plants C. esculenta  and S. articulatusare   given in T able 6.,Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
"http://e-eht.org/ Page 5 of 7Amina Khatun, et al.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
http://e-eht.org/ Page 6 of 7Environmental Health and Toxicology    2016;31:e2016021 suitable for phytostabilization due to their comparatively high  BCF and low TF values.,Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
ORCID Amina Khatun http://orcid.org/0000-0003-1005-7206 Sandipan Pal http://orcid.org/0000-0003-3552-1722 Aloke Kumar Mukherjee http://orcid.org/0000-0002-2309-0681 Palas Samanta http://orcid.org/0000-0001-9369-7502 Subinoy Mondal http://orcid.org/0000-0001-6212-2423 Debraj Kole http://orcid.org/0000-0002-3083-8168 Priyanka Chandra http://orcid.org/0000-0002-8848-0146 Apurba Ratan Ghosh http://orcid.org/0000-0003-1454-7720 References 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
"http://e-eht.org/ Page 7 of 7Amina Khatun, et al.",Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
Available from: http://www.isric.org/isric/webdocs/docs/ ISRIC_T echPap09_2002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
Available  from: https://clu-in.org/download/toolkit/phyto_o.pdf .,OADS,/arxiv_data1/oa_pdf/1f/fe/eht-31-e2016021.PMC5144572.pdf
"Copyright © 2016 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7 http://e-eht.org/ Introduction With the development of telecommunication technology, mo - bile phones have been rapidly introduced to the public over the  past few decades.",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"A mobile phone terminal, which is a type of low-power, wire -A cross-sectional study of the association between  mobile phone use and symptoms of ill health  Y ong Min Cho1, Hee Jin Lim2, Hoon Jang2, Kyunghee Kim2, Jae Wook Choi2, Chol Shin3,  Seung Ku Lee3, Jong Hwa Kwon4, Nam Kim5  1Institute for Life and Environment T echnology, Smartive Corporation, Seoul; 2Institute for Occupational and Environmental  Health, Korea University, Seoul; 3Institute of Human Genome Study, Korea University Ansan Hospital, Ansan; 4EM  Environment Research T eam, Electronics and T elecommunications Research Institute, Daejeon; 5Division of Information and  Communication Engineering, Chungbuk National University, Chungju, Korea  • Original articleOpen Access Environmental Health and Toxicology Volume: 31, Article ID: e2016022, 7 pages https://doi.org/10.5620/eht.e2016022 eISSN: 2233-6567  Objectives  This study analyzed the associations between mobile phone call frequency  and duration with non-specific symptoms.",OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"Keywords  Mobile phones, Headaches, Headache Impact Test-6, Non-specific symptoms Correspondence:  Jae Wook Choi  73 Inchon-ro, Seongbuk-gu, Seoul 02841,  Korea  Tel: +82-2-2286-1470 Fax: +82-2-927-7220 E-mail: shine@korea.ac.kr   Received:  September 5, 2016 Accepted:  October 21, 2016 Published:  October 26, 2016 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"http://e-eht.org/ Page 2 of 7Environmental Health and Toxicology    2016;31:e2016022 less transmitter-receiver, is a source of radiofrequency-electro - magnetic fields (RF-EMF) [3].",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"http://e-eht.org/ Page 3 of 7Yong Min Cho, et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
http://e-eht.org/ Page 4 of 7Environmental Health and Toxicology    2016;31:e2016022 ble 4).,Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"http://e-eht.org/ Page 5 of 7Yong Min Cho, et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
http://e-eht.org/ Page 6 of 7Environmental Health and Toxicology    2016;31:e2016022 culties to be applied to large-size population and to find repre - sentative value of exposure.,Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
ORCID  Y ong Min Cho http://orcid.org/0000-0002-8999-8916  Hee Jin Lim http://orcid.org/0000-0001-5295-0137   Hoon Jang http://orcid.org/0000-0001-8549-8001 Kyunghee Kim http://orcid.org/0000-0002-5333-9716  Jae Wook Choi http://orcid.org/0000-0002-1996-7524 Chol Shin http://orcid.org/0000-0002-2928-8576 Seung Ku Lee http://orcid.org/0000-0001-5120-5557 Jong Hwa Kwon http://orcid.org/0000-0002-2132-7403 Nam Kim http://orcid.org/0000-0001-8109-2055 References 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
Available from: http://www.kcc.go.kr/user.do?page=A02060400 &dc=K02060400&boardId=1030&cp=13 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
Available from: http://www.digi - taltrends.com/mobile/mobile-phone-world-population-2014/.,Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
Available from: http://monographs.iarc.fr/ENG/Monographs/ vol102/mono102.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"http://e-eht.org/ Page 7 of 7Yong Min Cho, et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/eht-31-e2016022.PMC5144583.pdf
"Morgera, ‘The Need for an International Legal Concept of Fair and Equitable Benefit-sharing’, European Journal of International Law (forthcoming), found at: <http://papers.ssrn.com/sol3/papers.cfm?",Non-OADS,/arxiv_data1/oa_pdf/81/a5/REEL-24-353.PMC5144629.pdf
"19Typical cases concern benefit-sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture; see the review by E. Tsioumani, ‘Exploring Benefit-sharing from theLab to the Land (Part I): Agricultural Research and Developmentin the Context of Conservation and Sustainable Use’ (2014), found at:<http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2524337 >.20See E. Morgera, n. 1 above, at 26.",Non-OADS,/arxiv_data1/oa_pdf/81/a5/REEL-24-353.PMC5144629.pdf
"Savaresi, ‘The Emergence of Benefit-sharing Under the Climate Regime: A Preliminary Exploration and Research Agenda’ (2014),found at: <http://papers.ssrn.com/sol3/papers.cfm?abstract_id=252 4335 >.",Non-OADS,/arxiv_data1/oa_pdf/81/a5/REEL-24-353.PMC5144629.pdf
"This view of constantlychanging meanings is also inherent to the epistemol- 78Benefit-sharing was thus included in a package of issues to be addressed under that international process in 2011; Oceans and the Law of the Sea (UNGA Resolution A/RES/66/231, 5 April 2012), Annex, paragraph (b); see also E. Morgera, ‘Benefit-sharing in MarineAreas beyond National Jurisdiction: Where Are We At?’ (Parts I, II andIII) (2015), found at: <http://www.benelexblog.law.ed.ac.uk >.",Non-OADS,/arxiv_data1/oa_pdf/81/a5/REEL-24-353.PMC5144629.pdf
"Nollkaemper, ‘Framing Elephant Extinction’, 3:5 European Soci- ety of International Law Reflection (2014), found at: <http://www.esil- sedi.eu/node/643 >.",Non-OADS,/arxiv_data1/oa_pdf/81/a5/REEL-24-353.PMC5144629.pdf
"See the discussion in E. Morgera and L. Parks, ‘An Inter-disciplinary Methodology forResearching Benefit-sharing as a Norm Diffusing in Global Environ-mental Law’ (2014), found at: <http://papers.ssrn.com/sol3/papers.",Non-OADS,/arxiv_data1/oa_pdf/81/a5/REEL-24-353.PMC5144629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/d0/ofw207.PMC5144652.pdf
Available at: http://www.statistikdatabasen.scb.se .,OADS,/arxiv_data1/oa_pdf/62/d0/ofw207.PMC5144652.pdf
Available at:  https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/s/ Swedres-Svarm-2014/.,Non-OADS,/arxiv_data1/oa_pdf/62/d0/ofw207.PMC5144652.pdf
"This  is an Open Access article distributed under the terms of the  Creative Commons Attribution-NonCommercial-NoDerivs  licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),  which permits non-commercial reproduction and distribution  of the work, in any medium, provided the original work is  not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/ofw209.PMC5144653.pdf
Carbapenem- resistant Enterobacteriaceae  represent 1 of the 3 urgent antibiotic  resistance threats ranked by the Centers for Disease Control and Prevention ([CDC] the other 2 are Clostridium difficile  and drug-resistant Neisseria gonorrhoeae [http://www.cdc.gov/drugresistance/threat-report-2013]).,Non-OADS,/arxiv_data1/oa_pdf/1f/d8/ofw222.PMC5144654.pdf
Carbapenem-resistant  K pneumoniae  that produce other types of carbapenemases such  as New Delhi metallo-β-lactamase (NDM) and oxacillinase-48 have also been increasingly reported [6 ] (http://www.cdc.gov/ hai/organisms/cre/TrackingCRE.html).,Non-OADS,/arxiv_data1/oa_pdf/1f/d8/ofw222.PMC5144654.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/  by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/d8/ofw222.PMC5144654.pdf
"Within  the past few years, CRKP proportions have been trending down according to the NHSN’s online report (http://gis.cdc.gov/grasp/ PSA/MapView.html); the percentage of carbapenem-resistant  Klebsiella  isolates decreased from 9.8% to 7.8% in the nation  and 16.2% to 14.2% in New Y ork state (NYS) from 2011 to 2014, based on the collected data for hospital-acquired infections (HAIs).",Non-OADS,/arxiv_data1/oa_pdf/1f/d8/ofw222.PMC5144654.pdf
"Nine-Y ear Trends of CRKP in NYC • OFID • 7United States, and most states (48 of 50 states; https://www.cdc.",OADS,/arxiv_data1/oa_pdf/1f/d8/ofw222.PMC5144654.pdf
"Literature and national reports showed sharp increases of  CRKP proportions in 2000s [6, 11, 22], then slight decreases in  2011−2014 (http://gis.cdc.gov/grasp/PSA/MapView.html).",OADS,/arxiv_data1/oa_pdf/1f/d8/ofw222.PMC5144654.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/6c/ofw208.PMC5144655.pdf
http://www.eulerdiagrams.org/eulerAPE).,Non-OADS,/arxiv_data1/oa_pdf/93/6c/ofw208.PMC5144655.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/f0/ofw213.PMC5144656.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/20/ofw205.PMC5144657.pdf
"Although the primary  data source was published data, for the RCT data, we searched the US National Institutes of Health trial registry and results database ( https://clinicaltrials.gov) and contacted all principal  investigators to verify the HZ definition used, whether SAE or not, and the reported numbers.",OADS,/arxiv_data1/oa_pdf/92/20/ofw205.PMC5144657.pdf
"1174 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/70/hyw131.PMC5144660.pdf
"Key words: RNASeq, APEC, thymus, transcriptome, immune response 2017 Poultry Science 95:2803–2814 http://dx.doi.org/10.3382/ps/pew202 INTRODUCTION Colibacillosis, caused by avian pathogenic Es- cherichia coli (APEC ), is an extraintestinal disease that may manifest as septicemia, pericarditis, or air- sacculitis in poultry (JanBen et al., 2001 ; Stordeur et al., 2004 ).",Non-OADS,/arxiv_data1/oa_pdf/47/9a/pew202.PMC5144662.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribu- tion Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/9a/pew202.PMC5144662.pdf
"Key words: Salmonella , XPC, virulence, antibiotic sensitivity, broiler chickens 2016 Poultry Science 95:2902–2910 http://dx.doi.org/10.3382/ps/pew254 INTRODUCTION Most Salmonella , except for serovars Pullorum and Gallinarum (Wilson et al., 2000 ) and possibly other strains [e.g., S. Kentucky (Ogunleye and Carlson 2012 )], are capable of asymptomatically residing in the in- testinal tracts of poultry.",Non-OADS,/arxiv_data1/oa_pdf/84/72/pew254.PMC5144663.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by- nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/72/pew254.PMC5144663.pdf
Reports of Salmonella Outbreak Investigations from 2015. http://www.cdc.gov/salmonella/outbreaks-2015.html .,OADS,/arxiv_data1/oa_pdf/84/72/pew254.PMC5144663.pdf
Accessed at: http://www.abstractsonline.com/Plan/ViewAbstract.aspx .,Non-OADS,/arxiv_data1/oa_pdf/84/72/pew254.PMC5144663.pdf
"Key words: bone mineral density, corticosterone, laying performance, stock density, Hy-line Brown laying hens, animal welfare 2016 Poultry Science 95:2764–2770 http://dx.doi.org/10.3382/ps/pew264 INTRODUCTION The welfare of laying hens raised in standard com- mercial cages has been placed under intense scrutiny.",Non-OADS,/arxiv_data1/oa_pdf/cd/04/pew264.PMC5144664.pdf
"This is an Open Access article dis- tributed under the terms of the Creative Commons Attribution Non- Commercial License ( http://creativecommons.org/licenses/by-nc/ 4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/04/pew264.PMC5144664.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/91/kew316.PMC5144667.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/8c/dsw032.PMC5144674.pdf
Information about the sequencesand gene annotations are also available in the genome database ofmicroorganisms sequenced at NITE (DOGAN; http://www.bio.nite.go.jp/dogan/top).,OADS,/arxiv_data1/oa_pdf/f6/8c/dsw032.PMC5144674.pdf
17. http://www.cbrc.jp/cbrc/team/researcher/asai/index.ja.html 18.,OADS,/arxiv_data1/oa_pdf/f6/8c/dsw032.PMC5144674.pdf
71. http://www.jcm.riken.jp/cgi-bin/jcm/jcm_number?JCM ¼2261.,Non-OADS,/arxiv_data1/oa_pdf/f6/8c/dsw032.PMC5144674.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/51/dsw035.PMC5144675.pdf
"Thus, an artiﬁcial variable, as a dummy variable (orindicator variable), was created to represent the variation of M(¼LB, MAA or M63) and was introduced to the multiple regression analysis.To increase the regression efﬁciency, regression variable selection wasperformed on the basis of AIC (Akaike Information Criteria), 35which evaluated the relative quality of regression models for the data set.36 Computational analyses were performed with R,37and a 3D-plot was created by using the car package.38 2.7 Organization and graphics of reduced genomes Information on the deleted genomic sequences (genomic position anddeletion ID) was obtained from the website http://shigen.nig.ac.jp/ecoli/strain/, which distributed the E. coli strains (KHK collection).",OADS,/arxiv_data1/oa_pdf/3b/51/dsw035.PMC5144675.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/49/dsw036.PMC5144676.pdf
"16Next, a Neighbour- Joining method was used to construct the phylogenetic tree on the ba-sis of the distance matrix, calculated by the software PHYLIP (http://evolution.genetics.washington.edu/phylip.html).",OADS,/arxiv_data1/oa_pdf/ce/49/dsw036.PMC5144676.pdf
All assembly results and annotation results can bedownloaded from http://chuanh.tll.org.sg/oilpalm/.,OADS,/arxiv_data1/oa_pdf/ce/49/dsw036.PMC5144676.pdf
"Pritchard, J. K., Wen, W. and Falush, D. 2003, Documentation for STRUCTURE software: version 2 http://pritchardlab.stanford.edu/struc ture_software/release_versions/v2.3.4/structure_doc.pdf.",OADS,/arxiv_data1/oa_pdf/ce/49/dsw036.PMC5144676.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"Based on these data, we con-structed the free-access Quinoa Genome DataBase (QGDB; http://quinoa.kazusa.or.jp), which provides annotations of in silico predicted genes.",OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"27Sequences homologous to bacterial, fungal, and human (hg19) genome sequences, vector sequences from UniVec(http://www.ncbi.nlm.nih.gov/tools/vecscreen/univec/), chloroplast(Accession number: NC_000932.1) and mitochondrial (Accession number: NC_001284.2) genome sequences from A. thaliana , and the PhiX sequence used for background controlling in Illumina sequenc-ing by BLASTN 39searches with an E-value cutoff of 1E-10 and length coverage of /C2110%, were excluded as probable contamination.",OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
40and RepeatMasker 4.0.3 (http://www.repeat masker.org) as described previously.35 2.11.,Non-OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
The predicted genes were subjected to similarity searches against the NCBI NR database (ftp://ftp.ncbi.nlm.nih.gov/blast/db/FASTA/nr.gz) and amino acid sequences of A. thaliana from TAIR10 (https://www.arabidopsis.org) using BLASTX with an E-value cutoffof 1E-10.,OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
A domain search againstInterPro (http://www.ebi.ac.uk/interpro/) was conducted usingInterProScan 49with an E-value cutoff of 1.0.,OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"In addition, the genes were mapped onto the KEGG reference pathways by BLAST searches against the KEGGGENES database (http://www.genome.jp/kegg/genes.html) with anE-value cut-off of 1E-4, length of coverage of 25%, and identity of 50%.",OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"The draft genome sequence (Cqu_r1.0), predicted gene sequences, deduced amino acid sequences, annota- tions derived from BLAST searches against the NCBI NR andTAIR10 databases, and domains identiﬁed in the search againstInterPro were included in the free-access Quinoa Genome DataBase(QGDB; http://quinoa.kazusa.or.jp).",OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"The draft genome sequence Cqu_r1.0, CDS and pro-tein sequences, and annotation ﬁle (gff ﬁle) are also available from thefree-access Quinoa Genome DataBase (QGDB; http://quinoa.kazusa.or.jp).",OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"Phytozome 11, https://phytozome.jgi.doe.gov/pz/portal.html85.",Non-OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"The Beta vulgaris Resource, http://bvseq.molgen.mpg.de/index.shtml.",Non-OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"EMBOSS Transeq, http://www.ebi.ac.uk/Tools/st/emboss_transeq/.",OADS,/arxiv_data1/oa_pdf/a8/38/dsw037.PMC5144677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/4b/dsw038.PMC5144678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
"Gene models were produced by running AUGUSTUS on arepeat-masked genome, produced with RepeatMasker 4.0.6 (http://ftp.genome.washington.edu/RM/RepeatMasker.html) and reﬁned with PASA.",OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
"A second approach used for genes encoding proteins with one ormore speciﬁc protein domains, was to screen the models against thePfam database (Pfam-A.hmm, release 24.0; http://pfam.sanger.ac.uk), 31which contains approximately 11,000 conserved domains us- ing HMMER (hmmer3).32 In the case of complex multigene families, a third annotation method was employed; sets of related sequences were subjected tophylogenetic analyses in order to more precisely determine ortholo-gous relationships between proteins of C. okamuranus andE.",OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
36The assembled sequence and gene models are accessible at http://marinegenomics.oist.jp/gallery/.,OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
38Gene expression levels were visualized with R 3.2.2 (https://www.r-project.org/) using the pheatmap 1.0.8package.,OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
"(B) The lo- cation of candidate genes for L-fucosinase (FK) and GDP-fucose pyrophosphorylase (GFPP) in the C. okamuranus genome, suggesting the presence of an enzy- matic gene cluster having shared synteny with E. siliculosus (http://bioinformatics.psb.ugent.be/orcae/overview/Ectsi).",OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
Data availability A genome browser has been established at: http://marinegenomics.oist.jp/gallery/.,OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
Gene annotations from domain searches andBlast2GO 51are available at: (http://marinegenomics.oist.jp/gallery/).,OADS,/arxiv_data1/oa_pdf/2e/5a/dsw039.PMC5144679.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/51/dsw040.PMC5144680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/b8/dsw041.PMC5144681.pdf
"Theannotation data of the complete genome sequences were obtained byPGAAP (Prokaryotic Genome Annotation Pipeline, http://www.ncbi.nlm.nih.gov/genome/annotation_prok/; 22 August 2016, date lastaccessed), and was curated with the dedicated software bundled inthe GenomeMatcher programme (http://www.ige.tohoku.ac.jp/joho/gmProject/gmhome.html; 22 August 2016, date last accessed) 37as well as by consulting the MiGAP auto-annotation system (MicrobialGenome Annotation Pipeline, http://www.migap.org/; 22 August2016, date last accessed).",OADS,/arxiv_data1/oa_pdf/a3/b8/dsw041.PMC5144681.pdf
"Computational analyses of sequence data The nucleotide and protein sequences were analysed using theGenetyx programme version 13–18 (Genetyx Corp., Tokyo, Japan).Homology searches were performed using the BLAST programmesavailable at the National Center for Biotechnology Information web- site (http://www.ncbi.nlm.nih.gov/BLAST/; 22 August 2016, date last accessed) with the default parameters.",OADS,/arxiv_data1/oa_pdf/a3/b8/dsw041.PMC5144681.pdf
"Venn diagram was de-picted using the result obtained by BLASTClust analysis (ftp://ftp.ncbi.nlm.nih.gov/blast/executables/; 22 August 2016, date lastaccessed) 38for all predicted open reading frames (ORFs) of the four c-HCH degraders with a parameter set ‘-p T -L .6 -b T -S 60 -a 24’.",OADS,/arxiv_data1/oa_pdf/a3/b8/dsw041.PMC5144681.pdf
"All neighbour-joining phylogenetic trees shown inthis study were constructed using MAFFT programme (http://mafft.cbrc.jp/alignment/software/; 22 August 2016, date last accessed) 39 and visualized by NJplot software (http://pbil.univ-lyon1.fr/software/njplot.html; 22 August 2016, date last accessed).",OADS,/arxiv_data1/oa_pdf/a3/b8/dsw041.PMC5144681.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/85/6f/main.PMC5144742.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.009 442,OADS,/arxiv_data1/oa_pdf/85/6f/main.PMC5144742.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AddictionAlcohol dependenceCingulate cortexCue reactivityFunctional connectivityRelapse 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/52/main.PMC5144743.pdf
http://dx.doi.org/10.1016/j.nicl.2016.10.019 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/52/main.PMC5144743.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/52/main.PMC5144743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Traumatic brain injury Magnetic resonance imaging Diffusion-weighted magne tic resonance imaging Probabilistic tractographyGlobal approach 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.016 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1136/jnnp-2012-302742 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.06.021 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/S0720-048X(02)00311-X .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/S0006-3495(94)80775-1 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1006/ jmrb.1994.1037 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
19:85 –91.http://dx.doi.org/ 10.1080/02699050410001720158 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/nbm.782 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.07.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
455 –473http://dx.doi.org/10.1007/978-0-387-09749-7_25 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
16:2. http://dx.doi.org/10.1186/s12883-015-0525-8 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.nicl.2013.12.009 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/ 10.3171/2013.2.JNS121294 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.2214/ajr.149.2.351 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1097/TA.0b013e3182684fe8 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
"NeuroRehabilitation 22, 341–353 (doi:http://iospress.metapress.com/content/103177/?sortorder=asc).",Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.3171/jns.2005.103.2.0298 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/hbm.21032 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/ hbm.22099 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/nbm.1543 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/(SICI)1522-2594(199909)42:3 b515::AID- MRM14 N3.0.CO;2-Q .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1080/02699050903014915 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.11.094 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/ 10.1212/WNL.0b013e3181c33afb .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1161/STROKEAHA.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/ mrm.21890 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/mrm.25816 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.3647-07.2007 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
J. Neurotrauma 31:26 –33.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.ncl.2013.08.002 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/hbm.21092 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1080/02699050801888816 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.nicl.2014.07.010 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1089/brain.2012.0121 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/aur.1332 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
8:28. http://dx.doi.org/10.3389/fninf.2014.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
Autism 6:4. http://dx.doi.org/10.1186/2040-2392-6-4 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.media.2015.01.001 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1007/s11682-012-9156-5 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
Sports Health 8:26 –36.http://dx.doi.org/ 10.1177/1941738115588745 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
7:301 – 317. http://dx.doi.org/10.1191/096228098672090967 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1037/0033-2909.86.2.420 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1080/02699050902926309 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1006/nimg.2002.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.01.028 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1148/ radiol.2471070707 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
NeuroImage 86:67 –80.http://dx.doi.org/10.1016/j.neuroimage.2013.07.067 .179 M. Mohammadian et al.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1136/jnnp.41.7.603 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
J. Neurotrauma 30:2 –10.http://dx.doi.org/10.1089/neu.2012.2486 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/mrm.22924 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1002/nbm.3017 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
J. Neurotrauma http://dx.doi.org/10.1089/neu.2016.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1089/ neu.2014.3750 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1212/01.wnl.0000305961.68029.54 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1089/neu.1998.15.573 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1089/neu.2006.0208 .,Non-OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1016/j.archger.2007.07.004 .,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
http://dx.doi.org/10.1089/neu.2013.3171 .180 M. Mohammadian et al.,OADS,/arxiv_data1/oa_pdf/ac/72/main.PMC5144744.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/bd/main.PMC5144745.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.010 436,OADS,/arxiv_data1/oa_pdf/4b/bd/main.PMC5144745.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/de/ec/main.PMC5144746.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.011 439,OADS,/arxiv_data1/oa_pdf/de/ec/main.PMC5144746.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/42/main.PMC5144747.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.015 433,OADS,/arxiv_data1/oa_pdf/46/42/main.PMC5144747.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Endometriosis CYP17DNA sequence analysisRNA extraction by qRT-PCRPolymorphism and gene expression 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/67/main.PMC5144748.pdf
"http://dx.doi.org/10.1016/j.gdata.2016.11.019 2213-5960/© 2016 Al-Mustansiriyah University ,College of Science, Chemistry Department,Baghdad-Iraq.",Non-OADS,/arxiv_data1/oa_pdf/e0/67/main.PMC5144748.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/67/main.PMC5144748.pdf
"(2014), http://dx.doi.org/10.1159/000365329 .",Non-OADS,/arxiv_data1/oa_pdf/e0/67/main.PMC5144748.pdf
"Cancer (2012), http://dx.doi.org/10.1158/1078-0432.CCR-12-2812 .",Non-OADS,/arxiv_data1/oa_pdf/e0/67/main.PMC5144748.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2017) 8,4 5–53 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.11.001 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/ab/2a/main.PMC5144749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/2a/main.PMC5144749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/2a/main.PMC5144749.pdf
DARU2014;22:43. http://dx.doi.org/10.1186/2008-2231-22-43 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2a/main.PMC5144749.pdf
http://dx.doi.org/10.17795/whb-31414 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2a/main.PMC5144749.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/b7/main.PMC5144750.pdf
"1a,b) http://dx.doi.org/10.1016/j.ijscr.2016.11.041 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/ff/b7/main.PMC5144750.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/78/main.PMC5144751.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.043 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/41/78/main.PMC5144751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Deep brain stimulationEssential tremor Probabilistic mapping Zona incerta 1.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.019 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1159/000314357 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
50:23 –32.http://dx.doi.org/10.1007/s11517-011-0842-z .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1109/TBME.2014.2363494 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.expneurol.2011.04.005 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.parkreldis.2014.09.021 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.10.059 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
10:56023. http://dx.doi.org/10.1088/1741-2560/10/5/056023 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1002/ana.24187 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1093/brain/awh551 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10 .1093/brain/awq267 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/ 10.1002/mds.23195 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1093/ brain/awp315 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
115:65 –71.http://dx.doi.org/10.1016/j.clineuro.2012.04.015 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.clinph.2008.06.003 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1093/brain/awm077 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1002/mds.1089 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.clinph.2008.02.025 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1002/mds.22838 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.3174/ajnr.A2906 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.clinph.2003.10.033 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.03.068 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1044/ 2014_JSLHR-S-13-0155 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
15:1 –25.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1227/NEU.0b013e318236a809 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
2:29 –40.http://dx.doi.org/10.3233/JPD-2012- 11049 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/0360-3016(87)90201-X .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1016/j.jneumeth.2007.10.007 .,OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1002/mds.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
1:20. http://dx.doi.org/10.1186/ 2047-9158-1-20 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.3171/2009.10.JNS09371 .,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
http://dx.doi.org/10.1093/brain/awn201 .173 T.A.,Non-OADS,/arxiv_data1/oa_pdf/92/52/main.PMC5144752.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ImagingPathologyAmyloidAlzheimer ’sd i s e a s e 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/45/main.PMC5144753.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.008 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/45/main.PMC5144753.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/45/main.PMC5144753.pdf
"Irfan Yavasoglu, Gokhan Sargin Adnan Menderes University Medical Faculty, Division of Hematology, Aydin, 09000 Turkey Adnan Menderes University Medical Faculty, Division of Internal Medicine, Aydin, 09000 Turkey E-mail address: dr_yavas@yahoo.com http://dx.doi.org/10.1016/j.lrr.2016.11.001Leukemia Research Reports 7 (2017) 1 Available online 29 November 2016 2213-0489/ © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/cb/main.PMC5144754.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/cb/main.PMC5144754.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/7d/main.PMC5144755.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.015 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7d/main.PMC5144755.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/7d/main.PMC5144755.pdf
http://rsb.info.gov/ij/ .,Non-OADS,/arxiv_data1/oa_pdf/09/7d/main.PMC5144755.pdf
"Recently, the results of our study http://dx.doi.org/10.1016/j.redox.2016.11.012 Received 3 October 2016; Received in revised form 8 November 2016; Accepted 15 November 2016⁎Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/af/d6/main.PMC5144757.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/d6/main.PMC5144757.pdf
158 Copyright © 2016 The Korean Audiological SocietyORIGINAL ARTICLE J Audiol Otol 2016 ;20(3):158-167 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.158 Introduction Individuals with auditory neuropathy spectrum disorder  (ANSD ) experience poor speech perception especially in the  presence of back ground noise [1].,Non-OADS,/arxiv_data1/oa_pdf/41/da/jao-20-158.PMC5144811.pdf
Copyright © 2016 The Korean Audiological Society  131REVIEW J Audiol Otol 2016 ;20(3):131-138 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.131 Introduction The present review article was aimed to discuss distinct  and common functions of the three members of miR-183 in  cell fate determination in the inner ear.,Non-OADS,/arxiv_data1/oa_pdf/92/f1/jao-20-131.PMC5144812.pdf
http://dx.doi.org/10.1371/journal.pone.0018195.,Non-OADS,/arxiv_data1/oa_pdf/92/f1/jao-20-131.PMC5144812.pdf
"Copyright © 2016 The Korean Audiological Society  127REVIEW J Audiol Otol 2016 ;20(3):127-130 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.127 Introduction Together with myringotomy or tympanocentesis, tympa - nostomy tube insertion (TTI) has been one of the most com - monly performed otologic surgical procedures in children.",Non-OADS,/arxiv_data1/oa_pdf/fd/50/jao-20-127.PMC5144813.pdf
"Copyright © 2016 The Korean Audiological Society  187LETTER TO THE EDITOR J Audiol Otol 2016 ;20(3):187 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.187 We have read with great interest the article by Yoo, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/d2/jao-20-187.PMC5144814.pdf
"Copyright © 2016 The Korean Audiological Society  183CASE REPORT J Audiol Otol 2016 ;20(3):183-186 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.183 Introduction The occurrence of carcinoma in the external auditory canal  (EAC ) is rare, with an annual incidence of one per one mil - lion people, accounting for less than 0.2% of all head and  neck cancers [1,2].",Non-OADS,/arxiv_data1/oa_pdf/be/51/jao-20-183.PMC5144815.pdf
"Copyright © 2016 The Korean Audiological Society  139ORIGINAL ARTICLE J Audiol Otol 2016 ;20(3):139-145 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.139 Introduction The tympanic membrane perforation (TMP ) can be classi - fied according to their duration, in acute and chronic (more  than 3 months ), and by the presence or absence of drainage,  in wet and dry perforation [1].",Non-OADS,/arxiv_data1/oa_pdf/aa/0c/jao-20-139.PMC5144816.pdf
Copyright © 2016 The Korean Audiological Society  153ORIGINAL ARTICLE J Audiol Otol 2016 ;20(3):153-157 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.153 Introduction Tympanometry is one the most important audiological  tests for the assessment of neonatal hearing screening pro - grams.,Non-OADS,/arxiv_data1/oa_pdf/dc/e7/jao-20-153.PMC5144817.pdf
174 Copyright © 2016 The Korean Audiological SocietyORIGINAL ARTICLE J Audiol Otol 2016 ;20(3):174-178 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.174 Introduction Dizziness is a common complaint in the primary care set - ting and ranks among the most common reasons for consulta - tion and referral to specialist care [1].,Non-OADS,/arxiv_data1/oa_pdf/98/e5/jao-20-174.PMC5144818.pdf
Copyright © 2016 The Korean Audiological Society  179CASE REPORT J Audiol Otol 2016 ;20(3):179-182 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.179 Introduction Choristoma is the presence of a histologically normal tis - sue in an abnormal location.,Non-OADS,/arxiv_data1/oa_pdf/57/5b/jao-20-179.PMC5144819.pdf
"146 Copyright © 2016 The Korean Audiological SocietyORIGINAL ARTICLE J Audiol Otol 2016 ;20(3):146-152 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.146 Introduction Hearing loss is caused by a combination of factors, includ- ing genetic characteristics, noise exposure, and aging.",Non-OADS,/arxiv_data1/oa_pdf/0a/50/jao-20-146.PMC5144820.pdf
Available  from : http://www.krila.re.kr/common/filedown.asp?ix=7221.,OADS,/arxiv_data1/oa_pdf/0a/50/jao-20-146.PMC5144820.pdf
Available from : https://www.verywell.com/hear - ing-loss-mild-1046139.,Non-OADS,/arxiv_data1/oa_pdf/0a/50/jao-20-146.PMC5144820.pdf
Available from :http://www.disabled-world.com/disability/types/ hearing/communication/types-hearing-aids.php.,Non-OADS,/arxiv_data1/oa_pdf/0a/50/jao-20-146.PMC5144820.pdf
168 Copyright © 2016 The Korean Audiological SocietyORIGINAL ARTICLE J Audiol Otol 2016 ;20(3):168-173 pISSN 2384-1621 / eISSN 2384-1710 https://doi.org/10.7874/jao.2016.20.3.168 Introduction Cholesteatoma of the middle ear is a keratin-filled anoma - ly that is found medial to the tympanic membrane.,Non-OADS,/arxiv_data1/oa_pdf/1d/57/jao-20-168.PMC5144821.pdf
Hertz-Knudsen-Langmuir (HKL) equation with Schrage ’s‘accommo- dation factor ’η= 1.66 provide excellent agreement with experiments for weakReceived: 4 May 2016 Revised: 24 August 2016 Accepted: 14 November 2016 Heliyon 2 (2016) e00199 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Average thicknesses of lithium flow during the 25 days that in continuous manner was in operation with 12 measurements (all overlapped) spanned in 571 h. Article No~e00199 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
"The dependence of the sticking factor with the beam tube temperature was confirmed: if the temperature of the simulated beam pipe was below the vapoursaturation temperature at the beam pipe pressure, then the sticking factor α=1 Article No~e00199 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Adsorption accounts for the temporary permanence of agas molecule in the surface of solids upon their impact whereas absorption implies Article No~e00199 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
"To overcome the frustration, the conclusion from Hertz in his seminal work from 1882 was that his expression would define the maximum possible rate of evaporation, which depends only on the temperature ofsurface and nature of the substance (the existence of such a maximum had been Article No~e00199 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
"Schragedeveloped further this model, implementing continuum mechanics principles in the off-equilibrium Knudsen layer discontinuity, with the inclusion of a new coefficient, which he called ‘accommodation factor ’η, that yielded double HKL Article No~e00199 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
"Atoms striking a surface, if not Article No~e00199 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
*** This value conservatively assumes that an area of 260 × 230 mm 2exhibits a uniform temperature of 574 K and 260 × 170 mm2above the beam footprint a uniform temperature of 523 K. Article No~e00199 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Element Lithium LiSodium NaPotassium K Tf[K] 453.5 370.7 336.4 Tb[K] 1615 1156 1032 Article No~e00199 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
Article No~e00199 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00199 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/18/main.PMC5144822.pdf
The effects of smallReceived: 21 April 2016 Revised: 1 July 2016 Accepted: 21 November 2016 Heliyon 2 (2016) e00203 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"Beyond these molecules, aspartate- Article No~e00203 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Patients Article No~e00203 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
HPRT1 served as the Article No~e00203 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"Immunoreactivity was detected with horseradish peroxidase conjugated goat antirabbit antibody (1:10,000; 1hr, room temperature) followed by Pierce Supersignal Article No~e00203 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
The ALMI assay is similar to the Cytoselect assay described earlier with the following exceptions: 1) cells were seeded into eachupper chamber in medium containing 0.1% FCS; 2) medium containing 1% FBS Article No~e00203 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
1 B10 Article No~e00203 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"To extend our investigations to an independent and larger data source, we interrogated The Cancer Genome Atlas (TCGA; http://cancergenome.nih.gov ) database and found that the ASPH gene is expressed in both neural and mesenchymal subtypes of GBM, and that thehighest expression levels are associated with the aggressive mesenchymal subtype of GBM ( Fig.",OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
These findings correspond with previous reports using the same Article No~e00203 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
levels of mRNA normalized to Article No~e00203 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Directional cell motility was measured in [C] A172 and [F] WTEGFR cells using a Boyden Article No~e00203 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"Correspondingly, higher levels of ASPH correlated withincreased cellularity (cell density) and proliferation indices as determined by Ki-67 Article No~e00203 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"Correspondingly, we demonstrated reduced viability and directional motility in GBM cells treated with MO-Is targeting ASPH ’s catalytic Article No~e00203 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"doi.org/10.1016/j.heliyon.2016.e00203 Acknowledgements The authors acknowledge Dr Alain Charest (Tufts University Medical Center,Boston, MA) for his generous donation of the mouse model derived cell lines for Article No~e00203 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"Charpentier, H. Safran, R.I. Carlson, J. Wands, Tumor progressi on-related transmembrane protein Article No~e00203 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"de la Monte, Insulin resistance, ceramide accumulation, and Article No~e00203 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
Article No~e00203 31 http://dx.doi.org/10.1016/j.heliyon.2016.e00203 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/main.PMC5144823.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.VECTOR-BORNE AND ZOONOTIC DISEASES Volume 16, Number 12, 2016Mary Ann Liebert, Inc.DOI: 10.1089/vbz.2016.1959 744",Non-OADS,/arxiv_data1/oa_pdf/57/64/vbz.2016.1959.PMC5144871.pdf
"5  599–601 https://doi.org/10.1083/jcb.201611079Macroautophagy, hereafter autophagy, is a highly conserved  catabolic pathway critically involved in intracellular homeo - stasis, quality control, and stress responses.",Non-OADS,/arxiv_data1/oa_pdf/7c/d9/JCB_201611079.PMC5144889.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/a1/ott-9-7367.PMC5144890.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7367–7372OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7367Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12178 5 Mutations in hepatitis B virus small S genes  predict postoperative survival in hepatocellular  carcinoma li Peng1 guang Yang2 chensi Wu3 Wenshuai Wang1 Jianhua Wu4 Zhanjun guo3 1Department of hepatobiliary  surgery, 2Department of radiology,   3Department of gastroenterology and  hepatology, 4animal center, Fourth  hospital of hebei Medical University,   shijiazhuang, People’s republic  of chinaAbstract:  Hepatitis B virus (HBV) DNA is prone to mutations due to proofreading deficiencies of  HBV polymerase.",Non-OADS,/arxiv_data1/oa_pdf/45/a1/ott-9-7367.PMC5144890.pdf
"HBV infection may be associated with a large spectrum of liver  diseases including chronic hepatitis, cirrhosis, and HCC.6,7 In the People’s Republic  of China, HBV infection is a challenging health issue with approximately 93 million  people being HBV carriers and 30 million people being chronic hepatitis B patients.8  Eight geography-related HBV genotypes (genotypes A–H) have been identified with  genotypes B and C predominant in eastern Asia.9 The HBV genome is a relaxed, circular, partially double-stranded DNA (rcDNA)  with approximately 3,200 nucleotides and comprises four partially overlapping open  reading frames (ORFs) that encode the surface protein (PreS/S), the core protein  (preC/C), a polymerase (pol), and a multifunctional nonstructural protein (HBx).7 correspondence: Zhanjun guo Department of gastroenterology and  hepatology, the Fourth hospital of hebei  Medical University, 12 Jiankang road,  shijiazhuang 050011, hebei, People’s  republic of china Tel +86 311 8609 5342 email zjguo5886@aliyun.co m  Jianhua Wu animal center, Fourth hospital of hebei  Medical University,12 Jiankang road,  shijiazhuang 050011, hebei, People’s  republic of china Tel +86 311 8609 5721 email wujh-890@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Peng et al Running head recto: Hepatitis B virus small S genes and HCC survival DOI: http://dx.doi.org/10.2147/OTT.S121785",Non-OADS,/arxiv_data1/oa_pdf/45/a1/ott-9-7367.PMC5144890.pdf
HBV genotypes were deter - mined by multiplex-PCR as described previously.18 The DNA  sequences flanking the small S region were amplified with the  primer pairs listed in Table  1 according to the NCBI database (http://www.ncbi.nlm.nih.gov/genome/553 6).,OADS,/arxiv_data1/oa_pdf/45/a1/ott-9-7367.PMC5144890.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/45/a1/ott-9-7367.PMC5144890.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/a1/ott-9-7367.PMC5144890.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/97/6b/rmhp-9-271.PMC5144891.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/97/6b/rmhp-9-271.PMC5144891.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 271–274Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 271 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S117472 Using the failure mode and effects analysis  model to improve parathyroid hormone and  adrenocorticotropic hormone testing Racheli Magnezi1 Asaf Hemi1 Rina Hemi2 1Department of Management,   Public Health and Health Systems  Management Program, Bar Ilan University, Ramat Gan,  2Endocrine  Service Unit, Sheba Medical Center,  T el Aviv, IsraelBackground: Risk management in health care systems applies to all hospital employees and  directors as they deal with human life and emergency routines.",Non-OADS,/arxiv_data1/oa_pdf/97/6b/rmhp-9-271.PMC5144891.pdf
"4–6 The FMEA method has been used before in medical processes and has shown improve- ments in multidisciplinary areas, including documentation compliance,7 blood transfusion,8 Correspondence: Racheli Magnezi Public Health and Health Systems Management Program, Bar Ilan University, Ramat Gan 52900, IsraelTel +972 3 531 8276Fax +972 3 738 4041Email magnezir@biu.ac.ilJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Magnezi et alRunning head recto: Implementing FMEA in the labDOI: http://dx.doi.org/10.2147/RMHP .S117472",Non-OADS,/arxiv_data1/oa_pdf/97/6b/rmhp-9-271.PMC5144891.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/97/6b/rmhp-9-271.PMC5144891.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 274 Magnezi et al the cooling problem, and it also freed the shipping department  to manage other assignments.",Non-OADS,/arxiv_data1/oa_pdf/97/6b/rmhp-9-271.PMC5144891.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 653–660Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 653 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S122841 Risk assessment of student performance in the  International Foundations of Medicine Clinical  Science Examination by the use of statistical  modeling Michael C David1  Diann S Eley2  Jennifer Schafer2  Leo Davies3 1School of Public Health, 2School  of Medicine, The University of  Queensland, Herston, QLD, 3Sydney  Medical School, The University of Sydney, NSW, AustraliaPurpose: The primary aim of this study was to assess the predictive validity of cumulative  grade point average (GPA) for performance in the International Foundations of Medicine (IFOM)  Clinical Science Examination (CSE).",Non-OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
"Keywords: academic performance, benchmarking, medical education, predictive validity, risk  assessment, students at risk Introduction The term “global village” implies commonalities of human behavior across geographic  barriers.1 This phenomenon is manifested in medical education in multiple initiatives,2  including telemedicine,3,4 distance learning technologies,5 and the establishment  of satellite campuses.6 There is increasing mobility in the medical workforce, with  movement of practitioners and students from one country to another, in addition to the  emergence of the “global professional” for reasons related to training opportunities,7  labor demands, and initiatives.8,9 Increasing professional mobility has highlighted the need to develop common  educational standards to guide quality improvement efforts and to serve as the Correspondence: Michael C David School of Public Health, The University of Queensland, Herston Road, Herston, Queensland 4006, Australia   Tel +61 7 3839 1621   Fax +61 7 3839 1631   Email m.david@uq.edu.auJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: David et alRunning head recto: Risk assessment of student performance in the IFOM examinationDOI: http://dx.doi.org/10.2147/AMEP .S122841",Non-OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
Available from: http://www.nbme.org/Schools/iFoM/index.,Non-OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 660 David et al  26.,Non-OADS,/arxiv_data1/oa_pdf/7b/d2/amep-7-653.PMC5144892.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/93/82/dmso-9-417.PMC5144893.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/93/82/dmso-9-417.PMC5144893.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 417–424Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 417 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S120326 Evaluation of serum ferritin and some metal  elements in type 2 diabetes mellitus patients:  comparative cross-sectional study Amare Desalegn Wolide1 Belay Zawdie2 Tilahun Alemayehu3 Samuel Tadesse1 1Department of Medical Physiology,   2Department of Medical Biochemistry,   3Department of Human Anatomy,   College of Health Sciences, Jimma  University, Jimma, EthiopiaBackground: The chronic hyperglycemia of diabetes has been associated with an imbalance  of some trace metal elements in the blood sample of type 2 diabetes patients.",Non-OADS,/arxiv_data1/oa_pdf/93/82/dmso-9-417.PMC5144893.pdf
"4 Mortality attributable to diabetes accounts for 2%–3% of deaths in poor  countries and by 2030, ~ 8% of the adult population is estimated to have diabetes.5  According to the International Diabetes Federation, there were over 1.33 million Correspondence: Amare Desalegn  WolideDepartment of Medical Physiology, College of Health Sciences, Jimma University, Jimma 378, EthiopiaTel +251 93 244 5922Email amaju2002@yahoo.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Wolide et alRunning head recto: Evaluation of serum ferritin and some metal elements in T2DM patientsDOI: http://dx.doi.org/10.2147/DMSO.S120326",Non-OADS,/arxiv_data1/oa_pdf/93/82/dmso-9-417.PMC5144893.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/93/82/dmso-9-417.PMC5144893.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 424 Wolide et al  57.,Non-OADS,/arxiv_data1/oa_pdf/93/82/dmso-9-417.PMC5144893.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/31/67/ijn-11-6449.PMC5144894.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6449–6458International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6449OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11834 3 systemic delivery and activation of the TRAIL  gene  in lungs, with magnetic nanoparticles of chitosan  controlled by an external magnetic field cynthia a alvizo-Baez1 Itza e luna-cruz1 Natalia Vilches-cisneros2 cristina rodríguez-Padilla1 Juan M alcocer-gonzález1 1laboratory of Immunology and  Virology, Biological sciences  Faculty, University autonomous  of Nuevo león, san Nicolás de  los garza, 2Pahologic anatomy  and cytopathology service of the  University hospital, University  autonomous of Nuevo león,   Monterrey, MexicoAbstract:  Recently, functional therapies targeting a specific organ without affecting normal  tissues have been designed.",Non-OADS,/arxiv_data1/oa_pdf/31/67/ijn-11-6449.PMC5144894.pdf
"Clearly, there is a lack of diagnostics and effective treatment regimens.4  Different approaches for the delivery of genes to the lungs, such as intravenous (IV)  injection and nasal or intratracheal instillation, have been reported.5–7correspondence: Juan M alcocer- gonzález laboratorio de Inmunología y Virología,  Facultad de ciencias Biológicas,  Universidad autónoma de Nuevo león,  avenida Pedro de alba, san Nicolás de  los garza, Nuevo león 66450, Mexico Tel +52 83 294 000 ext 5112 email juan.alcocerg@uanl.m x Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Alvizo-Baez et al Running head recto: Chitosan MNPs for TRAIL delivery  DOI: http://dx.doi.org/10.2147/IJN.S118343",Non-OADS,/arxiv_data1/oa_pdf/31/67/ijn-11-6449.PMC5144894.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/67/ijn-11-6449.PMC5144894.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/67/ijn-11-6449.PMC5144894.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/61/ppa-10-2449.PMC5144895.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2449–2457Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2449OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11971 9 Utility of the Morisky Medication Adherence  scale in gout: a prospective study csl Tan1 gg T eng1,2 KJ chong2 PP cheung1,2 AYn lim1,2 hl Wee3,4 A santosa1,2 1University Medicine cluster, Division  of rheumatology, national University  health system, 2Department of  Medicine, Yong loo lin school of  Medicine, 3Department of Pharmacy,   Faculty of science, 4saw swee hock  school of Public health, national  University of singapore, singaporeBackground:  The outcomes of any chronic illness often depend on patients’ adherence with  their treatment.",Non-OADS,/arxiv_data1/oa_pdf/fe/61/ppa-10-2449.PMC5144895.pdf
"Adherence in gout was  lowest at 36.8% among six common chronic diseases in a longitudinal study.5 In a recent correspondence: A santosa University Medicine cluster, Division  of rheumatology, national University  health system, level 10 Tower Block,  1e lower Kent ridge road, singapore  119228, singapore Fax +65 6872 4130 email amelia_santosa@nuhs.edu.s g Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tan et al Running head recto: Morisky Medication Adherence scale in gout DOI: http://dx.doi.org/10.2147/PPA.S119719",Non-OADS,/arxiv_data1/oa_pdf/fe/61/ppa-10-2449.PMC5144895.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/fe/61/ppa-10-2449.PMC5144895.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/dddt-10-3947.PMC5144896.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3947–3957Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3947Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12375 9 Increased therapeutic efficacy of a newly  synthesized tyrosinase inhibitor by solid lipid  nanoparticles in the topical treatment of  hyperpigmentation Md al-amin Jiafu cao Muhammad naeem hasanul Banna Min-soo Kim Yunjin Jung hae Y oung chung hyung ryong Moon Jin-Wook Y oo college of Pharmacy, Pusan national  University, Busan, south KoreaAbstract:  Hyperpigmentation caused by melanin overproduction is a major skin disorder in  humans.",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/dddt-10-3947.PMC5144896.pdf
"Among them, inhibition of tyrosinase has emerged  as an effective strategy to treat hyperpigmentation because tyrosinase controls the rate- limiting steps of melanogenesis where tyrosine is converted to dopaquinone, which  subsequently produces eumelanin and pheomelanin.10,11correspondence: Jin-Wook Yoo college of Pharmacy, Pusan national  University, 2 Busandaehak-ro,   63 Beon-gil, geumjeong-gu,   Busan 609-735, south Korea Tel +82 51 510 2807 Fax +82 51 513 6754 email jinwook@pusan.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Al-Amin et al Running head recto: MHY-SLNs for the treatment of hyperpigmentation DOI: http://dx.doi.org/10.2147/DDDT.S123759",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/dddt-10-3947.PMC5144896.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/dddt-10-3947.PMC5144896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/a2/dddt-10-3947.PMC5144896.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/ef/ott-9-7315.PMC5144897.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7315–7330OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11381 5 Mesoporous silica nanoparticles functionalized  with folic acid/methionine for active targeted  delivery of docetaxel Pegah Khosravian1 Mehdi shafiee ardestani2 Mehdi Khoobi3 seyed n aser Ostad4 Farid abedin Dorkoosh1 hamid akbari Javar1,* Massoud amanlou5,6,* 1Department of Pharmaceutics,   2Department of radiopharmacy,   3Department of Pharmaceutical  Biomaterials, 4Department of  Pharmacology and T oxicology,   5Department of Medicinal  chemistry, Faculty of Pharmacy  and Pharmaceutical sciences  research center, 6Drug Design and  Development research center, Tehran  University of Medical sciences, T ehran,   iran *These authors contributed equally   to this workAbstract:  Mesoporous silica nanoparticles (MSNs) are known as carriers with high loading  capacity and large functionalizable surface area for target-directed delivery.",Non-OADS,/arxiv_data1/oa_pdf/6a/ef/ott-9-7315.PMC5144897.pdf
"As of now, several targeting agents, such as some types of recombinant proteins,  vitamins, amino acids, and sugars, have been applied for active targeting in breast  cancers.5 Identification of the best targeting agent for more effective and promising  applications in the market should depend on stability, size uniformity, controlled release  rate and large-scale manufacturing cost of fabricated nanoparticles.6 However, small correspondence: hamid akbari Javar Department of Pharmaceutics, Faculty of  Pharmacy, Tehran University of Medical  sciences, PO Box 14155-6451, Tehran,  iran Tel +98 912 130 3177 Fax +98 216 646 1178 email akbarijo@tums.ac.i r  Massoud amanlou Department of Medicinal chemistry,  Faculty of Pharmacy and Drug Design  and Development research center,  PO Box 14155-6451, Tehran University  of Medical sciences, Tehran, iran Tel +98 216 695 9067 Fax +98 216 412 1111 email amanlou@tums.ac.i r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Pegah et al Running head recto: MSNs functionalized with FA/Met for active targeted delivery of DTX DOI: http://dx.doi.org/10.2147/OTT.S113815",Non-OADS,/arxiv_data1/oa_pdf/6a/ef/ott-9-7315.PMC5144897.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6a/ef/ott-9-7315.PMC5144897.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/ef/ott-9-7315.PMC5144897.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/a3/jiw281.PMC5144898.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/cd/jiw344.PMC5144899.pdf
"Online, North America: AAAI Publications, 2014 .https://www.aaai.org/ocs/index.php/ICWSM/ICWSM14/ paper/viewFile/8114/8120 .",Non-OADS,/arxiv_data1/oa_pdf/9c/cd/jiw344.PMC5144899.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 425–441Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 425 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S87873 rDNA insulin glargine U300 – a critical appraisal Fei Wang1  Stefanie Zassman1 Philip A Goldberg2 1Department of Pharmacy Practice,   School of Pharmacy, University  of Connecticut, Storrs, CT, USA;   2Department of Internal Medicine,   Section of Endocrinology, Yale University School of Medicine,    New Haven, CT, USABackground:  As the first once-daily basal insulin analog, insulin glargine 100 U/mL (Gla-100;  Lantus®) rapidly evolved into the most commonly prescribed insulin therapy worldwide.",Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
"The ideal basal insulin would provide a flat, peakless glucose-lowering profile, and would have a protracted Correspondence: Fei Wang Department of Pharmacy Practice, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT 06269, USATel +1 860 972 4125Email fei.wang@uconn.eduJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Wang et alRunning head recto: rDNA insulin glargine U300DOI: http://dx.doi.org/10.2147/DMSO.S87873",Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
Available from: http://seekingalpha.com/article/2395325-sanofi-confronting-lantus-patent-expiry-with-more-efficient-successor-toujeo.,Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce-ments/ucm477734.htm.,Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
Available from: http://www.fda.gov/News - Events/Newsroom/PressAnnouncements/ucm464321.htm.,Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
Available from: http://www.ema.europa.eu.,Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 441 rDNA insulin glargine U300  51.,Non-OADS,/arxiv_data1/oa_pdf/45/03/dmso-9-425.PMC5144903.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/d4/ott-9-7345.PMC5144904.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7345–7353OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7345Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10852 6 structure–activity relationships study of mTOr  kinase inhibition using Qsar and structure-based  drug design approaches Wiame lakhlili1 abdelaziz Yasri2 azeddine ibrahimi1 1Biotechnology laboratory  (Medbiotech), rabat Medical and  Pharmacy school, Mohammed V  University in rabat, rabat, Morroco;   2OribasePharma, Montpellier, FranceAbstract:  The discovery of clinically relevant inhibitors of mammalian target of rapamycin  (mTOR) for anticancer therapy has proved to be a challenging task.",Non-OADS,/arxiv_data1/oa_pdf/c8/d4/ott-9-7345.PMC5144904.pdf
"This approach finds its place in the early development phases before the  preclinical stage, especially in the investigation of physicochemical, pharmacodynamic, correspondence: Wiame lakhlili Biotechnology laboratory (Medbiotech),  rabat Medical and Pharmacy school,  Mohammed V University in rabat,  avenue Med Belarbi alaoui, souissi- rabat, BP 6203 rabat instituts, rabat,  10000, Morroco Tel +212 537 77 2850   email wiame.lakhlili@um5s.net.m a Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lakhlili et al Running head recto: Structure–activity relationships study of mTOR kinase inhibition DOI: http://dx.doi.org/10.2147/OTT.S108526",Non-OADS,/arxiv_data1/oa_pdf/c8/d4/ott-9-7345.PMC5144904.pdf
"Available from: http://chemoinfo.ipmc.cnrs.fr/lea.htm l.  Accessed July 1, 2012.",OADS,/arxiv_data1/oa_pdf/c8/d4/ott-9-7345.PMC5144904.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c8/d4/ott-9-7345.PMC5144904.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/d4/ott-9-7345.PMC5144904.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3023–3030International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3023OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12063 7 Clinical factors and comorbidities affecting the  cost of hospital-treated COPD sami Deniz1 Aysun Şengül2 Yusuf aydemir3 Jülide Çeldir Emre4 Mustafa hikmet Özhan5 1Clinics of Chest Diseases, Dr suat  seren Chest Diseases and Thoracic  surgery education and research  hospital, I ˙zmir, 2Clinics of Chest  Diseases, Kocaeli Derince research  and education hospital, Kocaeli,   3Department of Chest Diseases,   sakarya University Faculty of  Medicine, sakarya, 4Clinics of Chest  Diseases, T urgutlu state hospital,   Manisa, 5Department of Chest  Diseases, Faculty of Medicine, ege  University I ˙zmir, T urkeyPurpose:  We aimed to assess the effects of comorbidities on COPD costs and to investigate  the relationship between comorbidities and clinical variables.",Non-OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
"These exacerbations comprise the Correspondence: Yusuf aydemir Department of Chest Diseases, sakarya  University Faculty of Medicine, hastane  Caddesi, 54100 sakarya, Turkey Tel +0090 505 636 94 94 email dryaydemir@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Deniz et al Running head recto: Clinical factors affecting the cost of COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S120637",Non-OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
"Analyses were  performed using the MedCalc statistical software program  (Version 12.7.7; MedCalc Software bvba, Ostend, Belgium;  http://www.medcalc.or g; 2013).",OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
Available from: http://goldcopd.org/global- strategy-diagnosis-management-prevention-copd-2016/.,Non-OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/b8/copd-11-3023.PMC5144905.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/5c/ott-9-7355.PMC5144906.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7355–7365OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7355Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9980 7 Next-generation sequencing: advances and  applications in cancer diagnosis Simona Serratì Simona De Summa Brunella Pilato Daniela Petriella Rosanna Lacalamita Stefania T ommasi Rosamaria Pinto Molecular Genetics Laboratory,   iRCCS istituto Tumori Giovanni  Paolo  ii, Bari, italyAbstract:  Technological advances have led to the introduction of next-generation sequencing  (NGS) platforms in cancer investigation.",Non-OADS,/arxiv_data1/oa_pdf/ed/5c/ott-9-7355.PMC5144906.pdf
"There are currently three main companies Correspondence: Stefania Tommasi Molecular Genetics Laboratory,  iRCCS istituto Tumori Giovanni  Paolo ii, 65 viale Orazio Flacco,  Bari, Puglia 70124, italy Tel +39 080 555 5283 email s.tommasi@oncologico.bari.i t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Serratì et al Running head recto: Next-generation sequencing in cancer diagnosis DOI: http://dx.doi.org/10.2147/OTT.S99807",Non-OADS,/arxiv_data1/oa_pdf/ed/5c/ott-9-7355.PMC5144906.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ed/5c/ott-9-7355.PMC5144906.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/5c/ott-9-7355.PMC5144906.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/f8/rru-8-225.PMC5144907.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b2/f8/rru-8-225.PMC5144907.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 225–231Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  225 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S120748Evaluation of biochemical recurrence in patients  with high-risk prostate cancer treated with radical  prostatectomy and radiotherapy plus androgen  deprivation therapy Yutaka Yamamoto1  Keisuke Kiba1  Motokiyo Y oshikawa1  Akihide Hirayama1  Seiji Kunikata1  Hirotsugu Uemura2 1Department of Urology, Nara  Hospital, Kindai University Faculty  of Medicine, Ikoma, 2Department of  Urology, Kindai University Faculty of Medicine, Osakasayama, JapanObjective: The aim of this study was to evaluate the biochemical recurrence (BCR) in patients  with high-risk prostate cancer (PCa) treated with radical prostatectomy (RP) or radiotherapy  (RT) plus androgen deprivation therapy (ADT).",Non-OADS,/arxiv_data1/oa_pdf/b2/f8/rru-8-225.PMC5144907.pdf
"Some reported better outcomes after RP , 5–7 while others reported improved outcomes after RT,8,9 and a few Correspondence: Yutaka Yamamoto Department of Urology, Nara Hospital, Kindai University Faculty of Medicine, 1248-1 Otodacho Ikoma, Nara 630-0293, Japan   Email yamamotokindai@yahoo.co.jpJournal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Y amamoto et alRunning head recto: Classification of high-risk prostate cancerDOI: http://dx.doi.org/10.2147/RRU.S120748",Non-OADS,/arxiv_data1/oa_pdf/b2/f8/rru-8-225.PMC5144907.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/b2/f8/rru-8-225.PMC5144907.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 231 Classification of high-risk prostate cancer  2.,Non-OADS,/arxiv_data1/oa_pdf/b2/f8/rru-8-225.PMC5144907.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/c6/jpr-9-1153.PMC5144908.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/c6/jpr-9-1153.PMC5144908.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1153–1160Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1153 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S118581TRPA1 in the spinal dorsal horn is involved in  post-inflammatory visceral hypersensitivity: in vivo  study using TNBS-treated rat model Qian Li1,* Cheng-Hao Guo2,* Mohammed Ali Chowdhury1 Tao-Li Dai1 Wei Han1,3 1Department of Gastroenterology,   Qilu Hospital of Shandong University,   2Department of Pathology, Medical  School of Shandong University,   3Laboratory of Translational  Gastroenterology, Shandong  University, Qilu Hospital, Jinan,  Shandong Province, People’s Republic of China *These authors contributed equally to  this workIntroduction: The transient receptor potential ankyrin-1 (TRPA1) channel, a pain transducer  and amplifier, is drawing increasing attention in the field of visceral hypersensitivity, commonly  seen in irritable bowel syndrome and inflammatory bowel disease.",Non-OADS,/arxiv_data1/oa_pdf/95/c6/jpr-9-1153.PMC5144908.pdf
"4–6 However, there  is a lack of knowledge in the mechanisms underlying the visceral hypersensitivity.Correspondence: Wei Han Department of Gastroenterology, Qilu Hospital of Shandong University, 44 Wenhua West Road, Jinan 250012, Shandong Province, People’s Republic of ChinaTel +86 531 8216 9382Fax +86 531 8838 2084Email hanwei@sdu.edu.cnJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Li et alRunning head recto: TRPA1 and visceral hypersensitivityDOI: http://dx.doi.org/10.2147/JPR.S118581",Non-OADS,/arxiv_data1/oa_pdf/95/c6/jpr-9-1153.PMC5144908.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/95/c6/jpr-9-1153.PMC5144908.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1160 Li et al  21.,Non-OADS,/arxiv_data1/oa_pdf/95/c6/jpr-9-1153.PMC5144908.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management Psychology Research and Behavior Management 2016:9 329–338 329Dovepress submit your manuscript | www.dovepress.com Dovepress  ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S113218 Predictors of disability-related attitudes:  considering self-esteem, communication  apprehension, contact, and geographic location Kate Magsamen-Conrad1 Dinah T etteh2 Yen-I Lee3 1Department of Communication,   Bowling Green State University,   Bowling Green, OH, 2Department  of Communication, Arkansas State University, Jonesboro, AR,  3Grady  College of Journalism and Mass Communication, University of Georgia, Athens, GA, USAAbstract: Individuals’ attitudes about persons with disability (PwD) strongly affect differently- abled persons’ quality of life and position in society.",Non-OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
"The ability of attitudes to influence behavior is well supported by previous studies 3,4 as well as in  interventions founded in classic behavior change theories.5,6 The foundational ideas from  these theories may relate to attitudes about the self (eg, self-esteem), cultural attitudes Correspondence: Kate Magsamen-Conrad Department of Communication, Bowling Green State University, 324 West Hall, Bowling Green, OH, 43403, USATel +1 614 419 372 9544Fax +1 614 419 372 0202Email kmagsam@bgsu.eduJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Magsamen-Conrad et alRunning head recto: Predictors of disability-related attitudesDOI: http://dx.doi.org/10.2147/PRBM.S113218",Non-OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
Available from: http://www.ada.gov/cguide.htm.,OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
Avail- able from: http://www.dvrgetsjobs.com/Documents/Pubs/ImpactOfT - heADA.pdf.,OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/78/0e/prbm-9-329.PMC5144909.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/34/copd-11-3031.PMC5144910.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3031–3042International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3031OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12084 9 Cigarette smoke extract induces placental growth  factor release from human bronchial epithelial  cells via r Os/MaPK (erK-1/2)/egr-1 axis Dong Wu1,* Yalian Yuan1,* Zhixiu lin2,* Tianwen lai1 Min Chen1 Wen li1 Quanchao lv1 Binfan Yuan1 Dongmin li1 Bin Wu1 1Department of respiratory,   Institute of respiratory Diseases,   2Department of Pharmacy, The  affiliated hospital of guangdong  Medical University, Zhanjiang, People’s  republic of China *These authors contributed equally  to this workAbstract:  Etiological evidence demonstrates that there is a significant association between  cigarette smoking and chronic airway inflammatory disease.",Non-OADS,/arxiv_data1/oa_pdf/fe/34/copd-11-3031.PMC5144910.pdf
"Keywords:  cigarette smoke, reactive oxygen species, airway epithelium, placental growth  factor, extracellular signal-regulated kinase1/2, early growth response-1 Introduction Epidemiologic data link cigarette smoking to many pulmonary disorders such as COPD  and chronic bronchitis.1,2 Cigarette smoke (CS) contains 4,000 different kinds of  constituents, including a mass of toxic oxidants.3,4 Airway epithelial cells are directly  exposed to CS and serve as a major target of oxidative stress.5 Activation of the airway  epithelium by oxidative stress is identified as an important pathologic process linking  to chronic airway inflammatory disease.6,7 Placental growth factor (PlGF) is a member of the vascular endothelial growth  factor (VEGF) family, which is composed of VEGF-A, VEGF-B, VEGF-C, VEGF-D  and VEGF-E.8 PlGF-deficient mice develop normally, suggesting that PlGF is dis - pensable for development and health;9 however, it has been associated with tissue  ischemia, malignancy, inflammation and multiple other diseases.10–12 In fact, increased  expression of PlGF has been observed in the serum and bronchoalveolar lavage fluid Correspondence: Bin Wu; Dongmin li Department of respiratory,  Institute of respiratory Diseases,  The Affiliated Hospital of Guangdong  Medical University, 57 renmin avenue,  Zhanjiang 524001, People’s republic of  China Tel +86 759 238 6792; +86 759 238 7413 email wubin1190@126.co m;  3064264@qq.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wu et al Running head recto: Understanding the mechanisms of PlGF upregulation DOI: http://dx.doi.org/10.2147/COPD.S120849",Non-OADS,/arxiv_data1/oa_pdf/fe/34/copd-11-3031.PMC5144910.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fe/34/copd-11-3031.PMC5144910.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/34/copd-11-3031.PMC5144910.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2016:8 111–116Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 111 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S112903 Acute chest pain fast track at the emergency  department: who was misdiagnosed for acute  coronary syndrome?",Non-OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
"For STEMI, thrombolytic therapy should be administered within 30 minutes (door to drug), or Correspondence: Yuwares  SitthichanbunchaDepartment of Emergency Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10120, ThailandEmail yuwares.sit@mahidol.ac.thJournal name: Open Access Emergency Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Prachanukool et alRunning head recto: Acute coronary syndrome: a common disease in EDDOI: http://dx.doi.org/10.2147/OAEM.S112903",Non-OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
Available from: http://www.openepi.com/Menu/OE_Menu.html.,Non-OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
"Open Access Emergency Medicine 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 116 Prachanukool et al,Non-OADS,/arxiv_data1/oa_pdf/ea/28/oaem-8-111.PMC5144911.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/ndt-12-3073.PMC5144912.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3073–3081Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3073OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11758 1 categorical improvements in disease severity  in patients with major depressive disorder  treated with vilazodone: post hoc analysis of  four randomized, placebo-controlled trials suresh Durgam1 changzheng chen1 carl P gommoll1 John edwards1 leslie citrome2 1allergan, Jersey city, NJ, Usa;   2Department of Psychiatry and  Behavioral sciences, New York  Medical college, Valhalla, NY, UsaBackground:  In three 8-week studies of vilazodone 40 mg/d (NCT00285376, NCT00683592,  and NCT01473394) and a 10-week study of vilazodone 20 or 40  mg/d (NCT01473381),  adults with major depressive disorder (MDD) showed significantly greater improvement  with vilazodone versus placebo in global disease severity as measured by mean change from  baseline in Clinical Global Impression of Severity (CGI-S) score.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/ndt-12-3073.PMC5144912.pdf
"Keywords:  depression, antidepressant, global improvement, clinical trial Introduction In clinical trials of major depressive disorder (MDD), the primary efficacy end point  is usually defined by a mean score change in a validated depression scale such as the  Montgomery–Åsberg Depression Rating Scale (MADRS)1 or Hamilton Depression  Rating Scale (HAMD).2 Statistical superiority compared to placebo indicates efficacy correspondence: suresh Durgam allergan, harborside Financial center,  Plaza V, suite 1900, Jersey city, NJ  07311, Usa Tel +1 201 427 8172 Fax +1 201 427 8200 email suresh.durgam@allergan.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Durgam et al Running head recto: Categorical improvements with vilazodone in MDD DOI: http://dx.doi.org/10.2147/NDT.S117581 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/ndt-12-3073.PMC5144912.pdf
Or use: http://youtu.be/zTV_fuFO2D IVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/fe/f1/ndt-12-3073.PMC5144912.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/ndt-12-3073.PMC5144912.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/f1/ndt-12-3073.PMC5144912.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/30/68/lra-9-087.PMC5144913.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/30/68/lra-9-087.PMC5144913.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2016:9 87–93Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  87 ORiginAL  ReseARch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S119483The analgesic efficacy of intravenous lidocaine  infusion after laparoscopic fundoplication: a  prospective, randomized, double-blind,   placebo-controlled trial Gregory J Dale1 stephanie Phillips2  Gregory L Falk3 1Westmead hospital clinical school,   The University of Sydney, 2Sydney  Adventist hospital clinical school,   The University of Sydney, 3concord  Clinical School, The University of  Sydney, Sydney, AustraliaAbstract:  This study aimed to determine if intravenous lidocaine infusion reduces postopera- tive pain intensity following laparoscopic fundoplication surgery and to also validate the safety  of intravenous lidocaine at the dose tested.",Non-OADS,/arxiv_data1/oa_pdf/30/68/lra-9-087.PMC5144913.pdf
"2–4 While most commonly  used in infiltration and for central neuraxial and peripheral nerve blocks, lidocaine can also be given intravenously (IV) to treat acute perioperative pain 4 and chronic  neuropathic pain.5 The current evidence for using IV lidocaine to treat perioperative  pain is based on 45 clinical trials contributing to five systematic reviews.4,6–9 These  studies found that IV lidocaine infusion in the perioperative period decreases pain intensity, opioid requirements, the duration of postoperative ileus, and opioid-related Correspondence: Gregory J Dale Westmead Hospital, Cnr Hawkesbury Road and Darcy Road, Westmead, Sydney, NSW 2145, AustraliaEmail gregory.dale@health.nsw.gov.auJournal name: Local and Regional Anesthesia Article Designation: ORIgIn AL ReSeARch Y ear: 2016V olume: 9Running head verso: Dale et alRunning head recto: Intravenous lidocaine infusion for postoperative analgesiaDOI: http://dx.doi.org/10.2147/LRA.S119483",Non-OADS,/arxiv_data1/oa_pdf/30/68/lra-9-087.PMC5144913.pdf
"Local and Regional Anesthesia 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/30/68/lra-9-087.PMC5144913.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 93 Intravenous lidocaine infusion for postoperative analgesia Further investigation is warranted to define the optimal  dosage regimen for intravenous lidocaine to balance analgesic  efficacy and patient safety.,Non-OADS,/arxiv_data1/oa_pdf/30/68/lra-9-087.PMC5144913.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/79/c8/ceor-8-707.PMC5144914.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/79/c8/ceor-8-707.PMC5144914.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 707–715ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  707 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S115706Treatment effectiveness and treatment patterns  among rheumatoid arthritis patients after  switching from a tumor necrosis factor inhibitor  to another medication Machaon MK Bonafede1  Jeffrey R Curtis2  Donna McMorrow1  Puneet Mahajan3  Chieh-I Chen4 1Outcomes Research, Truven  Health Analytics, Cambridge, MA,   2Division of Clinical Immunology  and Rheumatology, University of  Alabama at Birmingham, Birmingham,  AL,  3Health Economics and Outcomes  Research, Sanofi, Bridgewater, NJ,   4Health Economics and Outcomes  Research, Regeneron Pharmaceuticals,  Inc., Tarrytown, NY,  USAObjectives: After treatment failure with a tumor necrosis factor inhibitor (TNFi), patients with  rheumatoid arthritis (RA) can switch to another TNFi (TNFi cyclers) or to a targeted disease- modifying antirheumatic drug (DMARD) with a non-TNFi mechanism of action (non-TNFi  switchers).",Non-OADS,/arxiv_data1/oa_pdf/79/c8/ceor-8-707.PMC5144914.pdf
"4 After an adequate trial (generally for ≥ 3 months) of a TNFi, switching  to another drug is  recommended if disease activity is moderate or high because of Correspondence: Machaon MK Bonafede   Truven Health Analytics, 150 Cambridge  Park Drive, Cambridge, MA 02140, USA   Tel +1 603 580 5587   Email machaon.bonafede@truvenhealth.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Bonafede et alRunning head recto: Outcomes of switching targeted DMARDs in rheumatoid arthritisDOI: http://dx.doi.org/10.2147/CEOR.S115706",Non-OADS,/arxiv_data1/oa_pdf/79/c8/ceor-8-707.PMC5144914.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/79/c8/ceor-8-707.PMC5144914.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 715 Outcomes of switching targeted DMARDs in rheumatoid arthritis,Non-OADS,/arxiv_data1/oa_pdf/79/c8/ceor-8-707.PMC5144914.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/02/tcrm-12-1827.PMC5144915.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1827–1829Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1827LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S12143 3 Complete blood cell count components and  coronary slow-flow phenomenon Nasim Arjmand Mohammad Reza Dehghani Department of Cardiology,   Seyyed-al-Shohada Heart Center,   Urmia University of Medical Sciences,   Urmia, IranDear editor Despite the implementation of preventive strategies, ischemic heart disease and stroke  remain the main causes of mortality and morbidity worldwide.1,2 Of the cardiovascular  diseases, coronary slow-flow phenomenon (CSFP), with a prevalence rate of 1%–7%  among patients undergoing diagnostic coronary angiography, has been found to be  associated with cardiovascular events, including cardiac arrhythmia and acute coro - nary syndrome.3–5 However, the potential mechanisms involved in the pathogenesis of  CSFP remain unknown.",Non-OADS,/arxiv_data1/oa_pdf/7e/02/tcrm-12-1827.PMC5144915.pdf
"Two studies demonstrated that red cell distribution width correlated with the pres - ence of CSFP,15,17 while in one study it did not.6 Furthermore, the elevated levels of Correspondence: Nasim Arjmand Department of Cardiology,  Seyyed-al-Shohada Heart Center,  Urmia  University of Medical Sciences,  17 Shahrivar Blvd, Urmia 5718749441, Iran email  nasim.arjmand@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Arjmand and Dehghani Running head recto: Complete blood cell count components and CSFP DOI: http://dx.doi.org/10.2147/TCRM.S121433",Non-OADS,/arxiv_data1/oa_pdf/7e/02/tcrm-12-1827.PMC5144915.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/7e/02/tcrm-12-1827.PMC5144915.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/02/tcrm-12-1827.PMC5144915.pdf
http://www.biomedcentral.com/ 1471-244X/10/3.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
"The Office of the National Coordinator for Health Information TechnologyData Brief, May 2014. http://www.healthit.gov/sites/default/files/ oncdatabrief16.pdf.",OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
http://www.implementationscience.com/content/5/1/30.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
"The Office of the National Coordinator for Health InformationTechnology Data Brief, December 2014. http://healthit.gov/ sites/default/files/oncdatabr ief-physician-ehr-adoption- motivators-2014.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
http://www.biomedcentral.com/content/ pdf/1471-244X-10-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
2012;12: 105. doi:10.1186/1472- 6947-12-105. http://www.biomedcentral.com/1472-6947/12/105.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
http://www.implementationscience.com/content/9/1/69.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
http://pareonline.net/getvn.asp?v=18&n=10.,OADS,/arxiv_data1/oa_pdf/c1/3d/cin-34-578.PMC5145246.pdf
"25 A more in depth discussion of the statistical methods and models is included in a supplementary appendix, SupplementalDigital Content 1 (http://links.lww.com/MLR/B247).",Non-OADS,/arxiv_data1/oa_pdf/2c/29/mlr-55-79.PMC5145247.pdf
"San Francisco, CA: American Academy of Ophthalmology; 2011 ; Available at: http://www.aao.org/preferred-practice-pattern/cataract-in-adult-eye-ppp– october-2011.",Non-OADS,/arxiv_data1/oa_pdf/ea/bb/cooph-28-73.PMC5145248.pdf
"Methods are provided in the online data supplement, Supplemental digital content 1, http://links.lww.com/MCA/A106 .",OADS,/arxiv_data1/oa_pdf/eb/23/mca-28-33.PMC5145249.pdf
"Treatment with MitoTEMPO decreased the level ofhydrogen peroxide and increased SOD activity (Supplementary Fig., Supplemental digital content 1, http://links.lww.com/MCA/A106 ); that is, we speculate that MitoTEMPO has a beneficial effect in preserving SERCA2 activity, similar to a mitochondrial catalase that contributes toward the restoration of cardiac diastolic function, in addition to improving the energyperformance of the electron transport complex in the mitochondria.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/mca-28-33.PMC5145249.pdf
"In addition, the scavenging activity of superoxide decreased with aging (Supplementary Fig, Supplemental digital content 1, http://links.lww.com/MCA/A106 ); there- fore, the increase in the ROS level in aging might be because of less reduction as well as more generation, although further study is needed.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/mca-28-33.PMC5145249.pdf
"Twenty-five individuals participated in  study N (Supplemental Digital Content, Supplemental Table 1, http://links.lww.com/AA/B428).",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"While results varied strongly among subjects, an Spo 2 reduction of  about 7% on average was induced by the hypoxic conditions: median Spo 2 values were 98.2% and 90.6% for studies N and  H, respectively (Supplemental Digital Content, Supplemental Table 1, http://links.lww.com/AA/B428).",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"Twenty-one individuals participated in study H (Supplemental Digital Content, Supplemental Table 2, http://links.lww.com/AA/B428), three were also in study N. The Climate Chamber (Study C) In the third study, the subject was seated comfortably in a chair in a climate-controlled room (Environmental Stress Chamber GMAPX-15CW, Hielkema Testequipment, Uden,  NL), with an initial temperature of approximately 22°C.",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"Five individuals participated in study C (Supplemental  Digital Content, Supplemental Table 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"Inclusion and exclusion criteria for studies N, H, and C are in Supplemental Digital Content, Supplemental Table 3 (http://links.lww.com/AA/B428).",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"RESULTS Filtering the Data Set and Determination of Qthr  and Calibration Constants C1, C2 A total of 46 data points from 39 individuals for studies N  and H are shown in Figure 5A and listed in Supplemental Table 1 (Supplemental Digital Content, http://links.lww.",OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"Pulsatile strengths varied considerably at any tempera-ture, which was due to a natural variation among indi- viduals (Supplemental Digital Content, Supplemental  Table 3, http://links.lww.com/AA/B428) and the fact  that temperature control was not perfect.",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"Analysis  of our data (Supplemental Digital Content, Supplemental  Table 1, http://links.lww.com/AA/B428) showed that  (Spo2,cam − Spo2,ref) in fact slightly trended in the oppo- site direction (not significant) illustrating that the mea-sured pulsatilities were caused by true PPG (skin color  changes) and did not have a significant noise compo- nent.",OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
"Unfortunately, the discarded group included 5 of   7 people with dark skin, leaving only 2 remaining sub- jects in the calibration set (subjects 7 and 29, Supplemental  Digital Content, Supplemental Table 3, http://links.lww.com/AA/B428).",Non-OADS,/arxiv_data1/oa_pdf/62/9e/ane-124-136.PMC5145250.pdf
Available at: http://www.acr.org/Quality-Safety/Resources/Con- trast-Manual.,Non-OADS,/arxiv_data1/oa_pdf/fa/e5/rli-52-55.PMC5145251.pdf
22. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM190850.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/e5/rli-52-55.PMC5145251.pdf
Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ 2007/ucm108919.htm.,Non-OADS,/arxiv_data1/oa_pdf/fa/e5/rli-52-55.PMC5145251.pdf
Available at: http://creativecommons.org/licenses/by-nc-nd/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/b8/0b/jscr-30-3531.PMC5145253.pdf
1Portuguese version (Avaliac ¸a˜o Global das Necessidades Individuais Y Inicial - AGNI-I) available for consultation: http://goo.gl/yJ19pt2Portuguese version (Avaliac ¸a˜o Global das Necessidades Individuais Y Rastreio Ra ´pido AGNI-RR) available for consultation: http://goo.gl/ 28BP2c 242 www.journalofaddictionsnursing.com October/December 2016 Copyright © 2016 International Nurses Society on Addictions.,Non-OADS,/arxiv_data1/oa_pdf/01/ef/jan-27-241.PMC5145254.pdf
Retrieved from http://www.teses.,Non-OADS,/arxiv_data1/oa_pdf/01/ef/jan-27-241.PMC5145254.pdf
"Retrieved from http://gaincc.org/_data/files/Instruments%20and%20Reports/Instruments%20Manuals/GAIN-SS_Manual_3_0.pdf Dennis, M., White, M., Titus, J., & Unsicker, J.",OADS,/arxiv_data1/oa_pdf/01/ef/jan-27-241.PMC5145254.pdf
"2009:2, 10-13.doi:  http://dx.doi.org/10.1234/jkh.v4i2 21.",Non-OADS,/arxiv_data1/oa_pdf/03/90/mejdd-8-310.PMC5145299.pdf
"Guidelines for the diagnosis and management of coeliac disease in adults, http://www.gain-ni.org/ index.php/guidelines-for-the-diagnosis-and-management-of-coeliac-disease-in-adults (accessed 16 August 2014).",Non-OADS,/arxiv_data1/oa_pdf/70/a7/mejdd-8-318.PMC5145300.pdf
"http://primarypsychiatry.com/women- with-schizophrenia-as-parents/ Smeriglio VL, Wilcox HC.",Non-OADS,/arxiv_data1/oa_pdf/c4/61/10.1177_1073858416635986.PMC5145769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.10.002 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 5 (2016) 26 e36,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1016/0166-2236(90)90107-L .,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1111/j.1467- 8721.2009.01615.x .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1017/thg.2012.11 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1016/j.neuroimage.2005.11.027 .,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
14. http://doi.org/10.3758/s13415-014-0270-2 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1002/dev.20447 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"1 e29, 2. http://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://journals.psychiatryonline.org/article.aspx?articleid ¼176376 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://linkinghub.elsevier.com/retrieve/pii/S0890856709661876 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"15 (2), 85 e93.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"14 (4), 14. http://doi.org/10.1016/S0749-3797(98)00017-8 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.apa.org/getdoi.cfm?doi ¼10.1037/0021- 843X.115.3.484 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://www.nature.com/ doiﬁnder/10.1038/nn958 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1177/ 1073191104269954 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1016/j.neuroscience.2014.06.041 .,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1348/026151008X315503 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1016/j.ynstr.2014.10.008 .,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1038/nn.4111 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"6 (October), 1 e14.http://doi.org/10.3389/fnint.2012.00089 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"7 (June), 200. http://doi.org/10.3389/fnhum.2013.00200 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1017/ S0033291701003622 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.3389/fnhum.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1007/s00401-013-1223-5 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1038/nrn2639 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"109 (2), 163. http://dx.doi.org/10.1037/0033-2909.109.2.",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"1032 (1), 1 e7.http://doi.org/10.1196/annals.1314.",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1038/nn.4086 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1006/cogp.1999.0734 .,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"21 (1), 8e14.http://doi.org/10.1177/0963721411429458 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1111/j.1469-8986.2007.00515.x .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"15 (1), 31 e45.http://doi.org/ 10.1016/S0926-6410(02)00214-8 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"8 (1), 54 e64.http://doi.org/10.3758/CABN.8.1.54 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1017/thg.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1016/j.bbr.2010.12.038 .,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1176/appi.ajp.2011.09121812 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://www.nature.com/doi ﬁnder/10.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://dx.doi.org/10.1038/mp.2014.196 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1016/j.psychres.,OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1038/ nrn2647 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.1038/nrg3243 .,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
"79 (1), 80 e90.http://linkinghub.elsevier.com/retrieve/ pii/S0301051108000070 .",Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/81/38/main.PMC5145909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/72/main.PMC5145910.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.08.005 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/72/main.PMC5145910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 5 (2016) 1 e7,Non-OADS,/arxiv_data1/oa_pdf/e1/72/main.PMC5145910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/ee/main.PMC5145912.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.09.002 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/ee/main.PMC5145912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 5 (2016) 8 e18,Non-OADS,/arxiv_data1/oa_pdf/ce/ee/main.PMC5145912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/52/main.PMC5145913.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.11.002 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/52/main.PMC5145913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 5 (2016) 37 e53,Non-OADS,/arxiv_data1/oa_pdf/6a/52/main.PMC5145913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/0d/main.PMC5146193.pdf
"1“ABC des psychotraumas ”network, http://www.abcpsychotraumas.fr .",Non-OADS,/arxiv_data1/oa_pdf/1a/0d/main.PMC5146193.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.002 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/0d/main.PMC5146193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 61 e67,Non-OADS,/arxiv_data1/oa_pdf/1a/0d/main.PMC5146193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/a6/main.PMC5146195.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.006 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/a6/main.PMC5146195.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 96 e104,Non-OADS,/arxiv_data1/oa_pdf/87/a6/main.PMC5146195.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/b0/main.PMC5146196.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.05.001 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/b0/main.PMC5146196.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 114 e121,Non-OADS,/arxiv_data1/oa_pdf/84/b0/main.PMC5146196.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/b0/main.PMC5146197.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.01.002 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/b0/main.PMC5146197.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 43 e51,Non-OADS,/arxiv_data1/oa_pdf/ea/b0/main.PMC5146197.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/37/main.PMC5146198.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.01.001 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/37/main.PMC5146198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 52 e60,Non-OADS,/arxiv_data1/oa_pdf/20/37/main.PMC5146198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/51/main.PMC5146199.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.005 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/51/main.PMC5146199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 44 e54,Non-OADS,/arxiv_data1/oa_pdf/1b/51/main.PMC5146199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/6f/main.PMC5146200.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2015.12.004 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/99/6f/main.PMC5146200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 62 e70,Non-OADS,/arxiv_data1/oa_pdf/99/6f/main.PMC5146200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/50/main.PMC5146201.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.007 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/50/main.PMC5146201.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 34 e43,Non-OADS,/arxiv_data1/oa_pdf/59/50/main.PMC5146201.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/fe/main.PMC5146202.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.001 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/fe/main.PMC5146202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 68 e73,Non-OADS,/arxiv_data1/oa_pdf/74/fe/main.PMC5146202.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.004 2352-2895/ ©2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/f3/24/main.PMC5146203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 74 e82,Non-OADS,/arxiv_data1/oa_pdf/f3/24/main.PMC5146203.pdf
"Front Psychiatry 7. http://dx.doi.org/10.3389/fpsyt.2016.00024 , 24.",Non-OADS,/arxiv_data1/oa_pdf/f3/24/main.PMC5146203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/main.PMC5146204.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.03.002 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/main.PMC5146204.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 105 e113,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/main.PMC5146204.pdf
http://dx.doi.org/10.1371/journal.pmed.1001547 .G.G.,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/main.PMC5146204.pdf
"Article ID 581976, http://dx.doi.org/10.1155/2015/581976 .",Non-OADS,/arxiv_data1/oa_pdf/6e/4b/main.PMC5146204.pdf
http://dx.doi.org/ 10.3791/4367 .,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/main.PMC5146204.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/2d/main.PMC5146205.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.03.001 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/2d/main.PMC5146205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 23 e33,Non-OADS,/arxiv_data1/oa_pdf/27/2d/main.PMC5146205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/22/main.PMC5146206.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2015.12.006 2352-2895/ ©2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/1d/22/main.PMC5146206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 3 (2016) 83 e95,Non-OADS,/arxiv_data1/oa_pdf/1d/22/main.PMC5146206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5146276.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.04.001 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5146276.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 1 e14,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5146276.pdf
http://www.nimh.nih.gov/health/statistics/ prevalence/major-depression-among-adolescents.shtml .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5146276.pdf
http://www.nimh.nih.gov/health/statistics/prevelence/major- depression-among adults.shtml .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5146276.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.03.003 2352-2895/ ©2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/bf/7e/main.PMC5146277.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 15 e22,Non-OADS,/arxiv_data1/oa_pdf/bf/7e/main.PMC5146277.pdf
http://dx.doi.org/10.1007/s12160-016-9783-y [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/bf/7e/main.PMC5146277.pdf
1 e12.http://dx.doi.org/10.1007/s12035-015-9443-4 .,Non-OADS,/arxiv_data1/oa_pdf/bf/7e/main.PMC5146277.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/7e/main.PMC5146277.pdf
http://dx.doi.org/10.1111/bjhp.12171 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/bf/7e/main.PMC5146277.pdf
"Eur J Microbio Immunol 6, (2016) doi: http://dx.doi.org/10.1556/1886.2015.00049 35.",Non-OADS,/arxiv_data1/oa_pdf/fe/c9/eujmi-06-272.PMC5146646.pdf
Extraction of DNA was performed from whole blood according to a proto-col described by Iranpour and Esmailizadeh (http://www.protocol-online.org/prot/Protocols/Rapid-Extraction-of-High-Quality-DNA-from-Whole-Blood-Stored-at-4-C-for-Long-Period-4175.html).,OADS,/arxiv_data1/oa_pdf/eb/70/eujmi-06-298.PMC5146648.pdf
Available at  http://www.acgih.org .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at http://www.ebrc.de/indus - trial-chemicals-reach/projects-and-references/mease.php .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at http://www.ece - toc.org .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at http://echa.europa.eu/guid - ance-documents/guidance-on-information-requirements- and-chemical-safety-assessment .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at  https://books.google.com/books?id=VYhIAAAACAAJ .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at http://www.ilo.org/legacy/english/protec - tion/safework/ctrl_banding/toolkit/icct/hgroup.htm .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available  at http://www.seirich.fr/ .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at  http://www.ioha2015.org/ioha-2015-presentations/ .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available  at http://www.safeworkaustralia.gov.au/sites/swa/whs-infor - mation/hazardous-chemicals/ghs/pages/ghs .,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
Available at http://www.ioha2015.org/wp-content/ uploads/2015/05/8c-Validation.Theo_Scheffers.,Non-OADS,/arxiv_data1/oa_pdf/75/ec/mew050.PMC5146680.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/0c/gfw047.PMC5146706.pdf
SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford- journals.org.,Non-OADS,/arxiv_data1/oa_pdf/1c/0c/gfw047.PMC5146706.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/79/ciw589.PMC5146717.pdf
"This is an Open Access article distrib- uted under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence  (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduc- tion and distribution of the work, in any medium, provided the original work is not altered or  transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/84/ofw221.PMC5146758.pdf
Available at: http://www.cdc.gov/pneumococcal/drug-resistance.,Non-OADS,/arxiv_data1/oa_pdf/07/84/ofw221.PMC5146758.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens - es/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/80/ofw230.PMC5146759.pdf
"Trial Registration:  ClinicalTrials.gov, NCT01698164; https://clinicaltrials.gov/ct2/show/NCT01698164?term=NCT01698164&rank=1.",Non-OADS,/arxiv_data1/oa_pdf/72/b0/CMJ-129-2773.PMC5146781.pdf
"ncbi.nlm.nih.gov/ RefSeq (http://www.ncbi.nlm.nih.‑ gov/RefSeq/),CCDS/CcdsBrowse.cgi), Ensembl (http:// www.ensembl.org), and Encode(http://genome.ucsc.edu/ ENCODE).",OADS,/arxiv_data1/oa_pdf/29/b6/CMJ-129-2810.PMC5146788.pdf
"Prioritized all the high‑quality mutations  including four major steps:  (1) mutations including intronic,  intergenic, untranslated regions and synonymous mutations  were excluded from downstream analysis; (2) mutations  in 1000 genome project (ftp://ftp.1000genomes.ebi.ac.uk/ vol1‑/ftp), dbSNP137 (http://www.ncbi.nlm.nih.gov/ projects/SNP/), YH database (http://yh.genomics.org.cn/),  and HapMap Project  (ftp://ftp.ncbi.nlm.nih.gov/hapmap)  were excluded; (3) SIFT  (http://sift.bii.astar.edu.sg/) and  Polyphen2 (http://genetics.bwh.harvard.edu/pph 2/) were  used to predict possible damaging impacts of each variant  on protein structure and function;  (4) KEGG pathway  annotations  (http://www.ebi.ac.uk./clustalw) and gene  ontology (http://www.geneontology.org) were used to predict  the biological function of each putative gene.",Non-OADS,/arxiv_data1/oa_pdf/29/b6/CMJ-129-2810.PMC5146788.pdf
"Trial Registration:  Chinese Clinical Trial Registry, ChiCTR‑IOR‑15007498; http://www.chictr.org.cn/ showproj.aspx?proj=12613.",Non-OADS,/arxiv_data1/oa_pdf/9d/7c/CMJ-129-2816.PMC5146789.pdf
Available from: http://www.cqlp.org/info/link.,Non-OADS,/arxiv_data1/oa_pdf/9b/30/CMJ-129-2890.PMC5146804.pdf
"5  687–703 https://doi.org/10.1083/jcb.201603079Introduction Progranulin (PGRN) is an evolutionarily conserved Cys-rich  secreted glycoprotein easily measurable in blood and cere - bral spinal fluid (Toh et al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/81/9c/JCB_201603079.PMC5146997.pdf
5  735–747 https://doi.org/10.1083/jcb.201604006Introduction Epithelial-to-mesenchymal transition (EMT) is a highly coordi - nated process that integrates multiple mechanisms to generate  a mesenchymal cell from one of epithelial origin.,Non-OADS,/arxiv_data1/oa_pdf/cc/23/JCB_201604006.PMC5146998.pdf
5  667–685 https://doi.org/10.1083/jcb.201604032Introduction The cornea is a remarkable system in that it must protect the  delicate understructures of the eye as well as maintain transpar - ency for proper vision.,Non-OADS,/arxiv_data1/oa_pdf/d6/32/JCB_201604032.PMC5146999.pdf
"5  719–734 https://doi.org/10.1083/jcb.201605046Introduction Astrocytes, a major class of glial cells in the central nervous  system (CNS), actively regulate axon guidance, synapse forma - tion and maturation, synapse function and plasticity, and neu - ronal survival during development (Eroglu and Barres, 2010;  Clarke and Barres, 2013; Fields et al., 2015; Haydon and Ned - ergaard, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d6/75/JCB_201605046.PMC5147000.pdf
5  649–665 https://doi.org/10.1083/jcb.201605093Introduction Macroautophagy (hereafter autophagy) is a catabolic process  that nonselectively degrades cytoplasmic components and or - ganelles.,Non-OADS,/arxiv_data1/oa_pdf/42/fe/JCB_201605093.PMC5147001.pdf
"5  705–718 https://doi.org/10.1083/jcb.201605121Introduction Glycosylphosphatidylinositol (GPI) is a glycolipid widely  used among eukaryotes as membrane anchors for many cell  surface proteins (Ferguson et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/8f/d3/JCB_201605121.PMC5147002.pdf
5  631–647 https://doi.org/10.1083/jcb.201606081Introduction The precise regulation of microtubule (MT) dynamics is es - sential to the accurate execution of mitosis and the faithful  segregation of chromosomes.,Non-OADS,/arxiv_data1/oa_pdf/a0/da/JCB_201606081.PMC5147003.pdf
"5  611–619 https://doi.org/10.1083/jcb.201607062Introduction Sexual reproduction relies on the fusion of paternal and mater - nal haploid gametes—the sperm and the extremely large oo - cyte, respectively—forming a new diploid organism.",Non-OADS,/arxiv_data1/oa_pdf/67/fc/JCB_201607062.PMC5147004.pdf
"5  621–629 https://doi.org/10.1083/jcb.201609019Introduction The double-membraned organelle mitochondria constantly re - models themselves by membrane fusion and fission (Hoppins  and Nunnari, 2009; Lackner and Nunnari, 2009; Youle and van  der Bliek, 2012; Mishra and Chan, 2016; Pernas and Scorrano,  2016).",OADS,/arxiv_data1/oa_pdf/be/4b/JCB_201609019.PMC5147005.pdf
"5  603–605 https://doi.org/10.1083/jcb.201610097Occasionally, a paper brings together two seemingly unrelated  strands of research in a new and illuminating fashion.",Non-OADS,/arxiv_data1/oa_pdf/47/cb/JCB_201610097.PMC5147006.pdf
"5  597–598 https://doi.org/10.1083/jcb.201611048Mitochondria undergo constant fission and fusion events, re - sulting in a highly dynamic and reticular network specialized  for cellular function.",Non-OADS,/arxiv_data1/oa_pdf/a8/a0/JCB_201611048.PMC5147007.pdf
"5  607–609 https://doi.org/10.1083/jcb.201611078Intense research over the past 25 years has identified a multi - tude of mechanisms by which astrocytes rapidly modulate neu - ronal activity, in addition to their classical roles in potassium  buffering and metabolic support.",Non-OADS,/arxiv_data1/oa_pdf/e7/25/JCB_201611078.PMC5147008.pdf
Available at: http://healthcommcapacity.org/.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/qai-74-s01.PMC5147028.pdf
"A table of intervention activities is included in the online Supplemental Digital Content (Table 4s, http://links.lww.com/QAI/A941) and more detailon the intervention is available elsewhere.",Non-OADS,/arxiv_data1/oa_pdf/9a/05/qai-74-s44.PMC5147031.pdf
Available at: http://www.unaids.org/sites/default/ ﬁles/ media_asset/90-90-90_en_0.pdf: Joint United Nations Programme on HIV/AIDS (UNAIDS).,Non-OADS,/arxiv_data1/oa_pdf/9a/05/qai-74-s44.PMC5147031.pdf
Av ailable at: http://www.genderjustice.,Non-OADS,/arxiv_data1/oa_pdf/9a/05/qai-74-s44.PMC5147031.pdf
"The unstandardized frequency of each sexual behavior, by HIV status, and strati ﬁed by sex, is presented in Supplemental Digital Content, Table 2, http://links.lww.com/QAI/A914.",Non-OADS,/arxiv_data1/oa_pdf/48/37/qai-74-e9.PMC5147032.pdf
"Unstandard- ized and age- and sex-standardized prevalence ratios comparingthe relative frequency of each sexual behavior across HIV status categories are presented in Supp lemental Digital Content, Table 3, http://links.lww.com/QAI/A915.",Non-OADS,/arxiv_data1/oa_pdf/48/37/qai-74-e9.PMC5147032.pdf
Available at: https://effectiveinterventions.cdc.gov/en/HighImpactPrevention/ Interventions.aspx.,Non-OADS,/arxiv_data1/oa_pdf/48/37/qai-74-e9.PMC5147032.pdf
Available at: http://www.who.int/healthinfo/survey/ ageingdefnolder/en/.,Non-OADS,/arxiv_data1/oa_pdf/48/37/qai-74-e9.PMC5147032.pdf
Available at: http://www.unaids.org/sites/default/ ﬁles/media_ asset/youngpeoplehivaids_en_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/37/qai-74-e9.PMC5147032.pdf
Available at: http://www.positiveprevention.ucsf.edu/CDROM/ HTML/PDF/REMAN01E.PDF.,Non-OADS,/arxiv_data1/oa_pdf/48/37/qai-74-e9.PMC5147032.pdf
Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/f7/93/pai-25-25.PMC5147033.pdf
Available at: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/f7/93/pai-25-25.PMC5147033.pdf
Available at: http://seer.cancer.gov/csr/ 1975_2011/.,Non-OADS,/arxiv_data1/oa_pdf/f7/93/pai-25-25.PMC5147033.pdf
Available at: http://menengage.org.,Non-OADS,/arxiv_data1/oa_pdf/7b/8f/qai-74-s69.PMC5147035.pdf
Available at: http://bhekisisa.org.,Non-OADS,/arxiv_data1/oa_pdf/7b/8f/qai-74-s69.PMC5147035.pdf
Available at: http://www.healthcommcapacity.org/wp-content/uploads/2014/03/consult-factsheet11-22.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/c7/qai-74-s23.PMC5147038.pdf
CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/ff/80/cir-134-1931.PMC5147039.pdf
"The online-only Data Supplement, podcast, and transcript  are available with this article at http://circ.ahajournals.org/look- up/suppl/doi:10.1161/CIRCULATIONAHA.116.024604/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/cir-134-1931.PMC5147039.pdf
Circulation is available at http://circ.ahajournals.org.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/cir-134-1931.PMC5147039.pdf
https://www.nice.org.uk/guidance/cg181.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/cir-134-1931.PMC5147039.pdf
"The study team developed a simple SMS reminderapplication using CommCare, an open source mobile plat-form developed by Dimagi (http://www.dimagi.com/), a Boston-based health informatics service provider that has supported many public health projects in developing coun-tries.",OADS,/arxiv_data1/oa_pdf/4f/e8/qai-74-s37.PMC5147041.pdf
Available at: http://www.ericsson.,Non-OADS,/arxiv_data1/oa_pdf/4f/e8/qai-74-s37.PMC5147041.pdf
Available at: http://www.pewglobal.org/2015/04/15/cell-phones-in-africa- communication-lifeline/.,Non-OADS,/arxiv_data1/oa_pdf/4f/e8/qai-74-s37.PMC5147041.pdf
Available at: https://www.icrw.org/ ﬁles/publications/Can-We-Measure- HIV-Stigma-and-Discrimination.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/e8/qai-74-s37.PMC5147041.pdf
Available at: http://www.unaids.org/en/ regionscountries/countries/senegal.,Non-OADS,/arxiv_data1/oa_pdf/28/bb/qai-74-s52.PMC5147043.pdf
Available at: https://www.path.org/publications/ ﬁles/CP_kenya_KARHP_curric_3-06.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/bb/qai-74-s52.PMC5147043.pdf
"Available at: http://www.nswp.org/sites/nswp.org/ ﬁles/Know%20It%20-%20The% 20Rights%20Framework,%20Asia%20Catalyst%20-%202010.pdf.",Non-OADS,/arxiv_data1/oa_pdf/28/bb/qai-74-s52.PMC5147043.pdf
Available at: http://www.jhsph.edu/research/centers-and-inst itutes/research-to-pre vention/publications- resources/iringa-briefs.html.,Non-OADS,/arxiv_data1/oa_pdf/da/99/qai-74-s60.PMC5147044.pdf
"The last row of the model presents health communication interventions found in the articlesreviewed, as well as the suggested approaches that address the identi ﬁed determinants (see Supplemental Digital Con- tent 1, http://links.lww.com /QAI/A942 for more information on the included interventions).",Non-OADS,/arxiv_data1/oa_pdf/d3/11/qai-74-s05.PMC5147045.pdf
Available at:  http://www.nlm.nih.gov/medlineplus/etr.html.,Non-OADS,/arxiv_data1/oa_pdf/bf/0a/gox-4-046b.PMC5147092.pdf
Available at:  http://www.nlm.nih.gov/medlineplus/etr.html.,Non-OADS,/arxiv_data1/oa_pdf/d9/fd/gox-4-047.PMC5147093.pdf
Available at:  http://www.nlm.nih.gov/medlineplus/etr.html.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/gox-4-048a.PMC5147094.pdf
Avail- able at: http://www.plasticsurgery.org/Documents/news-  resources/statistics/2015-statistics/cosmetic-procedure- trends-2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/8f/gox-4-068.PMC5147123.pdf
Avail- able at: http://www.plasticsurgery.org/Documents/news-  resources/statistics/2015-statistics/cosmetic-procedure- trends-2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e1/7e/gox-4-069a.PMC5147124.pdf
Avail- able at: http://www.plasticsurgery.org/Documents/news-  resources/statistics/2015-statistics/cosmetic-procedure- trends-2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/50/gox-4-069b.PMC5147125.pdf
at http://www.who.int/ disabilities/world_report/2011/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/fe/df/gox-4-120b.PMC5147205.pdf
at http://www.who.int/ disabilities/world_report/2011/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/a8/c4/gox-4-121a.PMC5147206.pdf
at http://www.who.int/ disabilities/world_report/2011/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/bf/85/gox-4-121b.PMC5147207.pdf
http://www.openscad.org/.,Non-OADS,/arxiv_data1/oa_pdf/8d/61/gox-4-131b.PMC5147224.pdf
http://www.slic3r.org/.,Non-OADS,/arxiv_data1/oa_pdf/8d/61/gox-4-131b.PMC5147224.pdf
"CT scans (≤1 mm slices)  were obtained (DICOM file) for volumetric conversion to 3D models (STL file) using free open-source software (3D Slicer, http://www.slicer.org).",OADS,/arxiv_data1/oa_pdf/8d/61/gox-4-131b.PMC5147224.pdf
http://www.openscad.org/.,Non-OADS,/arxiv_data1/oa_pdf/e7/cb/gox-4-132.PMC5147225.pdf
http://www.slic3r.org/.,Non-OADS,/arxiv_data1/oa_pdf/e7/cb/gox-4-132.PMC5147225.pdf
"CT scans (≤1 mm slices)  were obtained (DICOM file) for volumetric conversion to 3D models (STL file) using free open-source software (3D Slicer, http://www.slicer.org).",OADS,/arxiv_data1/oa_pdf/e7/cb/gox-4-132.PMC5147225.pdf
"2014 Mastectomy & Breast Reconstruction  Medicare Reimbursement Coding Guide website http://www.covidien.com/imageServer.aspx/doc267036.pdf?c ontentID=43861&contenttype=application/pdf accessed:  February 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/4a/71/gox-4-134.PMC5147226.pdf
http://www.burnfoundation.org/programs/resource.,Non-OADS,/arxiv_data1/oa_pdf/ec/22/gox-4-156b.PMC5147262.pdf
http://www.burnfoundation.org/programs/resource.,Non-OADS,/arxiv_data1/oa_pdf/b3/9a/gox-4-157a.PMC5147263.pdf
http://www.burnfoundation.org/programs/resource.,Non-OADS,/arxiv_data1/oa_pdf/52/47/gox-4-157b.PMC5147264.pdf
http://www.qualitynet.org/dcs/ContentSe rver?pagename=QnetPublic%2FPage%2FQnetTier3&cid=1219069855273.,Non-OADS,/arxiv_data1/oa_pdf/13/49/gox-4-158.PMC5147265.pdf
http://www.qualitynet.org/dcs/ContentSe rver?pagename=QnetPublic%2FPage%2FQnetTier3&cid=1219069855273.,Non-OADS,/arxiv_data1/oa_pdf/d9/14/gox-4-159.PMC5147266.pdf
http://www.qualitynet.org/dcs/ContentSe rver?pagename=QnetPublic%2FPage%2FQnetTier3&cid=1219069855273.,Non-OADS,/arxiv_data1/oa_pdf/50/9c/gox-4-160a.PMC5147267.pdf
Avail- able from: https://www.congress.gov/bill/114th-congress/ senate-bill/1192/text.,Non-OADS,/arxiv_data1/oa_pdf/27/84/gox-4-177.PMC5147295.pdf
Avail- able from: https://www.congress.gov/bill/114th-congress/ senate-bill/1192/text.,Non-OADS,/arxiv_data1/oa_pdf/32/fb/gox-4-178a.PMC5147296.pdf
Avail- able from: https://www.congress.gov/bill/114th-congress/ senate-bill/1192/text.,Non-OADS,/arxiv_data1/oa_pdf/50/d3/gox-4-178b.PMC5147297.pdf
http://www.nlm.,Non-OADS,/arxiv_data1/oa_pdf/95/29/gox-4-224b.PMC5147370.pdf
http://www.nlm.,Non-OADS,/arxiv_data1/oa_pdf/72/c9/gox-4-225.PMC5147371.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/97/jpr-9-1161.PMC5147393.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/97/jpr-9-1161.PMC5147393.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1161–1161Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e6/97/jpr-9-1161.PMC5147393.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1161 CoRRigendum open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S127280Humanistic and economic burden of fibromyalgia in Japan [Corrigendum] Lee LK, Ebata N, Hlavacek P , DiBonaventura M, Cappelleri  JC, Sadosky A. Humanistic and economic burden of fibro-myalgia in Japan.",Non-OADS,/arxiv_data1/oa_pdf/e6/97/jpr-9-1161.PMC5147393.pdf
Journal name: Journal of Pain Research  Article Designation: CorrigendumY ear: 2016V olume: 9Running head verso: Lee et alRunning head recto: Burden of fibromyalgia in JapanDOI: http://dx.doi.org/10.2147/JPR.S127280,Non-OADS,/arxiv_data1/oa_pdf/e6/97/jpr-9-1161.PMC5147393.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ceg-9-365.PMC5147394.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b7/ca/ceg-9-365.PMC5147394.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 365–375Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  365 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S120118Absorption and safety of serum-derived bovine  immunoglobulin/protein isolate in healthy adults Audrey L Shaw1 David W Mathews1 John E Hinkle2 Bryon W Petschow1 Eric M Weaver3 Christopher J Detzel1 Gerald L Klein4 Timothy P Bradshaw1 1Clinical Development, Entera Health,   Inc., 2Life Sciences Consulting and  Analytics, EarlyPhase Sciences, Inc.,   Cary, 3Executive Management, Prairie  Pharms, LLC, Nora Springs, 4Executive  Management, MedSurgPI, LLC, Raleigh,  NC, USAPurpose: Previous studies have shown that oral administration of bovine immunoglobulin  protein preparations is safe and provides nutritional and intestinal health benefits.",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ceg-9-365.PMC5147394.pdf
"3,4 More recently,  there has been increasing interest in the use of such immunoglobulin-containing protein isolates from bovine plasma or serum in human beings at risk for certain intestinal disorders or to help manage chronic conditions affecting the gastrointestinal (GI)   tract.Correspondence: Audrey L Shaw Clinical Development, Entera Health, Inc., 2000 Regency Parkway, Suite 255, Cary, NC 27518, USATel +1 919 971 8000Email audrey.shaw@enterahealth.comJournal name: Clinical and Experimental Gastroenterology Article Designation: CLINICAL TRIAL REPORTY ear: 2016V olume: 9Running head verso: Shaw et alRunning head recto: Evaluation of oral bovine immunoglobulin isolateDOI: http://dx.doi.org/10.2147/CEG.S120118",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ceg-9-365.PMC5147394.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ceg-9-365.PMC5147394.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 375 Evaluation of oral bovine immunoglobulin isolate  13.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ceg-9-365.PMC5147394.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1831–1840Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1831ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12317 2 high bone turnover elevates the risk of  denosumab-induced hypocalcemia in women  with postmenopausal osteoporosis Koji ishikawa1 Takashi nagai1 Keizo sakamoto1 Kenji Ohara2 Takeshi eguro1,2 hiroshi ito1 Y oichi T oyoshima1 akatsuki Kokaze3 T omoaki T oyone1 Katsunori inagaki1 1Department of Orthopaedic surgery,   showa University school of Medicine,   T okyo, 2Department of Orthopaedic  surgery, Yamanashi Red Cross  hospital, Yamanashi, 3Department  of Public health, showa University  school of Medicine, T okyo, JapanAbstract:  Hypocalcemia is the most common major adverse event in patients with osteoporosis  receiving the bone resorption inhibitor denosumab; however, limited information is available  regarding risk factors of hypocalcemia.",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
"In men and postmenopausal women with  osteoporosis, a single 60 mg dose of denosumab subcutaneously administered every  6 months significantly reduces bone turnover markers (BTMs), increases bone mineral  density (BMD), and reduces the risk of new vertebral and nonvertebral fractures, includ - ing hip fractures.1 Several studies have found that treatment with denosumab increases  both BMD and bone strength as estimated by quantitative computed tomography of the  radius, hip, and spine.2,3 In a long-term clinical study, denosumab treatment increased Correspondence: Koji ishikawa Department of Orthopaedic surgery,  showa University school of Medicine,  1-5-8 hatanodai, shinagawa-ku,  Tokyo 142-8666, Japan Tel +81 3 3784 8543 Fax +81 3 3784 9005 email o9o16979696koji@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Ishikawa et al Running head recto: High bone turnover elevates the risk of denosumab-induced hypocalcemia DOI: http://dx.doi.org/10.2147/TCRM.S123172",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
"Available from: http://pi.amgen.com/united_states/xgeva/ xgeva_pi.pd f. Accessed February 14, 2016.",OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
"Avail - able from: http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/ hc-sc/2012/14811a-eng.ph p. Accessed August 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/c3/tcrm-12-1831.PMC5147395.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/ea/ppa-10-2429.PMC5147396.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2429–2435Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2429Comment Aryopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S11780 2 ethical considerations in adherence research nupur U Patel1 Blake A moore1 rebekah F Craver2 Steven r Feldman1,2 1Department of Dermatology,   Center for Dermatology research,   2Department of Public Health  Sciences, Wake Forest University  School of m edicine, Winston-Salem,   nC, USAAbstract:  Poor adherence to treatment is a common cause of medical treatment failure.",Non-OADS,/arxiv_data1/oa_pdf/9d/ea/ppa-10-2429.PMC5147396.pdf
"Defined by the World Health Organization as “the degree to which the  person’s behavior corresponds with the agreed recommendations from a health care  provider,” adherence has become the focus of much clinical research.1 In recent years,  the term adherence has come to supersede that of compliance in the literature.2 The  term compliance was defined in the 1970s as “the extent to which a person’s behav - ior (in terms of taking medications, following diets, or executing lifestyle changes)  coincides with medical or health advice.”3,4 It can also be defined as “the extent to  which the patient’s behavior follows the prescribed recommendations.”5 A third term,  concordance, is defined by the Royal Pharmaceutical Society of Great Britain as an  agreement between patient and health care professional, which takes into account  the beliefs and wishes of the patient in determining how their medication is taken.2  Although these terms are similarly defined and oftentimes used interchangeably, they  differ in their implied meanings.1 Concordance refers to successful partnership in which  the patient is supported in their decisions about their medicine.6 While compliance  denotes patient obedience in following orders given by the physician in a position of  authority, adherence indicates collaboration between physician and patient that takes  into account medical knowledge along with patient preferences to improve patient  health.1,7 Adherence suggests that the patients have decided to act of their own free Correspondence: Steven r Feldman Department of Dermatology, Center  for Dermatology research, Wake  Forest University School of medicine,  4618 Country Club road Winston-Salem, nC 27104, USA  tel +1 336 716 7740 Fax +1 336 716 7732 email sfeldman@wakehealth.ed u Journal name: Patient Preference and Adherence Article Designation: Commentary Y ear: 2016 Volume: 10 Running head verso: Patel et al Running head recto: Ethical considerations in adherence research DOI: http://dx.doi.org/10.2147/PPA.S117802 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/9d/ea/ppa-10-2429.PMC5147396.pdf
Or use: http://youtu.be/iZ6smh81CN YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/9d/ea/ppa-10-2429.PMC5147396.pdf
"Available from: http://www.virginia.edu/vpr/irb/sbs/ resources_guide_deception_debrief.htm l. Accessed September 29,  2016.",Non-OADS,/arxiv_data1/oa_pdf/9d/ea/ppa-10-2429.PMC5147396.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9d/ea/ppa-10-2429.PMC5147396.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1163–1171Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1163 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S123454An investigation of completion times on the  Screener and Opioid Assessment for Patients  with Pain – revised (SOAPP-R) Matthew D Finkelman1 Ronald J Kulich2,3 Stephen F Butler4 William C Jackson3 Franklin D Friedman5 Niels Smits6 Scott G Weiner7 1Department of Public Health and  Community Service, T ufts University  School of Dental Medicine, Boston,  MA, USA;  2Craniofacial Pain and  Headache Center, T ufts University School of Dental Medicine, Boston,  MA, USA;  3Department of Anesthesia,   Critical Care and Pain Medicine,  Massachusetts General Hospital,   4Inflexxion Inc, Newton, MA, USA;   5Department of Emergency Medicine,   T ufts Medical Center, Boston, MA,  USA;  6Department of Methods and  Statistics, Research Institute of Child Development and Education,  University of Amsterdam, Amsterdam,  the Netherlands;  7Department of  Emergency Medicine, Brigham and Women’s Hospital, Boston, MA, USABackground: Respondents’ scores to the Screener and Opioid Assessment for Patients with  Pain – revised (SOAPP-R) have been shown to be predictive of aberrant drug-related behavior  (ADB).",Non-OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
"5 With the volume of chronic pain patients, limited treatment  options, high risk of misuse, and the public eye, development of time-sensitive and accurate technology for risk screening is essential for adequate care.Correspondence: Matthew D Finkelman Department of Public Health and Community Service, Tufts University School of Dental Medicine, 1 Kneeland Street, Boston, MA 02111, USATel +1 617 636 3449Fax +1 617 636 6511Email matthew.finkelman@tufts.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Finkelman et alRunning head recto: SOAPP-R completion timesDOI: http://dx.doi.org/10.2147/JPR.S123454",Non-OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1171 SOAPP-R completion times 36.,Non-OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
Available from: http://www.pdmpassist.org/content/prescription-drug-monitoring-frequently-asked-questions-faq.,Non-OADS,/arxiv_data1/oa_pdf/9a/29/jpr-9-1163.PMC5147397.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/44/cia-11-1773.PMC5147398.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1773–1780Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1773OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11729 2 Altered spontaneous brain activity pattern in  patients with late monocular blindness in middle- age using amplitude of low-frequency fluctuation:  a resting-state functional MrI study Qing li1,2,*  Xin huang2,3,* lei Ye2 rong Wei2  Ying Zhang2  Yu-lin Zhong2,4  nan Jiang2 Yi shao2 1Department of Pharmacy,   The Jiangxi Provincial People’s  hospital, nanchang, Jiangxi,   People’s republic of China;   2Department of Ophthalmology,   The First Affiliated hospital of  nanchang University, Jiangxi  Province Clinical Ophthalmology  Institute and Oculopathy research  Centre, nanchang, Jiangxi, People’s  republic of China; 3Department of  Ophthalmology, The First People’s  hospital of Jiujiang City, Jiujiang,   Jiangxi, People’s republic of China;   4Department of Ophthalmology,   The Affiliated hospital of Jiujiang  University, Jiujiang, Jiangxi, People’s  republic of China *These authors contributed equally  to this workObjective:  Previous reports have demonstrated significant brain activity changes in bilateral  blindness, whereas brain activity changes in late monocular blindness (MB) at rest are not  well studied.",Non-OADS,/arxiv_data1/oa_pdf/8d/44/cia-11-1773.PMC5147398.pdf
"Correspondence: Yi shao  Department of Ophthalmology, The  First Affiliated Hospital of Nanchang  University, no 17 Yongwaizheng street,  Donghu District, nanchang 330006,  Jiangxi, People’s republic of China Tel +86 791 8869 2520 email freebee99@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: ALFF study in late MB patients DOI: http://dx.doi.org/10.2147/CIA.S117292",Non-OADS,/arxiv_data1/oa_pdf/8d/44/cia-11-1773.PMC5147398.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8d/44/cia-11-1773.PMC5147398.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8d/44/cia-11-1773.PMC5147398.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3051–3058International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3051OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11513 7 Increased risk of community-acquired  pneumonia in COPD patients with comorbid  cardiovascular disease sheng-hao lin1,2 Diahn-Warng Perng3,4 Ching-Pei Chen5,6 Woei-horng Chai1 Chin-shui Yeh1 Chew-T eng Kor7 shih-lung Cheng8,9 Jeremy JW Chen2,* Ching-hsiung lin1,10,11,* 1Department of Internal Medicine, Division  of Chest Medicine, Changhua Christian  hospital, Changhua, 2Institute of Biomedical  sciences, n ational Chung hsing University,   Taichung, 3Department of Chest Medicine,   Taipei Veterans general hospital, Taipei,   4school of Medicine, national Yang- Ming University, Taipei, 5Department of  Internal Medicine, Division of Cardiology,   Changhua Christian hospital, 6Department  of Beauty science and graduate Institute  of Beauty science T echnology, Chien-Kuo  T echnology University, 7Department  of Internal Medicine, Internal Medicine  research Center, Changhua Christian  hospital, Changhua, 8Department of  Internal Medicine, Far eastern Memorial  hospital, Taipei, 9Department of Chemical  engineering and Materials science, Yuan  Ze University, Zhongli City, Taoyuan,   10Department of respiratory Care,   College of health sciences, Chang Jung  Christian University, Tainan, 11school of  Medicine, Chung shan Medical University,   Taichung, Taiwan *These authors contributed equally  to this workBackground and objective:  COPD patients with community-acquired pneumonia (CAP)  have worse clinical outcomes, as compared to those without COPD.",Non-OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
"Keywords:  chronic obstructive pulmonary disease, COPD, community-acquired pneumonia,  cardiovascular disease, inhaled corticosteroids, CAP, CVD Introduction COPD is the leading cause of death for both males and females in the US and is pro - jected to rise in ranking by 2020.1 According to data from the National Center for Health  Statistics of the Centers for Disease Control and Prevention, COPD became the third  leading cause of death by 2008.1,2 Like other chronic diseases, COPD is usually related  to pneumonia3 and is the most common fundamental clinical condition for patients who  need intensive care due to severe community-acquired pneumonia (CAP).4 Compared  to patients without COPD, CAP patients with COPD are likely to have more severe  pneumonia, increased number of hospital admissions, and worse outcome.5–8 The risk factors for acquiring CAP include increasing age and comorbid illnesses  such as neoplasia, liver  disease, renal disease, cardiac failure, and altered mental Correspondence: Ching-hsiung lin Department of Internal Medicine, Division of  Chest Medicine, Changhua Christian hospital, 135 nanxiao st, Changhua City, Changhua  County 500, Taiwan Tel +886 4 723 8595 1039 Fax +886 4 723 2942 email teddy@cch.org.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lin et al Running head recto: The CAP risk in COPD with comorbid CVD DOI: http://dx.doi.org/10.2147/COPD.S115137",Non-OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
"Calculations  of cumulative incidences and all competing risk analyses  were conducted using the “cmprsk” package (version 3.1.2;  https://cran.r-project.org/web/packages/cmprsk/index.htm l),  while the “survival” package ( https://cran.",OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
Available from: http://goldcopd.org/gold-reports/.,OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
"Available  from: http://www.goldcopd.it/materiale/2015/GOLD_Report_2015.pd f.  Accessed June 16, 2016.",OADS,/arxiv_data1/oa_pdf/c2/d4/copd-11-3051.PMC5147399.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/4c/ijn-11-6485.PMC5147400.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6485–6497International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6485OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11718 4 Using hyaluronic acid-functionalized ph stimuli- responsive mesoporous silica nanoparticles for   targeted delivery to cD44-overexpressing  cancer cells Zhihui Wang* Y ongfeng Tian* hua Zhang Yanmei Qin Dong li li gan Fanhong Wu Department of Pharmaceutical  engineering, school of chemical  and environmental engineering,   shanghai Institute of T echnology,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  In this study, novel hyaluronic acid-pH stimuli-responsive lipid membrane  mesoporous silica nanoparticles (HA-PL-MSNs) were designed and assembled, with the chemo - therapeutic agent doxorubicin (DOX) as the model drug.",Non-OADS,/arxiv_data1/oa_pdf/f2/4c/ijn-11-6485.PMC5147400.pdf
"In recent decades, nanoma - terials have been widely used in nanomedicine as potential diagnostic and therapeutic  agents for cancer imaging and treatment, with less toxicity and improved efficacy.3,4  Targeted delivery of more efficient cancer treatments has been well documented and  is vital to distribute the drug throughout the body to minimize the side effects, which  is desirable in order to increase the anticancer drug concentration at the target sites.5 The major goal of chemotherapy is to ensure the safe and efficient transportation  of drug molecules to the targeted sites.2 Over the past two decades, advances in  biotechnology and nanotechnology have brought about a paradigm shift to design more  sophisticated drug deliveries approaches.6 Recent reports on the design of capped and  gated mesoporous silica nanoparticles (MSNs)-based systems show they are attractive  carriers for drug delivery and have shown promise in preventing premature release correspondence: li gan; Fanhong Wu shanghai Institute of Technology,  100 haiquan road, shanghai 201418,  People’s republic of china Tel +86 135 6424 3471;   +86 136 0162 6489 email sit2016@vip.sina.co m;  wfh@sit.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: HA-PL-MSNs for targeted delivery to CD44-overexpressing cancer cells DOI: http://dx.doi.org/10.2147/IJN.S117184",Non-OADS,/arxiv_data1/oa_pdf/f2/4c/ijn-11-6485.PMC5147400.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f2/4c/ijn-11-6485.PMC5147400.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/4c/ijn-11-6485.PMC5147400.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/95/ijgm-9-441.PMC5147401.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b2/95/ijgm-9-441.PMC5147401.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 441–446International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 441 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S125183Bacteremia caused by a rare pathogen –  Chromobacterium violaceum : a case   report from Nepal Narayan Prasad Parajuli1,2 Anjeela Bhetwal2 Sumitra Ghimire2 Anjila Maharjan2 Shreena Shakya2 Deepa Satyal2 Roshan Pandit2 Puspa Raj Khanal2 1Department of Clinical Laboratory  Services, Manmohan Memorial  Medical College and T eaching Hospital, Kathmandu,  2Department  of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences,  Kathmandu, NepalAbstract: Chromobacterium violaceum is a gram negative saprophytic bacterium, prevalent in  tropical and subtropical climates.",Non-OADS,/arxiv_data1/oa_pdf/b2/95/ijgm-9-441.PMC5147401.pdf
"Written informed consent was taken from the patient for necessary investigations  and case publication in scientific journal.Correspondence: Narayan Prasad Parajuli Department of Clinical Laboratory Services, Manmohan Memorial Medical College and Teaching Hospital, Swoyambhu 15, Kathmandu, NepalTel +977 1 98 4728 2145Email narayan.parajuli@iom.edu.npJournal name: International Journal of General Medicine Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Parajuli et alRunning head recto: Bacteremia caused by a rare pathogenDOI: http://dx.doi.org/10.2147/IJGM.S125183",Non-OADS,/arxiv_data1/oa_pdf/b2/95/ijgm-9-441.PMC5147401.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b2/95/ijgm-9-441.PMC5147401.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 446 Parajuli et al References  1.,Non-OADS,/arxiv_data1/oa_pdf/b2/95/ijgm-9-441.PMC5147401.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/0b/dddt-10-3969.PMC5147402.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3969–3976Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3969Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11159 0 Paracetamol sharpens reflection and spatial  memory: a double-blind randomized controlled  study in healthy volunteers gisèle Pickering1–3 nicolas Macian1,2 claude Dubray1–3 Bruno Pereira4 1University hospital, chU clermont- Ferrand, centre de Pharmacologie  clinique, 2inserm, cic 1405, UM r  neurodol 1107, 3clermont Université,   laboratoire de Pharmacologie, Faculté  de médecine, 4chU de clermont- Ferrand, Délégation recherche  clinique innovation, clermont- Ferrand, FranceBackground:  Acetaminophen (APAP, paracetamol) mechanism for analgesic and antipyretic  outcomes has been largely addressed, but APAP action on cognitive function has not been  studied in humans.",Non-OADS,/arxiv_data1/oa_pdf/66/0b/dddt-10-3969.PMC5147402.pdf
"AM404 has   been shown to have analgesic properties and is a potent activator of transient receptor correspondence: gisèle Pickering Faculty of Medicine, clinical  Pharmacology centre, Bâtiment  3c, chU of clermont-Ferrand, 58  Montalembert road, 63001 clermont- Ferrand cedex, France Tel +33 4 7317 8416 Fax +33 4 7317 8412 email gisele.pickering@udamail.f r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Pickering et al Running head recto: Paracetamol and cognitive function DOI: http://dx.doi.org/10.2147/DDDT.S111590",Non-OADS,/arxiv_data1/oa_pdf/66/0b/dddt-10-3969.PMC5147402.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/66/0b/dddt-10-3969.PMC5147402.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/0b/dddt-10-3969.PMC5147402.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/dc/ndt-12-3069.PMC5147403.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3069–3072Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3069LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12486 7 Global economic burden of schizophrenia:  letter in response Amanda L Neil1 Vaughan J Carr2,3 1Menzies Institute for Medical  research, University of Tasmania,   Hobart, Tasmania, 2research Unit for  Schizophrenia epidemiology, School of  Psychiatry, University of New South  Wales, Sydney, New South Wales,   3Department of Psychiatry, School of  Clinical Sciences, Monash University,   Melbourne, Victoria, AustraliaDear editor In reference to the recent systematic review by Chong et al1 on cost-of-illness studies  in schizophrenia, we seek to highlight the limited scope and apparent inconsistencies  embedded within this review.",Non-OADS,/arxiv_data1/oa_pdf/6f/dc/ndt-12-3069.PMC5147403.pdf
"We also noted that productivity losses due to suicide were separately estimated within  the context of the analysis, although excluded from the total costs we presented.Correspondence: Amanda L Neil Menzies Institute for Medical research,  University of Tasmania, 17 Liverpool St,  Hobart, Tasmania 7000, Australia Tel +61 3 6226 4640 email a manda.neil@utas.edu.a u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Neil and Carr Running head recto: Letter to the editor “Global economic burden of schizophrenia: review” DOI: http://dx.doi.org/10.2147/NDT.S124867",Non-OADS,/arxiv_data1/oa_pdf/6f/dc/ndt-12-3069.PMC5147403.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6f/dc/ndt-12-3069.PMC5147403.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/dc/ndt-12-3069.PMC5147403.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/idr-9-269.PMC5147404.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ff/60/idr-9-269.PMC5147404.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 269–274Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 269 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S122879Availability, perceptions, and characteristics of  antibiograms among Illinois pediatricians Kathryn M Spiekerman1 Sameer J Patel2,3 Rupal Patel4 Larry K Kociolek2,3 1School of Public Health, University  of Illinois at Chicago, 2Division of  Pediatric Infectious Diseases, Ann &  Robert H. Lurie Children’s Hospital of Chicago,  3Department of Pediatrics,   Northwestern University Feinberg School of Medicine,  4Department  of Pharmacy, Ann & Robert H. Lurie Children’s Hospital of Chicago,  Chicago, IL, USAAbstract:  Despite the enormous volume of antibiotics prescribed by pediatricians, resources  to promote judicious antibiotic use are primarily limited to hospitals.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/idr-9-269.PMC5147404.pdf
"While outpatient ASPs utilizing audit and feedback are an effective resource for  optimizing antibiotic use,12 pediatricians may be skeptical of outpatient ASPs,13 and  the benefits of this intervention may not persist once it is discontinued.14 Because of Correspondence: Larry K Kociolek Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital of Chicago, 225 E. Chicago Ave, Box 20, Chicago, IL 60611, USATel +1 312 227 4080Fax +1 312 227 9709Email Larry-Kociolek@northwestern.eduJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Spiekerman et alRunning head recto: Availability, perceptions, and characteristics of antibiogramsDOI: http://dx.doi.org/10.2147/IDR.S122879",Non-OADS,/arxiv_data1/oa_pdf/ff/60/idr-9-269.PMC5147404.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/idr-9-269.PMC5147404.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 274 Spiekerman et al,Non-OADS,/arxiv_data1/oa_pdf/ff/60/idr-9-269.PMC5147404.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/f6/ott-9-7373.PMC5147405.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7373–7384OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7373Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11827 2 curcumin sensitizes human gastric cancer cells  to 5-fluorouracil through inhibition of the NF κB  survival-signaling pathway Yanting Kang1,2,* Wanle hu3,* encheng Bai1,2 hailun Zheng1 Zhiguo liu1 Jianzhang Wu1 rong Jin2 chengguang Zhao1 guang liang1 1chemical Biology research center,   School of Pharmaceutical Sciences,   2Department of Epidemiology, First  Affiliated Hospital, 3Department of  Coloproctology, Second Affiliated  hospital, Wenzhou Medical University,   Wenzhou, Zhejiang, china *These authors contributed equally  to this workAbstract:  Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent for gastric  cancer (GC).",Non-OADS,/arxiv_data1/oa_pdf/59/f6/ott-9-7373.PMC5147405.pdf
"I κBα, an inhibitor of NF κB, secludes correspondence: chengguang Zhao;  rong Jin chemical Biology research center,  School of Pharmaceutical Sciences,  Wenzhou Medical University, chashan,  Wenzhou 325035, china; Department  of Epidemiology, First Affiliated Hospital,  Wenzhou Medical University, chashan,  Wenzhou 325035, china Tel +86 577 8669 9892 Fax +86 577 8668 9982 email zhaocheng.uang@163.co m;   jinrongjrjr@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kang et al Running head recto: Curcumin mediates chemosensitization to 5-FU DOI: http://dx.doi.org/10.2147/OTT.S118272",Non-OADS,/arxiv_data1/oa_pdf/59/f6/ott-9-7373.PMC5147405.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/59/f6/ott-9-7373.PMC5147405.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/f6/ott-9-7373.PMC5147405.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/7f/opth-10-2427.PMC5147406.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2427–2432Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2427Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12210 7 Phacoemulsification without preoperative  mydriasis in patients with age-related cataract  associated with type 2 diabetes rajesh subhash Joshi Department of Ophthalmology,   Vasantrao naik government Medical  College, Yavatmal, indiaAim:  To study the effect of intracameral injection of preservative-free lignocaine to induce  pupil dilatation, without using any preoperative dilating eyedrops or intraoperative mydriatics  in patients with age-related cataract associated with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/6f/7f/opth-10-2427.PMC5147406.pdf
"Duration and control of diabetes are important factors in cataract development.3–6Correspondence: rajesh subhash Joshi Department of Ophthalmology,  Vasantrao naik government Medical  College, Yavatmal-4000001, india email jrajesh5@rediffmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Joshi Running head recto: Phacoemulsification without preoperative mydriasis DOI: http://dx.doi.org/10.2147/OPTH.S122107",Non-OADS,/arxiv_data1/oa_pdf/6f/7f/opth-10-2427.PMC5147406.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6f/7f/opth-10-2427.PMC5147406.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/7f/opth-10-2427.PMC5147406.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/22/3f/ijn-11-6471.PMC5147407.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6471–6483International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6471OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11429 5 Polycaprolactone nanofibrous mesh reduces  foreign body reaction and induces adipose flap  expansion in tissue engineering chamber lin luo1,* Yunfan he1,2,* Qiang Chang1,2 gan Xie1 Weiqing Zhan1 Xuecen Wang1 Tao Zhou1 Malcolm Xing2,3 Feng lu1 1Department of Plastic surgery,   Nanfang Hospital, Southern Medical  University, Guangzhou, People’s  Republic of China; 2Department of  Mechanical Engineering, Biochemistry  and Medical genetics, University  of Manitoba, Winnipeg, Manitoba,   canada, 3Children’s Hospital  Research Institute of Manitoba,   Winnipeg, Manitoba, Canada *These authors contributed equally  to this workAbstract:  Tissue engineering chamber technique can be used to generate engineered adipose  tissue, showing the potential for the reconstruction of soft tissue defects.",Non-OADS,/arxiv_data1/oa_pdf/22/3f/ijn-11-6471.PMC5147407.pdf
"Based on Fick’s diffusion theory, cells at a distance of more than  200 μm from a blood vessel or capillary in vivo are either inactive or necrotic due  to the limitations of nutrient diffusion.6–8 In 2003, the tissue engineering chamber  technique was introduced, which involves embedding a vascularized pedicled adi - pose flap in a chamber, making it possible to generate mature, vascularized, and correspondence: Feng lu Department of Plastic and Aesthetic  Surgery, Nanfang Hospital of Southern  Medical University, 1838 North  Guangzhou Avenue, Guangzhou,  Guangdong 510515, People’s Republic  of China email lufengmail2005@hotmail.co m  Malcolm Xing Department of Mechanical Engineering,  Biochemistry and Medical Genetics,  University of Manitoba and Children’s  Hospital Research Institute of Manitoba,  Winnipeg, MB, Canada email malcolm.xing@umanitoba.c a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Luo et al Running head recto: Tissue engineering chamber generates engineered adipose tissue DOI: http://dx.doi.org/10.2147/IJN.S114295",Non-OADS,/arxiv_data1/oa_pdf/22/3f/ijn-11-6471.PMC5147407.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/22/3f/ijn-11-6471.PMC5147407.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/3f/ijn-11-6471.PMC5147407.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/f0/ppa-10-2459.PMC5147408.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2459–2469Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2459OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11934 8 The employee’s productivity in the health care  sector in Poland and their impact on the  treatment process of patients undergoing elective  laparoscopic cholecystectomy Anna rosiek,1,2 Aleksandra  rosiek-Kryszewska,3  Łukasz Leksowski,4 Tomasz  Kornatowski,2 Krzysztof  leksowski2,5 1ross-Medica, 2Faculty of health sciences,   Public health Department, nicolaus  copernicus University, 3Faculty of  Pharmacy, Department of  inorganic and  Analytical chemistry, nicolaus copernicus  University, 4Faculty of health sciences,   Department of rehabilitation, nicolaus  copernicus University, 5Department of  general Thoracic and Vascular surgery,   Military clinical hospital in Bydgoszcz,   Bydgoszcz, PolandBackground:  Increasing the engagement of employees in the treatment process of patients may  benefit a hospital and employee productivity and may result in better patient care and satisfaction  with medical services.",Non-OADS,/arxiv_data1/oa_pdf/19/f0/ppa-10-2459.PMC5147408.pdf
"The health  care organizations are encouraged to form an accountable  care organization – a concept designed to overhaul the nation’s health care system by  implementing structures that monitor the quality and efficiency of entire groups of correspondence: Anna rosiek Faculty of health sciences, Public health  Department, nicolaus copernicus University  in Toruń, Przodowników Pracy 8/7,  85-843 Bydgoszcz, Poland Tel +48 668 327 327 email ania.rosiek@wp.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rosiek et al Running head recto: Employee’s productivity in the health care sector in Poland DOI: http://dx.doi.org/10.2147/PPA.S119348 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/19/f0/ppa-10-2459.PMC5147408.pdf
Or use: http://youtu.be/hv-081fAlx 4Video abstract,Non-OADS,/arxiv_data1/oa_pdf/19/f0/ppa-10-2459.PMC5147408.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/19/f0/ppa-10-2459.PMC5147408.pdf
Available from: http://www.findarticles.com/p/articles/ mi_m4467/is_200801/ai_n2130272 0.,Non-OADS,/arxiv_data1/oa_pdf/19/f0/ppa-10-2459.PMC5147408.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/0b/ijn-11-6459.PMC5147409.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6459–6470International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6459OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11758 4 Biocompatibility and antibacterial activity  of nitrogen-doped titanium dioxide nanoparticles  for use in dental resin formulations andrew Zane1 ranfang Zuo2 Frederick a Villamena3 antal rockenbauer4,5 ann Marie Digeorge  Foushee1 Kristin Flores1 Prabir K Dutta2 amber Nagy1 1Biomaterials and environmental  surveillance Department, Naval  Medical research Unit san  antonio, Joint Base san antonio,   Fort sam houston, san antonio,   TX, 2Department of chemistry  and Biochemistry, 3Department  of Biological chemistry and  Pharmacology, Davis heart and  lung research Institute, college  of Medicine, The Ohio state  University, columbus, Oh, Usa;   4research centre for Natural  sciences of the hungarian academy  of sciences, Institute of Materials  and environmental chemistry,   5Department of Physics, MT a-BMe  condensed Matter research group,   Budapest University of T echnology  and economics, Budapest, hungaryAbstract:  The addition of antibacterial functionality to dental resins presents an opportunity  to extend their useful lifetime by reducing secondary caries caused by bacterial recolonization.",Non-OADS,/arxiv_data1/oa_pdf/29/0b/ijn-11-6459.PMC5147409.pdf
"Overall failure rates during  this time period are as high as 45%.3 The acidic conditions associated with secondary caries primarily affect the remain - ing tooth, but not the restoration material.4 Streptococcus mutans  biofilms grown on  a resin–dentin interface cause a significant reduction in fatigue resistance of the joint  material due to degradation of dentin at the resin–dentin interface.5 The incorporation correspondence: amber Nagy Naval Medical research Unit san  antonio, 3650 chambers Pass, JBsa  Ft. sam houston, san antonio,  TX 78234, Usa Tel +1 210 539 7017 email amber.m.mallory2.civ@mail.mi l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zane et al Running head recto: Biocompatibility and antibacterial activity of N-doped TiO2 NPs DOI: http://dx.doi.org/10.2147/IJN.S117584",Non-OADS,/arxiv_data1/oa_pdf/29/0b/ijn-11-6459.PMC5147409.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/29/0b/ijn-11-6459.PMC5147409.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/0b/ijn-11-6459.PMC5147409.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/93/ndt-12-3093.PMC5147410.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3093–3095Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3093LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12194 6 Age-related issues of instruments screening  for autism in young children Loretta Thomaidis Antigoni Choleva Miltiades Kyprianou Second Department of Paediatrics,   Developmental Assessment Unit,   “P .",Non-OADS,/arxiv_data1/oa_pdf/3d/93/ndt-12-3093.PMC5147410.pdf
"& A.  Kyriakou” Children’s Hospital, National  and Kapodistrian University of Athens,  School of Medicine, 18, Makrinitsas  Street, Athens 11522, Greece Tel +30 697 744 0480 email miltosk@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Thomaidis et al Running head recto: Instruments screening issues for autism in children DOI: http://dx.doi.org/10.2147/NDT.S121946",Non-OADS,/arxiv_data1/oa_pdf/3d/93/ndt-12-3093.PMC5147410.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3d/93/ndt-12-3093.PMC5147410.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/93/ndt-12-3093.PMC5147410.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/3b/copd-11-3043.PMC5147412.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3043–3050International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3043RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S12243 3 effects of aclidinium on determinants of COPD  severity: symptoms and quality of life Marco Contoli1 Paolo Solidoro2 Fabiano Di Marco3,4 Nicola Scichilone5 Angelo Corsico6 Fulvio Braido7 Pierachille Santus4,8 1Research Centre on Asthma and  COPD, Department of Medical  Sciences, University of Ferrara,   Ferrara, Italy; 2Cardiovascular and  Thoracic Department, Città della  Salute, T urin, Italy; 3Department  of Health Sciences, University of  Milan, Milan, Italy; 4Respiratory Unit,   San Paolo Hospital, Milan, Italy;   5Department of Internal Medicine,   Section of Pulmonology (DIBIMIS),   University of Palermo, Palermo, Italy;   6Department of Molecular Medicine,   Fondazione IRCCS Policlinico San  Matteo, Pavia, Italy; 7Allergy and  Respiratory Diseases Clinic, DIMI,   University of Genoa, IRCS AOU San  Martino-IST, Genoa, Italy; 8Pulmonary  Rehabilitation Unit, Fondazione  Salvatore Maugeri, Scientific Institute  of Milan-IRCCS, Milan, ItalyAbstract:  The pathophysiology of chronic obstructive pulmonary disease (COPD) includes  persistent airflow limitation, altered gas exchange, and enhanced chronic inflammatory  response.",Non-OADS,/arxiv_data1/oa_pdf/5b/3b/copd-11-3043.PMC5147412.pdf
"Aclidinium bromide was approved by the European  Medicines Agency and the US Food and Drug Administration in 2012 for mainte - nance bronchodilator treatment in stable adult patients with COPD.3 Aclidinium has  high affinity for all five muscarinic receptors and a lower potential for anticholinergic  adverse events.4Correspondence: Pierachille Santus UOC Pneumologia, Ospedale L. Sacco,  via G.B Grassi, 74, 20157 Milan, Italy Tel +39 02 3904 3401 Fax +39 02 3904 2372 email pierachille.santus@unimi.i t Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Contoli et al Running head recto: Aclidinium on QoL of COPD patients DOI: http://dx.doi.org/10.2147/COPD.S122433",Non-OADS,/arxiv_data1/oa_pdf/5b/3b/copd-11-3043.PMC5147412.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5b/3b/copd-11-3043.PMC5147412.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/3b/copd-11-3043.PMC5147412.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/3f/ijn-11-6517.PMC5147414.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6517–6531International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6517OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11265 8 Peg- b-Pcl polymeric nano-micelle inhibits  vascular angiogenesis by activating p53-dependent  apoptosis in zebrafish Tian Zhou1 Qinglei Dong1 Yang shen2 Wei Wu1 haide Wu1 Xianglin luo3 Xiaoling liao4 guixue Wang1 1Key laboratory for Biorheological  science and Technology of Ministry  of education, state and local Joint  engineering laboratory for Vascular  Implants, Bioengineering college of  chongqing University, chongqing,   2Institute of Biomedical engineering,   school of Preclinical and Forensic  Medicine, sichuan University, 3college  of Polymer science and engineering,   sichuan University, chengdu, sichuan,   4chongqing Key laboratory of Nano/ Micro composite Materials and  Devices, school of Metallury and  Materials engineering, chongqing  University of science and T echnology,   chongqing, People’s republic of chinaAbstract:  Micro/nanoparticles could cause adverse effects on cardiovascular system and increase  the risk for cardiovascular disease-related events.",Non-OADS,/arxiv_data1/oa_pdf/5a/3f/ijn-11-6517.PMC5147414.pdf
"Based on this property, increasing efforts have been made to encapsulate correspondence: guixue Wang Bioengineering college of chongqing  University, chongqing University,  174 shazheng st, chongqing 400044,  People’s republic of china Tel +86 23 6510 2508 Fax +86 23 6510 2507 email wanggx@cqu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhou et al Running head recto: PEG- b-PCL nanoparticle inhibits angiogenesis DOI: http://dx.doi.org/10.2147/IJN.S112658",Non-OADS,/arxiv_data1/oa_pdf/5a/3f/ijn-11-6517.PMC5147414.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5a/3f/ijn-11-6517.PMC5147414.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/3f/ijn-11-6517.PMC5147414.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/db/opth-10-2417.PMC5147415.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2417–2425Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2417Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12023 7 The new Bruch’s membrane opening – minimum  rim width classification improves optical coherence  tomography specificity in tilted discs gema rebolleda alfonso Casado noelia Oblanca Francisco J Muñoz-n egrete Department of Ophthalmology,   hospital Universitario ramón y  Cajal, Madrid, spainBackground and objective:  To investigate and compare the false-positive (FP) diagnostic  classification of the Bruch’s membrane opening – minimum rim width (BMO-MRW) and retinal  nerve fiber layer (RNFL) thickness in healthy eyes with tilted optic disc.",Non-OADS,/arxiv_data1/oa_pdf/b9/db/opth-10-2417.PMC5147415.pdf
"Several known factors can affect these measurements such as age, ethnic back - ground, refractive errors, optic disc area, and foveal-disc angle.1–6 Recently, longer axial  length has been significantly associated with an increased incidence of false-positives  (FPs) on ganglion cell analysis (GCA) and RNFL maps after uni- and multivariate  analyses.3–7 Caution is recommended in moderate myopic individuals because a high  percentage can be misclassified as abnormal by RNFL and GCA Cirrus OCT maps.4  A study has reported that Spectralis OCT (Heidelberg Engineering, Dossenheim,  Germany) might be more specific than Cirrus (39% vs 18%) when evaluating RNFL  thickness for Caucasians and moderate myopic population.5 Axial length, mean  spherical equivalent, presence of peripapillary atrophy, and tilted disc were signifi - cantly related to the RNFL FP occurrence displayed by both the devices; therefore,  the degree of myopic optic disc tilt should be considered when interpreting the RNFL  thickness measured by OCT.5,7–10 Clinical features of tilted disc overlap with other Correspondence: alfonso Casado Department of Ophthalmology,  hospital Universitario ramón y Cajal,  Carretera de Colmenar Viejo Km 9,100,  28034 Madrid, spain Tel/fax +34 91 336 81 26 email casadorojo@hotmail.e s Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rebolleda et al Running head recto: Minimum rim width in healthy eyes with tilted optic discs DOI: http://dx.doi.org/10.2147/OPTH.S120237",Non-OADS,/arxiv_data1/oa_pdf/b9/db/opth-10-2417.PMC5147415.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b9/db/opth-10-2417.PMC5147415.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/db/opth-10-2417.PMC5147415.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/50/ndt-12-3083.PMC5147416.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3083–3092Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3083OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12118 3 mir-455 inhibits neuronal cell death by targeting  TraF3 in cerebral ischemic stroke shengtao Yao* Bo Tang* gang li ruiming Fan Fang cao Department of cerebrovascular  Disease, The First affiliated hospital  of Zunyi Medical college, Zunyi,   People’s republic of china *These authors contributed equally  to this workAbstract:  Ischemic stroke is one of the leading causes of brain disease, with high morbidity,  disability, and mortality.",Non-OADS,/arxiv_data1/oa_pdf/80/50/ndt-12-3083.PMC5147416.pdf
"MicroRNAs (miRNAs) are a group of endogenous 18- to 22-nucleotide (nt)-long  non-protein-coding short RNA molecules, which regulate gene expression by rec - ognizing binding sites situated in the 3 ′-untranslated region (3 ′-UTR) of mRNA  targets.6,7 It is well understood that miRNAs are capable of regulating the expression correspondence: Fang cao Department of cerebrovascular  Disease, The First Affiliated Hospital of  Zunyi Medical college, No 149 Dalian  road, Zunyi 563000, guizhou, People’s  republic of china Tel +86 851 2860 9843 email ffanggao@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Y ao et al Running head recto: miR-455 in cerebral ischemic stroke DOI: http://dx.doi.org/10.2147/NDT.S121183",Non-OADS,/arxiv_data1/oa_pdf/80/50/ndt-12-3083.PMC5147416.pdf
"TraF3 was a functional target of  mir-455 To define the target genes by which miR-455 regulates neu - ronal cell death, miRBase ( http://www.mirbase.org /) and  TargetScan 5.1 ( http://www.targetscan.org /) miRNA data - bases were applied.",OADS,/arxiv_data1/oa_pdf/80/50/ndt-12-3083.PMC5147416.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/80/50/ndt-12-3083.PMC5147416.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/50/ndt-12-3083.PMC5147416.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 661–670Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 661 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S116618 Evaluating an undergraduate interprofessional  education session for medical and pharmacy  undergraduates on therapeutics and prescribing:  the medical student perspective Bethany M Shelvey1 Sion A Coulman2 Dai N John2 1School of Medicine, 2School of  Pharmacy and Pharmaceutical  Sciences, Cardiff University, Cardiff,  Wales, UKBackground: The current literature on undergraduate interprofessional education (IPE) for  pharmacy and medical students highlights a range of positive outcomes, although to date IPE  has focused predominantly on student views and experiences of IPE sessions with these opinions  being sought at the end of the sessions.",Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
"Keywords: learning, case-based, medical education, pharmacist, qualitative research, thematic  analysis Introduction A commonly used definition for interprofessional education (IPE) is provided by  the UK Centre for the Advancement of IPE (CAIPE)1: “Interprofessional Education  occurs when two or more professions learn with, from, and about each other to improve collaboration and the quality of care.” 2 IPE is a broad term encompassing initiatives  between professionals in the workplace and between students in universities and other Correspondence: Dai N John School of Pharmacy and Pharmaceutical Sciences, Redwood, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UKTel +44 29 2087 5804Fax +44 29 2087 4149Email Jondn@cardiff.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Shelvey et alRunning head recto: Undergraduate medic pharmacy therapeutics and prescribing IPEDOI: http://dx.doi.org/10.2147/AMEP .S116618 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Or use: http://youtu.be/-ivHW--aG1c,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available from: http://dera.ioe.ac.uk/13612/1/Working%20together%20-%20learning%20together%20dept.%20of%20health.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available from: http://www.biomedcentral.com/1472-6920/14/52.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available from: http://www.gmc-uk.org/education/standards.asp.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 670 Shelvey et al 31.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available from: http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available from: http://www.gmc-uk.org/FINAL_Report_prevalence_and_causes_of_prescribing_errors.pdf_28935150.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available  from: http://medicine.cf.ac.uk/media/filer_public/2013/08/22/c21intro.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
Available from: http://epubs.surrey.ac.uk/1195/1/fulltext.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/amep-7-661.PMC5147417.pdf
"Clinicians, policymakers, and payers see CG as a  tool for making care more consistent and efficient and for closing the gap between what clinicians do Korean J Thorac Cardiovasc Surg 2016;49:413-420 □ REVIEW □ https://doi.or g/10.5090/k jtcs.2016.49.6.413",Non-OADS,/arxiv_data1/oa_pdf/dd/56/kjtcv-49-413.PMC5147465.pdf
Our center has used right anterolateral thoracotomy Korean J Thorac Cardiovasc Surg 2016;49:421-426 □ CLINICAL RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.6.421,Non-OADS,/arxiv_data1/oa_pdf/0a/04/kjtcv-49-421.PMC5147466.pdf
The occurrence of CKD is also known as an important Korean J Thorac Cardiovasc Surg 2016;49:427-434 □ CLINICAL RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.6.427,Non-OADS,/arxiv_data1/oa_pdf/2c/f9/kjtcv-49-427.PMC5147467.pdf
"In this study, we attempted to find fac- t o r s  a f f e c t i n g  t h e  p r o g n o s i s  o f  p a t i e n t s  w i t h  b l u n t   traumatic cardiac rupture.Korean J Thorac Cardiovasc Surg 2016;49:435-442 □ CLINICAL RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.6.435",Non-OADS,/arxiv_data1/oa_pdf/dc/ea/kjtcv-49-435.PMC5147468.pdf
Though patients with BAV disease can live with-Korean J Thorac Cardiovasc Surg 2016;49:443-450 □ CLINICAL RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.6.443,Non-OADS,/arxiv_data1/oa_pdf/9e/6b/kjtcv-49-443.PMC5147469.pdf
Most studies on SS have  regarded pulmonary metastasectomy as a good prog-Korean J Thorac Cardiovasc Surg 2016;49:451-455 □ CLINICAL RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.6.451,Non-OADS,/arxiv_data1/oa_pdf/c9/ac/kjtcv-49-451.PMC5147470.pdf
"Of these, 11 patients underwent thoraco- scopic diaphragmatic plication between January 2008 Korean J Thorac Cardiovasc Surg 2016;49:456-460 □ CLINICAL RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.6.456",Non-OADS,/arxiv_data1/oa_pdf/b3/1e/kjtcv-49-456.PMC5147471.pdf
"After the  induction of general anesthesia, a pulmonary arterial  catheter was placed via the left internal jugular vein, Korean J Thorac Cardiovasc Surg 2016;49:461-464 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.461",Non-OADS,/arxiv_data1/oa_pdf/31/8b/kjtcv-49-461.PMC5147472.pdf
"In 2012, the patient presented with back pain, ab-Korean J Thorac Cardiovasc Surg 2016;49:465-467 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.465",Non-OADS,/arxiv_data1/oa_pdf/50/39/kjtcv-49-465.PMC5147473.pdf
"Emergency open re-pair was necessary due to the rapid growth of the  mass observed over 3 days, and was accomplished  by the thoracic and cardiovascular surgery depart-Korean J Thorac Cardiovasc Surg 2016;49:468-471 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.468",Non-OADS,/arxiv_data1/oa_pdf/a8/fd/kjtcv-49-468.PMC5147474.pdf
"With extracorporeal  membrane oxygenator (ECMO) assistance, the patient Korean J Thorac Cardiovasc Surg 2016;49:472-474 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.472",Non-OADS,/arxiv_data1/oa_pdf/24/9d/kjtcv-49-472.PMC5147475.pdf
"However, the abdominal CT scan  from the previous admitting hospital showed multi- ple, variable sized, cystic lung lesions, suggesting pul-Korean J Thorac Cardiovasc Surg 2016;49:475-477 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.475",Non-OADS,/arxiv_data1/oa_pdf/ab/40/kjtcv-49-475.PMC5147476.pdf
After the Korean J Thorac Cardiovasc Surg 2016;49:478-480 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.478,Non-OADS,/arxiv_data1/oa_pdf/3a/f0/kjtcv-49-478.PMC5147477.pdf
"A large, right Korean J Thorac Cardiovasc Surg 2016;49:481-484 □ CASE REPORT □ https://doi.or g/10.5090/k jtcs.2016.49.6.481",Non-OADS,/arxiv_data1/oa_pdf/b8/7c/kjtcv-49-481.PMC5147478.pdf
"In detail, the first three-stitch  continuous suture is placed counterclockwise at the heel of the graft and at the proximal end of the cor-Korean J Thorac Cardiovasc Surg 2016;49:485-488 □ HOW-TO-DO IT □ https://doi.or g/10.5090/k jtcs.2016.49.6.485",Non-OADS,/arxiv_data1/oa_pdf/21/4d/kjtcv-49-485.PMC5147479.pdf
A sixth suture without pledgeting was Korean J Thorac Cardiovasc Surg 2016;49:489-492 □ HOW-TO-DO IT □ https://doi.or g/10.5090/k jtcs.2016.49.6.489,Non-OADS,/arxiv_data1/oa_pdf/15/ed/kjtcv-49-489.PMC5147480.pdf
"Sao Paulo 2016;58:86 http://dx.doi.org/10.1590/S1678-9946201658086 ORIGINAL ARTICLE RISK FACTORS ASSOCIATED WITH AMERICAN CUTANEOUS LEISHMANIASIS   IN AN ENDEMIC AREA OF BRAZIL Alberon Ribeiro de ARAUJO(1,2), N airomberg Cavalcanti PORTELA(1), Ana Paula Sampaio FEITOSA(1,2), O tamires Alves da SILV A(1),   Ricardo Andrade Arraes XIMENES(2), L uiz Carlos ALVES(1) & F ábio André BRAYNER(1,2) SUMMARY  Brazil is among the top five countries worldwide regarding the number of cases of leishmaniasis, which are present in all of the  regions of the country.",Non-OADS,/arxiv_data1/oa_pdf/b0/49/0036-4665-rimtsp-58-e86.PMC5147716.pdf
Available  from: http://dtr2004.saude.gov.br/sinanweb/  4.,Non-OADS,/arxiv_data1/oa_pdf/b0/49/0036-4665-rimtsp-58-e86.PMC5147716.pdf
Available from:  http://cidades.ibge.gov.br/painel/historico.php?lang=&codmun=261530  10.,Non-OADS,/arxiv_data1/oa_pdf/b0/49/0036-4665-rimtsp-58-e86.PMC5147716.pdf
"Sao Paulo 2016;58:87 http://dx.doi.org/10.1590/S1678-9946201658087 ORIGINAL ARTICLE SAND FLIES (DIPTERA: PSYCHODIDAE) IN AN ENDEMIC AREA OF LEISHMANIASIS IN AQUIDAUANA   MUNICIPALITY, PANTANAL  OF MATO GROSSO DO SUL , BRAZIL Helen Rezende de FIGUEIREDO(1), Mirella Ferreira da Cunha SANTOS(2), Aline Etelvina CASARIL(1,3), Jucelei Oliveira de Moura INFRAN(3),   Leticia Moraes RIBEIRO(3), Carlos Eurico dos Santos FERNANDES(4) & Alessandra Gutierrez de OLIVEIRA(1,3) SUMMARY The Aquidauana  municipality is considered an endemic area of leishmaniasis and an important tourist site in Mato Grosso do Sul   State.",Non-OADS,/arxiv_data1/oa_pdf/e4/b4/0036-4665-rimtsp-58-e87.PMC5147717.pdf
Available from: http://cidades.ibge.gov.br/ xtras/perfil.php?codmun=500110.,OADS,/arxiv_data1/oa_pdf/e4/b4/0036-4665-rimtsp-58-e87.PMC5147717.pdf
Available  from: http://www.fsp.usp.br/egalati/ApostilaPhlebotominae_2014_vol_I.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/b4/0036-4665-rimtsp-58-e87.PMC5147717.pdf
"Sao Paulo 2016;58:88 http://dx.doi.org/10.1590/S1678-9946201658088 ORIGINAL ARTICLE GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF   Helicobacter pylori- INFECTED EGYPTIAN PATIENTS Iman RAMZY(1), Hassan ELGAREM(1), Iman HAMZA(1), Doaa GHAITH(2), Tamer ELBAZ(1), Waleed ELHOSARY(1),   Gehan MOSTAFA(1) & Mohammad A. Mohey Eldin ELZAHRY(1) SUMMARY Introduction: Several genetic mutations affect the first-line triple therapy for  Helicobacter pylori .",Non-OADS,/arxiv_data1/oa_pdf/96/8c/0036-4665-rimtsp-58-e88.PMC5147718.pdf
"Sao Paulo 2016;58:89 http://dx.doi.org/10.1590/S1678-9946201658089 ORIGINAL ARTICLE DETECTION OF HUMAN ANTI-ZIKA VIRUS IgG BY ELISA USING AN ANTIGEN FROM in vitro   INFECTED VERO CELLS: PRELIMINARY RESULTS Laura Masami SUMITA(1), Jaqueline Polizeli RODRIGUES(2), Noely Evangelista FERREIRA(1), Alvina Clara FELIX(1),   Nathalia Caroline Santiago SOUZA(1), Clarisse Martins MACHADO(1) & Heitor Franco de ANDRADE JÚNIOR(2) SUMMARY Zika virus (ZKV) infection is a huge public health problem in Brazil because of the increased incidence of microcephaly in  neonates from infected mothers.",Non-OADS,/arxiv_data1/oa_pdf/fc/f1/0036-4665-rimtsp-58-e89.PMC5147719.pdf
"Sao Paulo 2016;58:90 http://dx.doi.org/10.1590/S1678-9946201658090 CASE REPORT VERTICAL TRANSMISSION OF DENGUE INFECTION: THE FIRST PUTATIVE   CASE REPORTED IN CHINA Xueru YIN(1), Xiaozhu ZHONG(2) & Shilei PAN(3) SUMMARY Dengue is a systemic viral infection that is commonly transmitted between humans via mosquitoes.",Non-OADS,/arxiv_data1/oa_pdf/82/77/0036-4665-rimtsp-58-e90.PMC5147720.pdf
"Sao Paulo 2016;58:91 http://dx.doi.org/10.1590/S1678-9946201658091 LETTER TO THE EDITOR REPORTING DELAY DURING THE YELLOW FEVER OUTBREAK, ANGOLA, 2016 Sao Paulo, October 17, 2016 Dear Editor A yellow fever outbreak was detected in Angola late in December 2015 and was confirmed by the National Institute for Communicable Diseases  in South Africa and Institut Pasteur of Dakar, Senegal in 20 January 20161.",Non-OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
Available from: http://www.who.int/emergencies/yellow-fever/mediacentre/timeline/en/  2.,Non-OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
Available from: http://apps.who.int/iris/bitstream/10665/250254/1/yellowfeversitrep30Sep16-eng.,OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
Available from:  http://www.afro.who.int/en/yellow-fever/sitreps/item/9039-situation-report-yellow-fever-outbreak-in-angola-11-september-2016.html  4.,Non-OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
Available from: http://apps.who.int/iris/bitstream/10665/246103/1/WHO-YF-ENB-16.2-eng.,OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
Available from: http://www.afro.who.int/en/yellow-fever/sitreps/  6.,Non-OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
Available from:  http://www.afro.who.int/en/yellow-fever/sitreps/item/8744-situation-report-yellow-fever-outbreak-in-angola-13-june-2016.html  7.,Non-OADS,/arxiv_data1/oa_pdf/e3/05/0036-4665-rimtsp-58-e91.PMC5147721.pdf
"Sao Paulo 2016;58:92 http://dx.doi.org/10.1590/S1678-9946201658092 LETTER TO THE EDITOR ALTERNATIVE METHODS FOR SEQUENCING FULL TSPyV GENOMES USING SANGER OR NGS Sao Paulo, 22 July, 2016 Dear Editor The trichodysplasia-spinulosa polyomavirus-associated (TSPyV)  was first described in a solid organ transplant recipient with a rare skin  disease1.",Non-OADS,/arxiv_data1/oa_pdf/ad/b7/0036-4665-rimtsp-58-e92.PMC5147722.pdf
Similarity analysis was done using the Blast  tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to assure that the primers  do not bind to other polyomaviruses.,OADS,/arxiv_data1/oa_pdf/ad/b7/0036-4665-rimtsp-58-e92.PMC5147722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/2f/main.PMC5147748.pdf
"Additionally, β-arrestin 2 overexpression prevents elevated levels of myocardial gp130 and p38 MAPK phosphoryla- tion in polymicrobial sepsis.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.05.021 2405-5808/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/24/2f/main.PMC5147748.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/2f/main.PMC5147748.pdf
Appendix A. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/main.PMC5147748.pdf
"The full terms of this license are available at https:// www.dovepress.com/terms.php  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License  (http://creativecommons.org/licenses/by-nc/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/67/cb/nihms798043.PMC5147752.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php ).",Non-OADS,/arxiv_data1/oa_pdf/67/cb/nihms798043.PMC5147752.pdf
